Biodata March 19

Prof.
Sarman Singh
Director & CEO,
All India Institute of Medical Sciences, Bhopal
Curriculum Vitae
Index of Contents
Title/chapter Page No
• Personal and educational details 1-2
• Positions Held 3
• Major Research Areas and Fellowships awarded 3
• Awards and Honours 4-7
• External Examiner for Universities/Institutions 7

• Office bearer of Medical & Scientific Societies, Administrative committees and
other bodies 8-10
• Referee for Scientific Journals and Research Grant Proposals 11-12
• Member of Medical and Scientific Societies, Editorial Boards 13
• Conferences / Workshops/ meetings attended/ papers presented 13-28
• Postgraduate Students Guided 28-34
• Short-term/hands-on trainings provided 34-35
• Scientific Conferences, Meeting and Medical Camps Organised 35-37
• Research Projects Directed 38-42
• Patents 42-43
• Gene Sequences and Whole genome Sequences submitted to NCBI 43
• Publications: 44-80
• Mass Awareness Publications/ films 81
1 of 81
Detailed Curriculum Vitae
Name: Prof. Sarman Singh
Date of Birth: November 9, 1956
Position & Affiliation: Director & CEO,

All India Institute of Medical Sciences,
Bhopal, (MP)
Postal Address: Director’s Bungalow , AIIMS Campus,

Saket Nagar
Bhopal-462020.
Madhya Pradesh
Phone: (Office) (+91) 0755- 2672317
Email: [email protected]
[email protected]
Webpage: http://www.drsarmansingh.com
Qualifications: University Degree with date:
B.Sc. Agra University 1976
M.B.B.S. KGMC, Lucknow 1982

D.H.A. (Dip. Hosp. Adm.) YMCA, New Delhi 1985
M.D. (Medical Microbiology) PGIMER, Chandigarh 1987

Post Graduate Course Epidemiology Univ. Michigan (USA) 1990
(Infectious Diseases)
2 of 81
Appointments in chronological order:
Appointment From To
Internship, Aligarh, UP 1-12-82 30-11-83
Junior Resident (Ortho) RML Hospital, New Delhi 01-01-84 31-12-84
Junior Resident (Clinical Microbiology), PGIMER, Chandigarh 01-01-85 31-12-87
Senior Resident (Clinical Microbiology), AIIMS, New Delhi 12-1-88 31-08-90
Assist. Professor (Clinical Microbiology) AIIMS, New Delhi 31-8-90 30-06-95
Overseas Research Associate (DBT), Chicago, USA 01-01-94 01-01-95
Assoc. Professor (Clinical Microbiology) AIIMS, New Delhi 01-07-95 30-06-99
National Consultant (HIC) WHO/NACO, New Delhi, India 16-07-99 15-02-00
Additional Professor (Clinical Microbiology) AIIMS, New Delhi 01-07-99 30-06-07
Professor & Head (Clinical Microbiology) AIIMS, New Delhi 01-07-07 03-06-2018
Director & CEO, AIIMS, Bhopal 04-06-18 Continue
MAJOR RESEACRH AREAS
• Diagnostic Device Development

• Tuberculosis: molecular epidemiology, diagnostics, MDR/XDR-TB, HIV-TB
• Leishmaniasis
• Toxoplasmosis – human and animal (both)
• HIV/AIDS
• Hepatitis : A, B, C, E
• Human Herpes Viruses
• NTDs: Intestinal Parasitosis
• FELLOWSHIPS
1. Fellow Association for Advanced Veterinary Research, 2017

2. Fellow Royal Society of Chemistry (UK), 2014 (# 556595)
3. Fellow International Medical Sciences Academy, 2009
4. Fellow Indian Academy of Tropical Parasitology, 2008
5. Fellow Royal Society of Tropical Medicine & Hygiene (UK), 2007 (#11868)
6. Fellow National Academy of Medical Sciences, 2006
7. Fellow Society for Immunology & Immunopathology, 2001
3 of 81
AWARDS/ HONOURS
• MAJOR AWARDS
8. Received AIIMS Research Excellence Award for published work on Tuberculosis,

September, 2017.
9. Received Senior Scientist Oration Award of Indian Immunology Society, at the 43rd IIS
Conference at Visakhapatnam, February 2017
10. Received AIIMS Research Excellence Award for best published work, September, 2016
(for Research in Tuberculosis) from Minister of Health & Family Welfare, Government
of India.
11. Received Dr. APJ Abul Kalam Life Time Achievement Award of Society of Bio-
Medical Laboratory Scientists, 2016.
12. Received Research Excellence Award 2015, Indus Foundation, USA/India, November
2015.
13. Received BMJ Excellence Award 2014 (India) for Innovation in Healthcare Technology
14. Received Med-Achiever Award of Indian Medical Association for Innovative Research,
July 2014.
15. Received Chikitsa Ratna Award of Delhi Medical Association, June 2014
16. Received Life Time Achievement Award of the Society for Immunology &
Immunopathology, December 2013.
17. Nominated for the Prestigious Padma Shri Award of Government of India, 2010, 2016.
18. Received Prof. BK Aikat Oration Award of Indian Council of Medical Research, 2008
for his original work on Kala-Azar.
19. Nominated for the Donald Mackay Medal of the American Society for Tropical
Medicine and Hygiene (ASTMH), USA, 2007.
20. Received BC Roy Award (Hari Om Ashram Alembic Research Award) of Medical
Council of India, for the year 2007.
21. Received Vigyan Ratna Samman awarded by Council of Science and technology,
Government of UP, for the year 2006.
22. Received Biotechnology Product, Process and Commercialization Award for
Commercialization of a novel recombinant antigen of Leishmania donovani for the
accurate diagnosis of kala-azar and PKDL. 2006.
23. Received Prof. BP Pandey Memorial Oration Award for Best Teacher in Parasitology,
Indian Society for Parasitology 2006.
24. Received Merit Award 1998 of the International Immunocompromised Host Society
(USA), June 1998, Davos (Switzerland).
25. Received ICMR Award for the work on Parasites in general and Toxoplasma gondii in
particular by the Indian Council of Medical Research, 1996.
26. Received Young Scientist Award 1996 of the International Immunocompromised Host
Society (USA), June 1996, Assisi (Italy).
27. Biotechnology Long Term Overseas Associateship for 1 year Awarded by the Ministry of
Science and Technology, Government of India, to work in USA, 1994-95
28. Received Best Citizen Award of the Best Citizen Publishing House (Delhi) for year 2006
29. Received “Man of the Year 1998” by the American Biographical Institute, Raleigh, USA.
30. Received First prize in Hindi dictation by any faculty member at AIIMS, New Delhi for
year 2006.
4 of 81
31. Task Force Member of SERC (FAST TRACK SCHEME) of Department of Science and
Technology, Government of India. 2004-2007 & again for 2008-2011.
32. Elected Consulting Editor of The contemporary "Who's Who" (USA). 2003.
33. Elected Member of Research Advisory Board 1999, American Biographical Institute,
Raleigh, USA
34. Elected Member of the New York Academy of Sciences, USA, 1997.
35. Awarded Full Scholarship from UNAIDS/Canada Government to present a paper in the
XI International Conference on AIDS, Vancouver, July 1996.
36. Awarded Japan Government Full Scholarship to present a paper in the X International
Conference on AIDS/STD, August 1994.
37. Awarded Young Scientist INSA travel grant to present a paper in the VII International
AIDS Conference, June 1991, Italy.
38. Awarded Young Scientist DST travel grant to attend the VII International AIDS
Conference, June 1991, Italy.
39. Awarded CSIR travel award for obtaining training in Epidemiology of Infectious
Diseases, University of Michigan, USA, 1990.
• OTHER AWARDS/HONOURS
1. Elected President of Indian Association of Medical Microbiologists (Delhi Chapter), for

2016.
2. Elected President of the Society for immunology and Immunopathology, for 3 years
2014-2016.
3. Chairman of the Award committee for best Hindi book writing on medical sciences.
Indian Council of Medical Research, 2013-2016.
4. Chaired the selection committee for Scientist C, at Indian Council of Medical Research,
New Delhi, 2013-2016.
5. Member, Fellowship committee of Indian Council of Medical Research, 2009-2013.
6. Member Expert committee of ICMR for reemployment of retired ICMR scientists, 2010
onward.
7. Member standing selection committee of ICMR for promotion of ICMR Scientists for
grade D, E and F, 2010-onward.
8. Subject Assessor of Medical Council of India, 2010-12
9. Member, Institutional Animal Ethics committee, Panacea Biotech, New Delhi 2010-2011
10. Chairman, Institutional Ethics Committee, of CARE Foundation, Namakkal, Tamilnadu,
2009- onward
11. Member of the Kala-azar elimination High power committee constituted by DGHS, Gov.
of India, 2005-2013.
12. Member Model Rural Health Research Unit (MRHRU), Department of Health Research,
Government of India.
13. Member- Advisory Board, Dr. B. Lal Institute of Biotechnology, Jaipur, 2009-
14. Invited Speaker on HIV-TB co-infection for the World AIDS Conference held at Mexico,
August 2008.
15. Member, Board of Faculty & RDC of Life Sciences, CSJM University, Kanpur, 2007-9.
16. Member of Joint Monitoring Mission of National Vector Borne Disease Control
Programme, Ministry of Health, Government of India, 2007-2008.
17. Chief Guest to inaugurate the Biotechnology Update of IP Degree College of CCS
University, Meerut.
18. Member of the “Scientific Expert Committee on QA/QC Implementation” National
Institute of Biological, Ministry of Health, Government of India, 2006-2009.
5 of 81
19. Member of the Selection Committee for "Rashtriya Gyan Vigyan Maulik Pustak Lekhan
Puruskar Yojana", Ministry of Home Affairs, Govt. of India for the duration of 2002-03
20. Honorary Member and only Representative from India for Prison Healthcare Committee
of Medical Advocates for Social Justice, Argentina., Since 2001.
STUDENTS AWARDED
a. International Fellowships
1. Arshi Munawwar. International Fellowship “HIV Research Trust –Award 2009”
International AIDS Society, Geneva, to work at NIH, USA for 6 months.
b. Shri Mohan Lal Wig Award for Best Clinical Research
1. Dr. Krishnamoorthy Gopinath was awarded this prestigious Award for the year 2008
for his thesis work titled “PCR and sequence based identification of Mycobacterium
sp from extra-pulmonary tuberculosis cases”
c. Best Oral Presentation Awards
2. K Gopinath and Sarman Singh. “Comparative Evaluation of in-house Multiplex
PCR with Conventional Methodologies for Detecting Mycobacteria Infections.”
International Conference on Opportunistic Pathogens in AIDS (ICOPA- India 2006)
March 27 – 29, 2006, at All India Institute of Medical Sciences, New Delhi.
3. Ayan Dey, Pawan Sharma, Sarman Singh. “Development of Chimeric DNA vaccine
as a strategy for control of L. donovani and M. tuberculosis co-infection.” October
30- November 2, 2008, Tropacon-2, India Institute of Medical Sciences, New Delhi.
d. Best Poster Presentation Award
4. Ramu Sivakumar, Pawan Sharma, Kwang-Poo Chang and Sarman Singh. “Cloning,
expression, and purification of a novel recombinant antigen from Leishmania
donovani” January 12–16, 2004, Bangalore University, Bangalore, India,.
5. Kishnamoorthy Gopinath and Sarman Singh. “Detection and Identification of
Mycobacterial infections in AIDS patients by Multiplex PCR.” IAMM Delhi Chapter,
6th August, 2005, at R.M.L Hospital, New Delhi.
6. Sandeep Kumar, K Gopinath, Mani Sankar, and Sarman Singh. “Tetrazolium
Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Anitubercular
Drug Susceptibility Testing.” International Conference on Opportunistic Pathogens in
AIDS (ICOPA) March 27-29, 2006, All India Institute of Medical Sciences, New
Delhi.
7. Amit Singh, K Gopinath., and Sarman Singh. “Proteomic analysis of Mycobacterium
tuberculosis strains sequentially acquired resistance to Isoniazid and Rifampicin.” 10-
11 March 2008, Indian Institute of Science, Bangalore.
8. Amit Singh, K Gopinath, and Sarman Singh. “ATP Binding Cassettes transporters of
M. tuberculosis and M. Avium paratuberculosis Phylogeny to Regulatory functions” in
International Conference on Opportunistic Pathogens in AIDS, January 27th-29th 2008 at,
New Delhi.
6 of 81
9. Arshi Munawwar, Swati Gupta, Sarman Singh. “Incidence and Prevalence of
Human Herpes Virus (HHVs) Infection in HIV-Positive North Indian Patients.”
AIDS Society of India (ASICON-2009) 28th Feb-1st March 2009, Jaipur, India.
10. Arshi Munawwar, Gupta S, Lisco A, Vanpouille C, Sharma SK, Grivel JC, Margolis
L, Sarman Singh.: Epstein Barr Virus" A Yet To Be Recognised Virus For Its Role In
AIDS: Indian Scenario. International Conference on Opportunistic Pathogens in AIDS
(ICOPA- India) October 27-30, 2010, New Delhi.
11. Amit Singh, K Gopinath, P. Sharma, D. Bisht, N. Singh and Sarman Singh. Young
Scientist Award for the work titled “Proteomics analysis of sequential isolates of M.
tuberculosis from a patient of drug resistant pulmonary tuberculosis” FEMS-2013, July
21-25, 2013 at Leizig, Germany.
12. Jitendra Singh, DBT Travel Award, Europe
13. Mani Sankar M, DST Travel Award, Europe
EXTERNAL MD/PhD/DSc. EXAMINER FOR VARIOUS UNIVERSITIES
1 Dr. BR Ambedkar University, Agra

2 Bombay University, Mumbai
3 Calcutta University, Kolkata
4 Madras University, Madras
5 MGR Medical University, Chennai
6 IMTech, Chandigarh
7 PGIMER, Chandigarh
8 Garhwal University, Srinagar
9 Bundelkhand University, Jhansi
10 Delhi University, Delhi
11 Jiwaji University, Gwalior,
12 Jamia Millia Islamia University, Delhi
13 BITS, Pilani
14 Pondicherry University
15 Jawaharlal Nehru University, New Delhi
16 Sher-e-Kashmir Institute of Medical Sciences, Srinagar
17 SGPGI, Lucknow
7 of 81
OFFICE BEARER / MEMBER OF SCIENTIFIC / ACADEMIC/ADMINISTRATIVE
COMMITTEES/ SOCIETIES AND OTHER BODIES
1. Chairman, Research Advisory Committee of Chettinad Academy of Research and

Edcation, Chettinad University, Chennai -2017-2019.
2. Member Scientific Advisory Committee of the JIPMER (JSAC), Pondicherry-2016-
2018.
3. Member Scientific Advisory Committee (SAC) of Desert Medicine Research Center
(DMRC), Indian Council of Medical Research, New Delhi-2015-till date.
4. Selection Committee Member (Subject Expert for Medical Microbiology)- Union Public
Service Commission (UPSC), 2006, 2014, 2015.
5. Member Task Force on Tuberculosis. Department of Biotechnology, Government of
India, 2013-till date.
6. Member –Joint Task Force on Tuberculosis Diagnostics. Indian Council of Medical
Research and Department of Biotechnology, Government of India, 2010-till date
7. Member Scientific Advisory Committee (SAC) of National JALMA Institute of Leprosy
and other Mycobacterial Diseases (NJILMOD), Indian Council of Medical Research,
New Delhi-2010-till date.
8. Member Task Force for SC/ST and Rural Health. Department of Biotechnology,
Government of India, 2014-2017.
9. Chairman, Condemnation Committee of Indian Council of Medical Research, New
Delhi, 2014 onwards.
10. Chairman, selection committee for various posts at International Health Division of
Indian Council of Medical Research, New Delhi, 2014
11. Member, Technical Evaluation Committee of Grant-in-Aid Schemes of the Department
of Health Research, 2014-2017.
12. Chairman, Condemnation Committee of Indian Council of Medical Research, New
Delhi, 2011-till date
13. Member, High power Technical Advisory Committee (TEC) to review and approve the
projects submitted to Department of Health Research, 2014-2017.
14. Member Global Technical Committee of International Organization for Standardization
(ISO), Geneva. 2013-till date
15. Member Biomedical Committee of the Bureau of Indian Standards (BIS), New Delhi,
2012-till date
16. CPCSEA (Ministry of Environment, Government of India) nominee for Institutional
Animal Ethics Committees (IAEC) of University of Delhi (DU)-2010-2013
Animal Ethics Committees (IAEC) of Jawaharlal University (JNU)-2009-2008
Animal Ethics Committees (IAEC) of International Centre for Genetic Engineering and
biotechnology (ICGEB), 2006-2012
Animal Ethics Committees (IAEC) of National Institute of Malaria Research (ICMR),
2008-2011
8 of 81
Animal Ethics Committees (IAEC) of Defence Institute of Physiology and Allied
Sciences (DIPAS), 2011-current
Animal Ethics Committees (IAEC) of Institute of Genomics and Integrative Biology (
IGIB). 2009- current
Animal Ethics Committees (IAEC) of Maharishi Dayanand University, Rohtak 2015-
current
23. Member, Condemnation Board of Indian Council of Medical Research, New Delhi,
2011-till date.
24. Member , Technical Evaluation Committee of Establishment of Model Rural Health
Research Units (MRHRU) in the Sates, 2010-till date
25. Member Equipment purchase committee of Indian Council of Medical Research, New
Delhi, 2010-till date.
26. Core Committee Member of the Assessment Board for Promotion of ICMR Scientists
under the Flexible Complementing Scheme for Scientists B to Scientist E , for 2011-ctill
date.
27. Member of the Selection Committee for recruitment of Sister Gd-II at AIIMS, October
2010- 2012.
28. Member Task Force of DBT for North Eastern Region-Biotechnology Programme
Management Cell (NER-BPMC), 2010 onward
29. Chairman of the Expert Group Meeting of directorate of NVBDCP to decide the disposal
of sodium antimony gluconate stocks, held on 28.10.2010.
30. Core Committee Member of the Fellowship Award committee of the Indian Council of
Medical Research for year 2010-onward.
31. Expert Panel Member of SERC (FAST TRACK SCHEME) of Department of Science
and Technology, Government of India. 2004-2007.
32. Member Kala-azar elimination High power committee constituted by DGHS, Gov. of
India.
33. Editor-in-Chief, Journal of Laboratory Physicians
34. Founder President- Association for Better Health & Society (ABHAS)- Regd. NGO.
2002-Till date
35. Secretary -General (founder) , Indian Association of Laboratory Physicians
36. Secretary, Forum for Inculcation of Rational & Scientific Temperament
37. Founder Vice- President, Society for Immunology & Immunopathology
38. President, Forum for rights and Equality (Regd., NGO), 1997-1998.
39. Vice-Chairman, Scientific Committee of Indian Medical Association (SDB) 1998-9.
40. Special invitee /co-opted member of the Animal Ethics committee of the ICGEB, New
Delhi
41. Working Group Member for revising NCERT books on Microbiology, Blood transfusion
and Physiology for Vocational courses.
42. Project reviewer for ICMR, DST and DBT, BCIL, BIRAC, Technology Development
Board.
43. Member Selection Committee meeting to select a Scientist D at RMRIMS, Patna on 25th
October, 2010.
9 of 81
44. External Examiner, Department of Microbiology as an External Examiner in B.P. Koirala
Institute of Health Sciences, Dharan, Nepal for conducting the postgraduate examinations
dated July 22 to 24, 2010
45. Member of the Doctoral Committee Meeting of the PhD student at SGPGI, Lucknow,
11th October, 2010.
46. Medical Council of India Assessor for MD Microbiology and MBBS courses in India
2010-onward.
47. Member, Technical Committee and Specification Committee of National Jalma Institute
for Leprosy and Other Mycobacterial Diseases, 2008-onward
48. Expert Member of the selection panel for the Department of Microbiology, Sir Ganga
Ram Hospital 23rd December 2007.
49. Member, Board of Faculty of Life Sciences, CSJM University, Kanpur, 2007-2010.
50. Task Force Member- DST (Life Sciences), Fast-Track project grants, 2004-2007.
51. Expert Committee Member- Kala-azar Elimination programme, Government of India,
2005.
52. Chairman, Departmental Promotion Committee for the post of Professors, of CCS HA
University, Hissar for
53. External Expert for the DPC of CCS HAU, Hissar for promotion to the post of Professors
in Microbiology, 2004-2006.
54. Member of the Medical board constituted for MBBS, BDS, B.Sc. (Human Biology) and
B.Sc. (Nursing) for 1991-93, 1995-2006, 2007-2011, 2012-2016.
55. Dean’s committee for the selection of senior residents/ demonstrators, December, 1992-
93.
56. Union Public Service Commission- Technical Expert for the selections of Assistant
Professors/specialists in Microbiology, 1993- 1998, 2014-2016.
57. Member Technical Committee of Central JALMA Institute for Leprosy, Agra. 2001-till
date.
58. Regular member of the Medical Board, constituted for all appointment at All India
Institute of Medical Sciences, New Delhi, since 1991-till date.
59. Member Advisory Board of AIIMS Employees Health Scheme 1997-8
60. Member, Primate Research Facility of AIIMS, 1998.
61. Working Group Member for revising the syllabi and text books for vocational (+2 level)
MLT courses, NCERT, Govt. of India, 1998-2000.
62. DBT and ICMR Expert for reviewing the Kala-azar research Projects, 1997 onward.
63. Member, Advisory Committee on Institutional Animal Ethics, International Centre for
Genetic engineering and Biotechnology (ICGEB), New Delhi, 1999-2003.
64. Member, Committee on AIIMS Orientation programme for Junior Residents, 1999-2000.
65. Member, High Power committee to finalise the BSc MLT course at AIIMS, 1999-2001
66. Member, High Power Committee to solve the issue of recognising/derecognising
Medical Lab. Technology Courses conducted by various Indian Institutions. 1999-2001.
10 of 81
REFEREE FOR SCIENTIFIC JOURNALS:
Journals (only selected)
1. Lancet. (UK)
2. JAMA (USA)
3. Clinical Infectious Diseases (USA),
4. Maternal & Child Health, (USA),
5. Clinical and Experimental Immunology (UK),
6. FEMS Immunology (Netherland)
7. Journal of Medical Virology (UK),
8. PLoS Neglected Tropical Diseases (UK)
9. PLoS One (UK)
10. Medicine (USA)
11. Gene and Immunity- NPG (UK
12. Scientific Reports-NPG (UK)
13. Antimicrobial Agents and Chemotherapy (USA)
14. Journal of Medical Microbiology (UK)
15. Journal of Infection (UK),
16. AIDS Care & Behaviour ,
17. Archives of Medical Research (Elsevier Science)
18. Infectious Diseases in Clinical Practice (USA)
19. International Journal of Integrative Biology
20. Journal of Parasitology (USA)
21. Medical Science Monitor (USA)
22. International Journal of Genetics and Molecular Biology (USA)
23. International Journal of Medicine and Medical Sciences USA)
24. International Journal of Integrative Biology (USA)
25. Expert Reviews in Molecular Medicine (USA)
26. Biomed Central- Infectious Diseases (UK)
27. Tropical Medicine and Health (UK)
28. Evidence Based Complementary and Alternative Medicine (UK)
29. Molecular and Cellular Biochemistry (MCBI)
30. Scandinavian Journal of Clinical & Laboratory investigation
31. Tropical Medicine and International Health
32. Annals of Clinical Microbiology and Antimicrobials
33. International Research Journal of Biotechnology
34. Infectious Diseases in Clinical Practice
35. Current Science (India)
36. Journal of Parasitic Diseases (India)
37. Journal of Laboratory Medicine (India)
38. Neurology India
39. Journal of Postgraduate Medicine
40. Indian Journal of Gastroenterology
41. Indian Journal of Leprosy
42. Indian Journal of Medical Research
43. Indian Journal of Experimental Biology
44. Indian Journal of Paediatrics
45. Indian Journal of Physiology & Pharmacology
46. Indian Journal of Medical Microbiology
11 of 81
47. Indian Journal of Animal Parasitology
48. Indian Journal of Vector Borne Diseases
49. Indian Pediatrics
50. Lung India
51. Indian Journal of Tuberculosis
52. Tropical Parasitology
53. World Journal of Hepatology and several others
REFEREE FOR RESEARCH GRANTS:

National
1. Indian Council of Medical Research, India
2. Department of Biotechnology, India
3. Department of Sciences and Technology, India
4. Council for Scientific and Industrial Research, India
5. Biotech Consortium India Limited, India
6. Bill & Melinda Gates Foundation (IKP/BIRAC), India
International
7. Medical Research Council, Government of South Africa (2015)
8. Ministry of Science and Technology, Life Sciences Division. Government of Israel
(2015-16)
9. Ministry of Health (General Direction for Scientific Research and Health
Innovation), Italy (2014-15)
10. United Arab Emeritus University Grant, UAE (2016-17).
11. Medical Research Council (MRC) –Newton Fund, United Kingdom (2017-18).
MEMBER OF EDITORIAL BOARDS OF PEER REVIEWED SCIENTIFIC JOURNALS
1. Editor-in-Chief, Journal of Laboratory Physicians, New Delhi, India, 1999- to till date
2. Elected Member of the Editorial Board of “Recent Patent Reviews on Anti-Infective
Drug Discovery”. Bentham Publications, USA, 2006 till date.
3. Elected Member of the Editorial Board of “The Open AIDS Journal” Bentham
Publications, USA, 2007 till date.
4. Elected Member of the Editorial Board of “Journal of Infection in Developing
Countries” Italy, 2007 till date
5. Member of the Editorial Board, Indian Journal of Medical Microbiology, 2003 Onward.
6. Elected Member of Editorial Board of “Clinical Medicine: Dermatology”, La-Press,
Australia, 2008- till date
7. Abstract Reviewer for International AIDS Society (IAS) world AIDS conference held
at Mexico, 2008
8. Editor, Tuberculosis Research and Treatment. Hindawi Publishing Corporation, USA
2009- till date
9. Abstract Reviewer for the 16th International AIDS Conference held at Vienna, Austria,
2010
10. Abstract Reviewer for the 17th International AIDS Conference held at Rome, Italy, 2011
11. Abstract Reviewer for the 16th International Conference on AIDS and STIs in Africa
(ICASA) held at Addis Ababa, Ethiopia, 2011.
12 of 81
12. International Society oIAbstract Reviewer for the 18th International AIDS Conference
held at Washington DC, USA, 2012.
13. Abstract Reviewer for the 19th International AIDS Conference held at Kuala Lumpur,
Malaysia in July 2013.
14. Abstract Reviewer for 20th International AIDS Conference held at Melbourne, Australia
July 20-25, 2014 .
15. Abstract Reviewer for 20th International AIDS Conference held at Cape Town, South
Africa July, 2015
MEMBERSHIP OF MEDICAL & SCIENTIFIC SOCIETIES
1. International AIDS Society (Switzerland)

2. American Society for Microbiology (USA)
3. International Society for Infectious Diseases (USA)
4. International Society for AIDS in Asia and the Pacific.
5. International Immunocompromised Host Society (USA).
6. American Society for Tropical Medicine & Hygiene (USA).
7. International Union of Tuberculosis and Lung Diseases (UK)
8. New York Academy of Sciences (USA).
9. Indian Medical Association (Life Member)
10. Indian Society of Gastroenterology (Life Member)
11. Indian Association of Medical Microbiologists (Life Member)
12. Indian Society of Parasitologists (Life Member)
13. Society for Immunology and Immunopathology (Founder-Vice-President & Life Member).
14. Indian Association of Laboratory Physicians ( Secretary-General & Life Member)
15. Indian Society for Prenatal Diagnosis and Therapy (Life Member)
16. Indian Academy of Tropical Parasitology (Life Member)
17. Indian Society of Immunology (Life Member)
18. AIDS Society of India ((Life Member)
19. National Academy of Vector Borne Diseases (Life member)
20. Indian Society for the Study of Reproduction and Fertilisation (Life Member)
CONFERENCES/SEMINARS/WORKSHOPS: PAPERS PRESENTED/ATTENDED
A: International
1. International Symposium on Amoebiasis: held at New Delhi, Dec. 14-16, 1990.
2. VII International Conference on AIDS/STD, Florence, Italy, June 16-21, 1991.
3. International Congress of Infectious Diseases, Nairobi, Kenya, June 7-11, 1992.
4. 2nd International Congress on AIDS in Asia and the Pacific, New Delhi, November 9-12,
1992.
5. International CME programme on AIDS, New Delhi from November 7-9, 1992.
6. IX International Conference on AIDS & International Conference on STD, Berlin, June
6-11, 1993.
7. Workshop on Animal Ethics. University of Health Sciences, Chicago, March 1994.
8. Seminar on Radiation Safety. University of Health Sciences, Chicago, August 1994.
13 of 81
9. X International Conference on AIDS and International Conference on STD, Yokohama,
Japan, August, 1994.
10. International workshop on Diagnosis of parasitic infections. Cincinnati, USA, Nov. 12,
1994.
11. Annual Congress of American Society of Tropical Medicine & Hygiene, Cincinnati,
USA, Nov. 13-17, 1994.
12. Third International Conference on AIDS in Asia and the Pacific, Chiang-Mai, Thailand,
Sept. 17-21, 1995.
13. International CME on Laboratory Approach to Paediatric Problems, New Delhi, Oct. 11-
13, 1995.
14. Global Meet on Parasitic Diseases, New Delhi, March 18-22, 1996.
15. International Symposium on Kala-azar Research, Banaras Hindu University, Varanasi,
March 22-24, 1996.
16. 9th International Symposium on Infections in the Immunocompromised Host. Assisi,
Italy, June 17-21, 1996.
17. XI International Conference on AIDS. Vancouver, Canada, July 7-12, 1996.
18. Second Global Meet on Parasitic Diseases, Hyderabad, India, August 18-22, 1997.
19. 10th International Symposium on Infections in Immunocompromised Host, Davos,
Switzerland, June 21-25, 1998.
20. XII International Conference on AIDS, Geneva, Switzerland, June 28-July 3, 1998
21. Tenth International Conference of Immunology, New Delhi, November 1-6, 1998.
22. International Conference and Workshop on recent advances in medical Toxicology and
Legal Medicine. New Delhi, November 2-7, 1998.
23. International CME of American College of Physicians and American Association of
Physicians from India, Hyderabad August 12-14, 1999.
24. XIII International Conference of AIDS, Durban South Africa, July 2000
25. Workshop on Ethical Issues in International Health Research, organised jointly by
Harvard and Tuft Universities of USA and Univ. of Natal, South Africa, Natal, South
Africa, July 2000.
26. 5th International Meeting on Molecular Epidemiology and Evolutionary Genetics of
Infectious Diseases. Hyderabad, India. November 12-16, 2000.
27. ICMR-WHO symposium on Kala-azar . Gave a talk on “problems associated with
repeated injection treatment in kala-azar patients”. The symposium was held on
December 18-19, 2000, at Hotel Imperial, New Delhi.
28. WHO-Safe injection Global Network Annual Meeting held at New Delhi, August 29-31,
2001.
29. Annual Conference of Australian Society for HIV Medicine, Melbourne. October 3-7,
2001
30. Sixth International Congress on AIDS in Asia & the Pacific, Melbourne, Australia, Oct.
5-10, 2001.
31. III International Conference of AIDS-India 2000, Chennai, December 2-5, 2001.
32. VIII International CME of Mediciti, Hyderabad, December 27-30, 2001.
33. International Symposium on Leishmaniasis. New Delhi, February 23-24, 2002.
34. First International Conference of the Society for Antimicrobial Chemotherapy, As
Rapporteur. New Delhi, March 9, 2002.
35. 10th International Conference of Infectious Diseases. Singapore March 11-14, 2002.
14 of 81
36. 12th International Symposium of International Immunocompromised Host Society,
Bergen (Norway), June 21-26, 2002.
37. 14th International AIDS Conference, Barcelona (Spain), July 5-11, 2002
38. International Symposium on Toxoplasmosis. Only Representative from India. Paris. Oct
11-12, 2002.
39. 3rd International Conference on Integrated Medicine organised by Mediciti, Hyderabad,
January 4-5, 2003.
40. International Conference of HospiMedica, Bangkok, Thailand, September 4-7, 2003.
41. 3rd International Conference of AIDS India. Chennai, India, November 9-12, 2003.
42. Attended 8th International Conference on Emerging Infectious Diseases in Pacific Rim”,
at Dhaka, December 11-12, 2003.
43. Delivered a lecture on Non-tuberculous Mycobacteria in Indian AIDS patients during
the 8th International Conference on Emerging Infectious Diseases in Pacific Rim at
Dhaka, Bangladesh, from December 11-12, 2003
44. 3rd Global Meet on Parasitic Diseases held at Bangalore, January 12-16, 2004.
45. 11th the International Conference of Infectious Diseases, Cancun, Mexico, March 4-8,
2004.
46. BioMerieux Science Foundation International Conference on Tuberculosis. Annecy,
France. July 1-4, 2004.
47. 10th Annual International Continuing Medical Education Program HIV Update at
MediCiti Hyderabad, India. August 7-8, 2004.
48. International Symposium on Emerging Trends in Tuberculosis. ICGEB, New Delhi,
November 15-17, 2004.
49. First Asia /Pacific Conference on Women, Girls & HIV /AIDS Best Practices, Islamabad,
Pakistan. November 31-December 1, 2004. (Could not go).
50. 9th International Conference on Emerging Infectious Diseases, Kyoto, Japan, December
7-10, 2004.
51. International Conference on Functional Genomics for Vaccine & Novel Drug Design
against Mycobacteria, IIT Kharagpur (WB) February 10-14, 2005.
52. Asian Regional Workshop on Emerging Infectious Diseases, Seattle Biomedical
Research centre, USA and JNU, India, New Delhi, March 8-10, 2005.
53. Indo-US workshop on Diarrhoeal diseases held at NICED, Kolkata from October 3-5,
2005
54. 5th International Conference on AIDS India. Chennai, India, October 22-24, 2005
55. International Conference on “Global Clinical Trials in India-Prospects & Challenges”
organised by FICCI, at New Delhi from New Delhi, November 14-16, 2005.
56. International Conference on Opportunistic Pathogens in AIDS, New Delhi, March 27-29,
2006.
57. Attended and delivered a lecture International Workshop on “Defining the Future-
HIV/AIDS next 25 years” Chennai, December 18-20, 2006.
58. Chaired a Scientific Session during the “International Workshop on Defining the Future –
HIV/AIDS- Next 25 years” Chennai, December 18-20, 2006.
59. International Workshop on “Laboratory Diagnosis of Enteric Parasites” Calcutta from
February 17-20, 2008.
60. Delivered an Invited lecture on “HIV-TB coinfection and emergence of drug resistance”
during XVII International AIDS Conference in Mexico City, Mexico, August 3-8, 2008.
15 of 81
61. Delivered an Invited lecture on Microbiological investigations for detecting MRSA
during the Symposium on Methicillin Resistant Staphylococcus aureus (MRSA),
Kathmandu, Nepal, August 22-24, 2008
62. Delivered an Invited lecture on Viral Hepatitis: Indian scenario during the Indo-Bulgarian
DST meeting on “Contemporary State of the VIH infections in Bulgaria” at Sofia, from
October 16-18, 2008
63. Delivered an Invited lecture on TB diagnosis in India during the Project Kick-off meeting
to be held at Brussels, Belgium from November 14-15, 2008.
64. Delivered an Invited lecture on “HIV-TB: coinfection” during the International
Tuberculosis Symposium at ICGEB, Delhi from December 1-3, 2008
65. Delivered an Invited lecture on “HIV and Hepatitis C virus coinfection” “International
Conference on Biotechnological Approaches to Neuroimmunomodulation and Infectious
Diseases” at NIPER, SAS Nagar, Punjab, December 11-13, 2008.
66. Delivered lecture on HIV and Leishmania coinfection during HIV Congress 2010 at
Mumbai on 10th January 2010.
67. Delivered lecture on HIV and opportunistic Toxoplasmosis during HIV Congress 2010 at
68. Participated in the 41st Union World Conference on Lung Health held at Berlin,
Germany from November 10-15, 2010.
69. Participated in an International meeting “Tuberculosis Diagnostic Research – from basics
to advanced techniques”, organized at the Tuberculosis Research Centre, Chennai, from
December 13th -15th, 2010.
70. Delivered Invited lecture titled “HIV-TB Co-infection: A diagnostic challenge” in the
International TB Symposium (ITBS-2010): TB Diagnostics - Innovating to Make an
Impact, New Delhi, India, 16 to 17 December 2010 .
71. Chaired a scientific session on Rapid Methods of Detecting Drug Resistance and
Strengthening of Laboratory Capacity” during the International Meeting on Facing the
reality of MDR-TB: challenges and potential solutions in India, organised jointly by
ICMR, INSA and Institute of Medicine (USA), at Delhi, from April 18-19, 2011.
72. Delivered an Invited Lecture on Quality Control in Molecular Medicine during the
workshop on Good Laboratory Practices (GLP) at BPKIHS, Dharan, Nepal, from June
26-27, 2011
73. Delivered an Invited Lecture on Quality Control in Clinical Microbiology during the
workshop on Good Laboratory Practices (GLP) at BPKIHS, Dharan, Nepal, from June
26-27, 2011
74. Participated in the International Workshop in TB diagnostics at St John’s Research
Institute, Bangalore from August 25-26, 2011.
75. Delivered a lecture on Clinical aspects of Indian visceral leishmaniasis during the
Symposium cum workshop on “Drugs for Neglected Diseases and Cancer” held at
IBMC, University of Porto, Portugal, September 8-10, 2011.
76. Presented a paper in the 42nd Union World Conference on Lung Health, Lille, France,
October 26-30, 2011
77. Participated in the DBT sponsored International Symposium on “Vaccine: Discovery to
Translation”, New Delhi, November 14-17, 2011.
78. Chaired a scientific Session during the International Conference on Reproductive Health
with Emphasis on Strategies fro Family Planning. New Delhi, February 19-21, 2012
79. Delivered guest lecture on “Point of care diagnostic methods for Leishmaniasis” during
the International Conference on In-Vitro Molecular Diagnostics, Mumbai, India, March
11-14, 2012.
80. Chaired a scientific Session during the 5th International FIMSA Congress of Immunology,
16 of 81
New Delhi, March 14-17, 2012.
81. Participated in the 112th Annual ASM meeting at San Francisco, USA, June 16-19, 2012.
82. Visiting Professor, Department of Pharmacology & Toxicology, University of Missouri,
Kansas, USA, June 20-21, 2012.
83. Vesting Professor, Department of Microbiology & Immunology, University of Rochester
Medical Centre, Rochester, USA, June 22-23, 2012.
84. Delivered guest lecture on HIV and HHV coinfection, Department of Microbiology &
Immunology, University of Rochester Medical Centre, Rochester, USA, June 22, 2012.
85. Visiting Professor National Institute of Health, Washington DC, USA September 25-
October 4, 2012.
86. Delivered guest lecture on HIV-TB at National Institute of Health, Washington DC, USA
September 27- 2012
87. Visiting Professor College of Dentistry, New York University, NY, USA, October 1-2,
2012
88. Delivered a Guest Lecture on HIV and Human Herpes Viruses: How they help each
other? College of Dentistry, New York University, NY, USA, October 1, 2012.
89. Represented Asia and Delivered an Invited lecture on “ Uniting to Combat Neglected
Tropical Diseases at World Bank, Washington, USA, November 17, 2012.
90. Delivered a guest lecture titled “Human herpes viruses in HIV seropositive Indian males”
at Department of Pharmacology, University of Missouri, Kansas City, Kansas, USA,
April 11, 2014.
91. Chaired a Scientific Session titled “Infectious Diseases and Infection Control” during the
Indo-Global Healthcare Summit & Expo, 2014, held at Hyderabad from June 20-22,
2014.
92. Delivered a guest lecture titled “Innovative Research: challenges in India” during the
Indo-Global Healthcare Summit & Expo, 2014, held at Hyderabad from June 20-22,
2014.
93. Delivered a guest lecture titled “Newer Diagnostic Modalities and Biomarkers for early
detection of drug resistant Tuberculosis” during the Indo-Global Healthcare Summit &
Expo, 2014, held at Hyderabad from June 20-22, 2014.
94. Participated and delivered a lecture on “Leishmaniasis in India: an overview”. During the
KINDRed project consortium meeting held at Porto, Portugal, September 14-17, 2014.
95. Participated and Delivered an invited guest lecture on “Newer advances in the TB
diagnosis” during the International Symposium on Recent advances in TB Therapy held
at Chennai, India, November 15, 2014.
96. Participated as guest of honour during the international workshop on Use of Experimental
Animals held at Institute of Genomic and Integrative Biology (IGIB) Jan 19, 2015
97. Participated and Delivered a guest Lecture on “Recent advances in the diagnosis of
Leishmaniasis” during the World IVD Conferences (China) held at New Delhi, February
5-6, 2015
98. Participated and Delivered invited guest lecture at 1st Congress of Asia Africa Society of
Mycobacteriologists, Isfahan, Iran, March 7-12, 2015.
99. Delivered an invited lecture on “Anti-Leishmanial drugs and threat of drug resistance”
during the SRM International Conference on “Antimicrobial resistance, Novel Drug
Discovery and Development: Challenges and Opportunities” held at New Delhi, March
22, 2015.
100. Participated and presented an ePoster during the 26th European Congress of Clinical
Microbiologists and Infectious Diseases (ECCMID) at Amsterdam from April 9-12, 2016
101. Delivered a lecture on HIV-TB co-infection at the University of Tennessee, Memphis,
USA as visiting Professor on May 17, 2016.
17 of 81
102. Presented the progress report in the KINDReD project review meeting at Modena, Italy
from June 15-16, 2016.
103. Delivered a guest lecture on Recent advances in the diagnosis of Leishmaniasis during
the International Medical Sciences Academy Conference (IMSACON-2016), held at
Mauritius, October 5-9, 2016.
104. Represented the Indian Research During the International Conference on Poverty-Related
and Neglected Disease: from Funding to Health Coverage. Brussels, Belgium, January
31-February 1, 2017
105. Presented a Paper on Emergence of Miltefosine resistant cases of visceral leishmaniasis
in India. During the 6th World Congress of Leishmaniasis held at Toledo, Spain, 18-20
May 2017
106. Delivered an invited Plenary lecture on “Toxoplasma and Toxoplasmosis” during the
Annual Scientific Session of Sri Lanka College of Microbiologists, held at Colombo,
August 31- September 1, 2017.
107. Judged the poster session during the Annual Scientific Session of Sri Lanka College of
Microbiologists, held at Colombo, August 31- September 1, 2017.
108. Invited Guest lecture on “Intestinal parasitic infections in children: during the 2nd
International Conference on Research in Tropical Medicine, University of Peradeniya,
Sri Lanka, December 8-9, 2017.
109. Invited Lecture on Toxoplasmosis in pregnant Women. The Continuing Medical
Education Programme of Sri Lanka College of Gynaecologists and Obstetricians,
Colombo, March 25, 2018. Invited Plenary Lecture on “Biotechnology in Infectious
Disease Diagnosis and Prevention” during the South Asian Conference on
Biotechnology, Organised by ICGEB and National Academy of Sciences, Sri Lanka at
Colombo, March 28-30, 2018.
B: National
1. Attended Computers: A management Tool: CMC limited 16-17, December 1985.

2. Attended XXVIII Annual Conference of Indian Society of Gastroenterology, Gandhi
Medical College, Bhopal, Nov. 26-29, 1987.
3. Attended XIII National Congress of Indian Association of Medical Microbiologist,
Jaipur, November 10-12, 1989.
4. Attended XXXI National Conference of ISG, Jaipur, November, 25-29, 1990.
5. Attended XXXII National Conference of ISG, Trivandrum, October, 6-9, 1991.
6. Attended National Symposium on Eye Banking (North Zone), guest lecture on “Rapid
diagnosis of corneal ulcers” New Delhi, August 25-26, 1990.
7. Delivered a lecture on Rapid diagnosis of corneal ulcers at National Symposium on Eye
Banking (North zone) held at New Delhi, from August 25-26, 1990.
8. Delivered a lecture and demonstrations on Acanthamoeba keratitis during "Workshop
on Ophthalmic Microbiology / Pathology, Dr. RPC for Ophthalmic Sciences., AIIMS,
New Delhi, September, 17-19, 1991
9. Attended Workshop on “Ophthalmic Microbiology and Pathology, Lectures and
demonstration on Acanthamoeba keratitis Dr. RPC for Ophthalmic Sciences, New Delhi,
September 17-19 1991.
10. Attended Workshop on “Media in Medical Education”, CMET, AIIMS, New Delhi, Jan.
2-3, 1992.
18 of 81
11. Attended ICMR sponsored Workshop on “Parasites in AIDS-Cryptosporidium”,
Department of Parasitology, PGIMER, Chandigarh, April 27-29, 1992.
12. Delivered a lecture and demonstrations on "Parasites in AIDS- Cryptosporidium" in
ICMR sponsored Workshop at Department of Parasitology, PGIMER, Chandigarh,
April 27-29, 1992
13. Attended XIX National Conference of Indian Immunology Society, Bangalore January 8-
11, 1993.
14. Attended XXXIV National Congress of ISG, Panji (Goa), October 13-17, 1993.
15. Delivered a lecture on Sero-epidemiology of Toxoplasmosis in sheep and goats of
Rajasthan state and their butchers. Centenary celebrations of IVRI, Mukteshwar
campus, December 2-3, 1993.
16. Attended Centenary Conference of Indian Veterinary Research Institute, Mukteshwar
Campus, Mukteshwar, Nainital, December 2-3, 1993.
17. Attended National Symposium on Toxoplasmosis, New Delhi, September 27-28, 1995.
18. Attended 37th Annual congress of Veterinary Science and Avian Research, IVRI,
Bareilly, February 22-23, 1996.
19. Chaired a Scientific Session during the Global Meet on Parasitic Diseases, New Delhi,
November, 1996
20. Panellist- Workshop on quality control and quality assurance in medical laboratory. April
26-8, 1997, New Delhi.
21. Guest Speaker, DBT Sponsored Training programme on “Immunopathology- Modern
trends in Diagnosis & Control” Department of Pathology, College of Veterinary
Sciences, GB Pant University of Agriculture and Technology, Pant Nagar, UP, February
17-19, 1998.
22. Attended Seminar on Accreditation of Clinical Laboratories, New Delhi, February 28,
1998
23. Attended Zoonotic Parasites- their diagnosis and control” - III National Training
Programme, Centre for Advanced Studies., Department of Parasitology, Veterinary
College, University of Agricultural Sciences, Bangalore, Bangalore, March 15-17, 1998.
24. Delivered a lecture on Molecular diagnosis of Kala-azar during 13th National Congress
of Indian Society of Parasitologists, February 24-26, 1999, Bangalore.
25. Delivered an invited lecture on “Current situation of HIV AIDS in India” during an
Annual Symposium of Immunology Society of India “An update on Clinical
Immunology”, Srinagar, August 24-5, 1999.
26. Participated in 49th National Conference of Indian Association of Pathologists and
Microbiologist at Safdarjung Hospital, New Delhi from November 15-19, 2000.
27. Participated in Ranbaxy Science Foundation- 7th Round Table Conference on
Tuberculosis. New Delhi, September 2000.
28. Delivered an invited lecture on recent advances in molecular tools in the Diagnosis of
Toxoplasmosis in a DBT-IVRI workshop at IVRI, Izatnagar, Bareilly, UP. March 26-27,
2001.
29. Participated in NACO/UNICEF workshop to draft a module on Mother-to-child-
transmission of HIV. Gurgaon, Haryana, July 4-5, 2001.
30. Attended Annual Conference of Australian Society for HIV Medicine, Melbourne,
October 3-7, 2001
19 of 81
31. Attended Sixth International Congress on AIDS in Asia & the Pacific, Melbourne,
Australia, October 5-10, 2001.
32. Attended III International Conference of AIDS-India 2000, Chennai, December 2-5,
2001.
33. Attended VIII International CME of Mediciti, Hyderabad, December 27-30, 2001.
34. Attended Second National Symposium of Society for Immunology &
Immunolopathology, Pantnagar, December 14-15, 2001.
35. Attended CII-CSIR Conference on Medicines in malaria. Hotel Hyatt, New Delhi.
February 11-12, 2002.
36. Attended Rheumatology Update (Delhi Chapter). New Delhi. February 17, 2002.
37. Attended Second National Conference of Laboratory Medicine, February 21-23, 2002.
38. Attended CII Sponsored HIV/AIDS Meeting, Hotel Tajmahal, New Delhi. February 27,
2002.
39. Attended Third Sir Dorabji Tata Symposium on Diarrhoeal Diseases. Bangalore, March
21-22, 2002.
40. Attended XXVI Annual Conference of IAMM, Bangalore, November 21-24, 2002 .
41. Attended Short term training course on Biotechnology and Intellectual Property Rights,
Bangalore, 8-13 December, 2002.
42. Lecture on HIV-TB co-infection, King George Medical College, Lucknow, December
27-29, 2002.
43. Delivered a lecture on Recent advances in the diagnosis of Toxoplasmosis during the
National Conference on Veterinary Public Health. GB Pant University, Pantnagar, UP.
November 28-29, 2002.
44. Chaired a Scientific Session during the WHO-ICMR sponsored International
Symposium on Leishmaniasis. New Delhi. February 23-24, 2002.
45. Chaired a Scientific Session during the LABCON-2, New Delhi. February 21-22, 2002.
46. Delivered a lecture on Medical Laboratory Technology: Key to Modern Medicine.
PGIMER, Chandigarh. April 26, 2002
47. Delivered a lecture on “Opportunistic Intestinal Pathogens” during the Sir Dorabji Tata
memorial Symposium on Diarrhoeal diseases. Bangalore, March 22-23, 2002.
48. Delivered a Talk on "TORCH Group of Infections", Chhattisgarh Association of
Pathologists at Raipur, Chhattisgarh, February 15-16, 2003.
49. Attended Workshop on Veterinary Medicine at IVRI, Izatnagar, Bareilly, February 27-
28, 2003
50. Attended Brainstorming session on "Molecules of therapeutic importance from Marine
and Estuarine environment" Calcutta, April 17-18, 2003.
51. Delivered Public Lecture on Waterborne diseases, Organised by an NGO, Gurgaon, April
26, 2003.
52. Attended 27th National Conference of Indian Association of Medical Microbiologists,
held at Mumbai, November 5- 9, 2003
53. Attended National Conference on Management of HIV/AIDS in Resource Restricted
Setting from February 20-22, 2004.
54. Attended Third Convention of Society for Immunology and Immunopathology &
National Symposium on Cytokines and Signal Transduction, JALMA, Agra, February
13-15, 2004.
20 of 81
held at Lucknow, November 25- 28, 2004.
56. Delivered a lecture on Leishmaniasis during the Fifth Sir Dorabji Tata Symposium on
“Leishmaniasis” to be held at J.N. Tata Auditorium, Bangalore from March 10-11, 2004.
57. Chaired a Scientific Session during the National Convention of SIIP at CJIL, Agra,
February 13-15, 2004
58. Delivered a lecture on Diagnosis and management of Lymphatic Filariasis. During the
NVBDCP, Government of India, Symposium, Pune, February 26-27, 2004.
59. Delivered a lecture on “Non-tuberculous Mycobacteria in AIDS” during the National
Conference on Management of HIV/AIDS in Resource Restricted Setting from February
20-22, 2004
60. Delivered a lecture on “Molecular Methods for Diagnosis of Tuberculosis” at
Bundelkhand University, Jhansi. October 15, 2004.
61. Delivered a lecture on “Recent advances in the diagnosis of Leishmaniasis” during the
Kala-azar capacity building CME. Patna, October 27-28, 2004
62. Attended Summer School Programme of Punjab Agriculture University, Ludhiana,
October 10, 2005.
held at Chennai, October 21- 23, 2005.
64. Attended 17th National Congress of Parasitology. Held at Dibrugarh, Assam, October 24-
26, 2005.
65. Attended 4th Biennial Conference of The Indian Association of Leprologists at JALMA,
Agra, from November 12-14, 2005.
66. Attended 4th National workshop on “Simple Diagnostic Methods in Infectious Diseases”
JIPMER, Pondicherry November 22-26, 2005.
67. Speaker and Chairperson of scientific session, XXX National Conference of Medical
Microbiologists” at Nagpur, October 26- 27, 2006.
68. Attended 46th Annual Conference of National Academy of Medical Sciences” at
Hyderabad, October 27- 29, 2006.
69. Speaker and Chairperson of scientific session 18th National Congress of Parasitology” at
Kolkata, November 22-24, 2006.
70. Delivered a lecture on “Intrauterine infections”. Perinatology CME of the Indian
Academy of Paediatrics, April, 24, 2005, NOIDA, UP
71. Delivered a lecture on “Diagnosis of non-tubercular mycobacteria” during the 4th
National workshop on “Simple Diagnostic Methods in Infectious Diseases” JIPMER,
Pondicherry November 22-26, 2005
72. Chaired a scientific session during the 4th Biennial Conference of The Indian Association
of Leprologists at JALMA, Agra, from November 12-14, 2005.
73. Delivered a lecture on “Toxoplasmosis in meat animals.” During the Summer School
Programme of Punjab. Agriculture University, Ludhiana, October 10, 2005.
74. Delivered a lecture on Food Borne Toxoplasmosis. 17th National Congress of
Parasitology. Held at Dibrugarh, Assam, October 24-26, 2005.
75. Delivered a lecture on “To Harness and Streamline the Regulatory Issues for Import and
Export of Biological Materials”. National Meeting on Global Clinical Trials in India-
Prospects & Challenges” FICCI, New Delhi from November 14-16, 2005
21 of 81
76. Chaired a Scientific Session during the International Conference on HIV/AIDS and TB:
Past, Present and Future, January 13-15, 2006.
77. Delivered a lecture on “TORCH investigations and their interpretation” during the
National conference of ISPAT, February 18, 2006, New Delhi.
78. Co-Chaired a Scientific Session during the International Conference on Opportunistic
Pathogens in AIDS, March 27-29, 2006, New Delhi
79. Delivered a lecture on “Quality Control of Diagnostic Medicine for Parasitic Diseases”
at National Institute of Biologicals, NOIDA, November 3, 2006.
80. Co-Chaired a Scientific Session during the XXX National Conference of Medical
Microbiologists” at Nagpur, October 26- 27, 2006
81. Chaired a Scientific Session during the 18th National Congress of Parasitology” at
Kolkata, November 22-24, 2006
82. Delivered a lecture on “Molecular Diagnostic Tools for the Diagnosis of Infectious
Diseases.” HNB Garhwal University, Sri Nagar. January 15, 2007.
83. Chaired and delivered a lecture on “Methods HIV Testing” during the First Hands-on
Workshop on Training course on HIV/AIDS for Medical Officers and Laboratory
technicians, National Institute of Biologicals, NOIDA, January 16, 2007.
84. Chaired a Scientific Session during the “33rd Indian Immunology Society Conference”
New Delhi, January 27-30, 2007.
85. Chaired and delivered a lecture on “Methods HIV Testing” during the Second Hands-on
technicians, National Institute of Biologicals, NOIDA, February 12, 2007.
86. Chaired and delivered a lecture on “Methods HIV Testing” during the Third Hands-on
87. Deliver a guest lecture on “Quality Assurance” during the Microbiology Update 2007 at
MAMC, Delhi on March 9, 2007
88. Chaired and deliver a invited lecture on Leishmaniasis and its diagnosis at Span
Diagnostics Pvt Ltd., Surat (Gujarat) on April 28, 2007
89. Delivered a guest lecture on “Molecular Epidemiology of Mycobacterium Para-
tuberculosis” during the National Seminar & Workshop on Johne’s Disease at Bareilly
(UP) from August 7-9, 2007
90. Chaired a Scientific Session and headed the jury to adjudge the best oral presentation
during the National Conference of Indian Academy of Tropical Parasitology (Tropacon),
Chennai, October 6-7, 2007.
91. Delivered guest lecture on indigenous developments in the Leishmania diagnostics.
National Conference of Indian Academy of Tropical Parasitology (Tropacon), Chennai,
October 6-7, 2007.
92. Delivered Dr. BP Pandey Oration on “Recent Advances in Leishmania diagnostics”
during 19th National Conference of Indian Society for Parasitology (NCP) at
Vishakhapatnam from October 26-28, 2007.
93. Delivered a lecture during 31st National Conference of Indian Association of Medical
Microbiologists (IAMM) at Mangalore from November 16-18, 2007
94. Delivered guest lecture on “Non-tubercular Mycobacteria in immunocompromised
patients” during the Indian Association of Leprologists (IAL) conference at Kanpur
University on 21st November, 2007.
22 of 81
95. Delivered a guest lecture “Recent trends in Diagnosis and Prevention of AIDS” during
the World AIDS Day celebrations at Bundelkhand University, Jhansi, UP on 1st
December, 2007.
96. Delivered a guest lecture in UP-MICROCON on “Emerging Viral Infections” at
Lucknow on 16th February 2008.
97. Chaired the Scientific Session in “Society for Free Radical Research – India (SFRR)-
India) Satellite Meeting” at All India Institute of Medical Sciences, New Delhi on
February 12, 2008.
98. Co-Chaired a scientific session during the International Workshop on “Laboratory
Diagnosis of Enteric Parasites” Calcutta from February 17-20, 2008.
99. Inaugurated Fourth Hands-on Workshop and Training course on HIV/AIDS for Medical
Officers and Laboratory technicians, and Delivered a inaugural lecture on “HIV and
Overview” at the National Institute of Biologicals, NOIDA, May 7, 2008.
100. Delivered a guest lecture on “Methicillin Resistant Staphylococcus aureus (MRSA)”
during an International Symposium on Staphylococcus. At Kathmandu, Nepal, August
23-24, 2008
101. Delivered an invited lecture on “Newer Diagnostic tests for Tuberculosis” during
MICROCON2008 from October 21-25, 2008 at Pune
102. Delivered an invited lecture on “Research Ethics in Animal Studies” at the Central
Council for Research in Unani Medicine, Janakpuri, Delhi on June 3, 2008
103. Delivered an invited lecture on Immunology at Boston College, Gwalior on June 13,
2008
104. Delivered an invited lecture on “Mechanisms and Clinical Implications of drug resistance
in tuberculosis” International TB Symposium” at MGR Medical College, Gwalior, Dec.
1, 2008
105. Delivered an invited lecture on “Immunology at Boston College, Gwalior on June 13,
2008.
106. Delivered key note lecture on “Microscope to Microarray” during the XIX National
Congress of Veterinary Parasitology at Ludhiana on February 3, 2009
107. Delivered guest lecture on CNS HIV infections, Central India Institute of Medical
Sciences, Nagpur, 8th February, 2009.
108. Delivered an invited talk during the training course on immunodiagnostics for infectious
diseases at Mahatma Gandhi Institute of Medical Sciences, Wardha on February 13-14,
2009.
109. Delivered an invited talk on “HIV and Tuberculosis” during the Second National
Conference of AIDS society of India (ASICON 2010) at Jaipur on February 27, 2009.
110. Delivered an invited talk on “HIV and Hepatitis infections” during the Second National
Conference of AIDS society of India (ASICON 2010) at Jaipur on February 28, 2009.
111. Delivered an invited lecture in Hindi on “Swine Flu: its epidemiology and Prevention” at
Indian Council of Medical Research, New Delhi, on September 16, 2009.
112. Delivered lecture in TROPACON Conference of Indian Academy of Tropical
Parasitology at PGIMER, Chandigarh. From 17th to 18th November 2009
113. Delivered lecture on Controlling Kala-azar in Bihar by ameliorating the soil pH with Zinc
Sulphate in house hold plastering materials. National Symposium on Weather, Climate
and Sustainable Development, New Delhi, December 17, 2009
114. Delivered lecture on HIV and Leishmania coinfection during HIV Congress 2010 at
115. Delivered lecture on HIV and opportunistic Toxoplasmosis during HIV Congress 2010 at
23 of 81
116. Delivered lectures on soil transmitted parasites and conducted wet workshop on parasite
prevalence study conducted by Deworm the World and Government of Bihar at Patna
from May 19th -23rd, 2010.
117. Delivered lectures on soil transmitted parasites and conducted wet workshop on parasite
prevalence study conducted by Deworm the World and Government of Bihar at Patna
from and again from May 26th-29th , 2010.
118. Delivered lecture on “Tuberculosis Disease Burden” at the Department of
Biotechnology, Biyani Girls College (University of Rajasthan), Jaipur, September 21,
2010.
119. Chaired a Scientific sessions and Delivered guest lecture on MDR/XDR Tuberculosis in
HIV Infected persons during the 3rd National Conference of AIDS society of India
(ASICON 2010) at Hyderabad on 30th October 2010
120. Delivered guest lecture on Emerging Viral infections and HIV infection during the 3rd
National Conference of AIDS society of India (ASICON 2010) at Hyderabad on 31st
October 2010
121. Delivered a guest lecture on “Automation in Liquid culture and DST in TB” during the
annual conference of IAMM at Calcutta on 27th November 2010.
122. Participated in the Consultative Meeting on “Galvanizing Evidence for HIV
Management” held at NARI, Pune from January 27-29, 2011.
123. Delivered guest lecture on “Methods for improvement in productivity in Forensic
Sciences Laboratory services” at Directorate of Forensic Sciences Services, New Delhi,
April 15, 2011.
124. Delivered a guest lecture on Recent Advances in the Laboratory Diagnosis of
Leishmaniasis during 8th Annual Conference of Indian Society of Malaria & Other
communicable Diseases, held at Bhubaneswar, from April 17, 2011
125. Delivered Guest Lecture on Rapid diagnosis of MDR/XDR Tuberculosis during the
bimonthly conference of Twin City Microbiologists at Lepra-India-BPRC , Hyderabad,
on July 1, 2011.
126. Delivered guest lecture on “Kala-azar diagnostics” during the XI Symposium on Vector
Borne diseases, 15-16.10.2011 Jabalpur
127. Delivered a Guest Lecture on “Quality control” during the XXXV National Conference
of Indian Association of Medical Microbiologists, Varanasi, November 23-26, 2011
128. Delivered a Plenary Lecture on “Past, Present and future of Research in Medical Faculties”
during the Annual conference of Association of Medical Biochemists of India
(AMBICON2011) , Government Medical College, Tiruchirapalli, Tamilnadu from
December 16-18, 2011
129. Delivered a Guest lecture on “Point of care tests for kala-azar: during the Annual
conference of Association of Medical Biochemists of India (AMBICON2011) ,
Government Medical College, Tiruchirapalli, Tamilnadu from December 16-18, 2011
130. Delivered guest lecture on “Evaluation of Diagnostic Kits in Microbiology Laboratory”
during the XXXV national conference of IAMM, Varanasi, November 22-25, 2011.
131. Participated in RNTCP-Regional Laboratory and PMDT Review Meeting of Northern
States at Chandigarh, Punjab, May 17-18, 2012.
132. Attended the 4 day training course on Internal Auditor & Quality Management System
(ISO 15989-2012) conducted by the National Accreditation Board for Laboratories
(NABL) from August 8-11, 2012.
24 of 81
133. Delivered a guest lecture on “Leishmaniasis in India: current diagnostic modalities”
during the 24th National Parasitology Congress (Indian Society of Parasitologists) held at
RMRCT, Jabalapur, India from April 27-29, 2013.
134. Delivered a lecture during the workshop on “Pre-requisites in Animal Experimentation”
at DIPAS, New Delhi on 15th May 2013
135. Presided over the inaugural function of the International Symposium on Latest Trends in
Immunodiagnosis, Immunopathology and Immunomodulation held at Bikaner,
Rajasthan., from December 22-24 , 2013.
136. Chaired a session during the International Symposium on Latest Trends in
Immunodiagnosis, Immunopathology and Immunomodulation held at Bikaner,
Rajasthan., from December 22-24 , 2013
137. Delivered a lead lecture titled “ Zoonotic Leishmaniasis in India” during the
International Symposium on Latest Trends in Immunodiagnosis, Immunopathology and
Immunomodulation held at Bikaner, Rajasthan., from December 22-24 , 2013
138. Chaired a Scientific Session during the National Symposium on “Innovation in TB
Diagnostics, Drug Targets and Biomarkers” being organized Mahatma Gandhi Institute
of Medical Sciences, Wardha, India, from January 27-28, 2014.
139. Delivered a lecture on “Banning the serology of TB diagnosis Ban on tuberculosis
serology: moratorium or opportunity for novel molecules? National Symposium on
“Innovation in TB Diagnostics, Drug Targets and Biomarkers” being organized Mahatma
Gandhi Institute of Medical Sciences, Wardha, India, from January 27-28, 2014.
140. Chaired a scientific session titled “TB Immunology & Laboratory Diagnosis ” during the
6th National Conference on Tuberculosis (NATCON), at NIRTD, New Delhi, from
February 24-26, 2014.
141. Delivered a keynote lecture titled “The Modern Detectives: Emerging Technologies for
Diagnosis of Tuberculosis & Drug Resistance” during the 6th National Conference on
Tuberculosis (NATCON) at NIRTD, New Delhi, from February 24-26, 2014.
142. Organized a TB awareness and anti-spitting rally on the occasion of World TB Day,
New Delhi, 24th March 2014.
143. Chief Guest of the valedictory function of the conference titled “Application of Computer
software in mathematical modelling” at Guru Govind Singh IP University, Delhi, May
17, 2014.
144. Delivered a guest lecture “Innovative Research: Challenges in India” during the Indo-
Global Health Summit & Expo 2014, Hyderabad, June 21, 2014.
145. Chaired the scientific session and delivered a guest lecture “Newer Diagnostic modalities
and Biomarkers for early detection of MDR Tuberculosis.” Indo-Global Health Summit
& Expo 2014, Hyderabad, June 22, 2014.
146. Participated in the joint DBT Task Force for Scheduled castes, Scheduled Tribes and
Rural women, held at Delhi, July 1-2, 2014.
147. Was chief guest and delivered a lecture on “Drug Resistance in Bacteria with special
emphasis on MDR & XDR-Tuberculosis: at RKG Institute of Technology, Ghaziabad, 27
August, 2014
148. Participated in the joint DBT Task Force for Scheduled castes, Scheduled Tribes and
Rural women, held at Jammu, September 4-6, 2014
149. Participated in the editors meeting of Wolters Kluwer India, held at AIIMS, New Delhi,
November 5, 2014.
150. Delivered an invited guest lecture on “Newer diagnostic tests in pulmonary Tuberculosis”
AIIMS Conference on Childhood Tuberculosis, Held at New Delhi, 15 Nov, 2014
25 of 81
151. Delivered an invited lecture on “Visceral Leishmaniasis: Changing trend in
Epidemiology and Management” during the 8th National Conference of Indian Academy
of Tropical Parasitology held at Dibrugarh, Assam on November 20, 2014
152. Chaired the session and Delivered an invited lecture on “Seroepidemiology of
Toxoplasmosis: National Scenario” during the pre-conference CME of 8th National
Conference of Indian Academy of Tropical Parasitology held at Dibrugarh, Assam on
November 21, 2014
153. Delivered invited guest lecture on “Comparison of different genotypic tests in TB”
during the 8th National Respiratory Update, at Bombay on 28th November 2014
154. Participated in the Joint Scientific Advisory Committee of of NIRT and JALMA, on
Tuberculosus held at Agra, November 29-30, 2014.
155. Delivered the special guest of Honour Lecture on “HIV/AIDS” at Bundelkhand
University, Jhansi, at the occasion of World AIDS Day, December 1, 20014.
156. Delivered an invited guest lecture titled “Tracking the drug resistance” during the
National Symposium on Hospital Acquired Infections & Antimicrobial Resistance, held
at Jawaharlal Nehru Medical College, AMU, Aligarh, December 9, 2014.
157. Delivered an invited guest lecture titled “Human Herpse Viruses in HIV/AIDS: Indian
scenario” during the Seventh National Conference of AIDS Society of India (ASICON-
2014), held at Calcutta, December 12-13, 2014.
158. Delivered a guest lecture on National Institute for Research in Tuberculosis (NIRT),
ICMR, Chennai. December 14-15, 2014
159. Participated in DBT task force meeting held at New Delhi, January 29-30, 2015
160. Delivered an invited guest lecture on “Molecular tests for the diagnosis of Tuberculosis”
during the “TB update” organized by Vadodra Chest association, held at Vadodara
March 22, 2015
161. Chaired a session and organized the “Brain storming symposium on Tuberculosis:
Challenges in diagnosis and management” organized at the occasion of World TB Day,
AIIMS, New Delhi, 24th March 2015.
162. Participated in the Editors Meeting of Wolters Kluwer India, held at Hotel Marriott,
March 26, 2015.
163. Delivered an invited lecture on “Human Toxoplasmosis in Pregnant women” during the
State Chapter of Tropacon, organized by Indian Academy of Tropical Parasitology, held
at Kasturba Medical College, Manipal, Karnataka, May 1, 2015.
164. Delivered an invited lecture on “Molecular tests for the diagnosis of Tuberculosis”: A
CME on TB organized by Uttarakhand Chest Association and Clinton Health Access
Initiative, Delhi, at Dehradun, May 17, 2015.
165. Delivered an invited lecture on Parasitic Zoonotic Diseases. During a CME organized
jointly by IMA and Millennium India Education Foundation , New Delhi, IMA HQ,
Delhi, July 6, 2015.
166. Delivered an invited lecture on on R & D in India: Infrastructure and Its role in
Economic growth of the country: during the Indo-Global Education Summit , ITC Hotel,
Hyderabad, November 12-14, 2015.
167. Delivered an invited lecture on AIDS/AIDS in young adults: what you need to knwo: A
key note address as Chief Guest, during the National Science Colloquium and 1 st
Scholar’s Meet, Ghaziabad, UP, October 26, 2015.
168. Delivered an invited lecture on Opportunistic Parasitic infections: Preconference Hands
On-Workshop on the Laboratory Diagnosis of Intestinal Parasitic Diseases: under the
aegis of Indian Association of Medical Microbiologists- Delhi Chapter (MICRO-D-CON
2015). AIIMS, New Delhi, December 10, 2015
26 of 81
169. Session Chair: Scientific session on infections in pregnancy, during the 59th All India
Congress of Obstetrics and Gynecology, Hotel Kalakriti, Agra, January 15, 2016.
170. Delivered an invited lecture on Toxoplasmosis in Pregnant women: an update, during the
59th All India Congress of Obstetrics and Gynecology Hotel Kalakriti, Agra, January 15,
2016.
171. Delivered an invited lecture on Diagnosis of pulmonary Tuberculosis: during the CME
organized by Agra Pathology Association, Agra, February 6, 2016.
172. Novel technologies in the diagnosis of Tuberculosis: CME to commemorate the World
TB Day at Mahatma Gandhi Mission University of Health Sciences (MGMUHS), Navi
Mumbai, March 19, 2016.
173. Gave a Radio-Live talk on Tuberculosis for general public awareness on FM Gold, All
India Radio, March 22, 2016
174. Delivered an invited lecture on Recent advances in the diagnosis of Tuberculosis: during
the National symposium on Challenges in Tuberculosis Diagnosis and Management:
organized by AIIMS at the occasion of World TB Day, AIIMS, New Delhi, March 30,
2016.
175. Chaired the Brainstorming Meeting on “MDR-TB in NER India” and delivered a lecture
held at Institute for Advanced Studies in Science and Technology (IASST), Guwahati,
August 19-20, 2016.
176. Speaker and panel discussant on Tuberculosis, during the 6th Annual Conference of
Clinical Infection Diseases Society, held at BHU, Varanasi, August 26-28, 2016.
177. Chief Guest and keynote speaker during the National Workshop on Latest Techniques in
Molecular Biology, Medical Biotechnology, Bioinformatics and Industrial Microbiology
at Amity University, Gwalior, October 12, 2016.
178. Delivered invited plenary lecture on Recent advances in Haemoparasites-Toxoplasmosis:
during the 9th National Conference of Indian Academy of Tropical Parasitology,
organised at JIPMER, Pondicherry, November 4, 2016.
179. Judged the poster session for various prizes during the 9th National Confreence of Indian
Academy of Tropical Parasitology, organised at JIPMER, Pondicherry, November 5,
2016.
180. Attended and actively participated as member of the SAC Meeting of DMRC (ICMR)
Jodhpur as its member and Delivered guest lecture in the Rajasthan Conclave, organized
by DMRC, Jodhpur, November 12-13, 2016.
181. Attended and actively participated as member of the Joint SAC Meeting of JALMA,
Agra and NIRT (ICMR) , Chennai held in Agra, November 15-16, 2016.
182. Delivered an invited lecture on Water born parasitic diseases, lecture during the 40th
National Conference of Medical Microbiologists (Microcon-2016) held at Chandigarh,
November 23-27, 2016.
183. Chaired the session during the 40th National Conference of Medical Microbiologists
(Microcon-2016) held at Chandigarh, November 23-27, 2016.
184. Delivered Oration Award Lecture on Leishmania research during the National
Conference of Indian Immunology Society, held at Vishakhapatnam, February 16-18,
2017.
185. Delivered a lecture on New Diagnostic tools for Tuberculosis during the symposium on
“Challenges in diagnosis and elimination of Tuberculosis” held at AIIMS, New Delhi,
March 24, 2017
186. Delivered invited lecture on Mycobacteria of Zoonotic importance: with special
emphasis on Mycobacterium avium subsp paratuberculosis during the 17th Indian
Veterinary Congress & National Symposium on New Generation Vaccines for Societal
benefits at IVRI, Bareilly from April 8-9, 2017
27 of 81
187. Chaired a Scientific Session during the17th Indian Veterinary Congress & National
Symposium on New Generation Vaccines for Societal benefits at IVRI, Bareilly from
April 8-9, 2017.
188. Delivered an invited talk on Recent Advances in the Diagnosis of Tuberculosis during the
national symposium on "Multidrug Resistant Tuberculosis: Challenges & Strategies”
held at Amity Universiry, Haryana, April 20, 2017.
189. Delivered an invited lecture on Recent Developments in the transmission of Visceral
Leishmaniasis during the 27th Indian Society of Parasitology Congress at NIMHANS,
Bangalore, April 25-27, 2017
190. Delivered an invited lecture on “Human Herpes Viruses and HIV: How much we know
about their co-pathogenesis” during the Second Euro International Conference on HIV
and AIDS , held at Kottayam, Kerala, May 12-14, 2017.
191. Delivered an invited lecture on Good Laboratory Practices during the workshop on
Molecular Biology Techniques & Stem Cells in Human Health and Diseases" at Amity
Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University
Noida, June 16, 2017
192. Delivered invited plenary lecture on “Recent advances in Toxoplasmosis Research”.
during the 10th National Conference of Indian Academy of Tropical Parasitology,
organised at SKIMS, Gangtok, Sikkim, September 7, 2017.
193. Presented a paper on “Prevalence of Soil Transmitted Helminthic parasitosis in Delhi
School Children” during the 10th National Conference of Indian Academy of Tropical
Parasitology, organised at SKIMS, Gangtok, Sikkim, September 7, 2017.
194. Judged the poster session for various prizes during the 10th National Conference of Indian
Academy of Tropical Parasitology, organised at SKIMS, Gangtok, Sikkim, September 7,
2017.
195. Organized a pre-conference hands-on workshop on “Diangosis of Opportunistic Parasitic
infections” during the 41st National Conference of IAMM, at Ranchi, Jharkhand, India,
November 22, 2017.
196. Organized and chaired a special Symposium on “Drug resistant Tuberculosis” as a part
of the 41st National Conference of IAMM, at Ranchi, Jharkhand, India, November 24-26,
2017.
197. Delivered an invited lecture on “Recent advances in the laboratory diagnosis of MDR
tuberculosis” during the special Symposium on “Drug resistant Tuberculosis” as a part of
the 41st National Conference of IAMM, at Ranchi, Jharkhand, India, November 24-26,
2017.
STUDENTS GUIDED/SUPERVISED
• STUDENTS GUIDED/SUPERVISED
For Degree of Ph.D.
As Chief Guide:
1. Ms. Shahdad Saba: Species identification of Mycobacteria using 16S rRNA gene
sequencing.1999
2. Mr. Mohapatra DP: Studies on the stage specific antigenic proteins of Toxoplasma
gondii and their possible diagnostic and immunoprophylactic application. 2000
28 of 81
3. Mr. Ramu Sivakumar: Studies on Kinesin related antigen gene of Leishmania
donovani and its diagnostic application.2001
4. Ms. Sudha Garg:. Studying the genetic basis of drug resistance in Leishmania
donovani.2000
5. Ms. Manjot Kaur: Study of the utility of automated Mycobacterial culture system
(Bactec-960) and PCR technique for Mycobacterial disease diagnosis. 2001
6. Mr. Ayan Dey: Developing chimeric DNA vaccines for Leishmaniasis and
Tuberculosis. 2004
7. Mr. Krishnamoorthy Gopinath: PCR and sequence based identification of
Mycobacterium sp from extrapulmonary tuberculosis cases. 2004
8. Ms. R.Kumud: Clinical and Molecular evaluation of Drug resistance patterns in HIV
positive and negative patients. 2005
9. Mr. Sandeep Kumar: Genotyping of Mycobacterium tuberculosis using Molecular
methods,Spoligotyping and IS6110 RFLP Contact investigations in tuberculosis.
2005
10. Ms. Anubha Saxena: Study of molecular mechanism of Miltefosin induced drug
resistance in Leishmania donovani. 2005
11. Mr. Umakant Sharma: Isolation and Purification of active compounds with Anti-
Leishmanial activity from Indian flora. 2006
12. Ms. Jyotsna Mishra: Elucidating the expression profile of the genes involved in
apoptosis of L. donovani & their possible role in miltefosine resistance. 2006
13. Mr. Manimuthu Mani Sankar: Detection of Mycobacterium in patients of
suspected extra pulmonary tuberculosis. 2006
14. Mr. Manoj Kumar:Prevalence of Beijing and non-Beijing genotypes of
Mycobacterium tuberculosis isolated from different human body sites. 2007
15. Mr. Amit Singh: Identification, molecular cloning and characterization of protein(s)
involved in multi-drug resistance of Mycobacterium tuberculosis. 2008
16. Ms. Arshi Munawwar: To study the Role of Various Human Herpes Viruses in the
Sexual Mode of Transmission and Pathogenesis of HIV-1. 2008
17. Mr. Parveen Kumar: Development of a Loop Mediated ISO thermal Amplification
Assay (LAMP) for rapid detection of Mycobacterium tuberculosis & Non
tuberculosis Mycobacteria (NTM) for clinical samples. 2010
18. Mr. Jitendar Singh: Molecular epidemiology of Mycobacterium tuberculosis
isolated from various parts of India. 2010
19. Mr. Prem Shankar: Isolation and characterization of Leishmania and Leishmania
like parasites from seropositive goats. 2011
20. Mr. Dinesh Kumar: To see the prevalence of Microsporidia in stool samples of
HIV-seropositive and HIV-seronegative adult and paediatric patients with diarrhoea.
2011.
21. Mr. Anil Kumar Gupta: Raising mono and polyclonal antibodies against novel
antigens of M. tuberculosis and their diagnostic value in clinical samples. 2012
22. Ms. Syed Beenish Rufai: “Development of new molecular test(s) for rapid diagnosis
of India specific Pre -XDR/XDR- TB. 2012.
23. Ms. Saumya Srivastava. Cloning expression and purification of the novel
recombinant protein from Toxoplasma gondii and its evaluation for the diagnosis of
human toxoplasmosis. 2014
29 of 81
As Co-guide:
1. Ms. Raj Kumari: Sequence based species identification of Mycobacteria from
tubercular lymphadenitis and environment. (Shri Shahu Ji Maharaj Kanpur
University). 2001-2008
2. Mr. Nagendra Kumar Kaushik: Effects of Stress proteins in Infectious Diseases.
Delhi University, Delhi, 2007-2011.
3. Mr. Mohammed Naseem Mansoor: Study of genetic predisposition and biochemical
risk factors for Alzheimer’s disease and vascular dementia. Department of
Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, 2005-2011
4. Ms. Nidhi Bhardwaj: Department of Laboratory Medicine, All India Institute of
Medical Sciences, New Delhi, 2010-2017
5. Ms. Ritu Singh: Survival Strategy of Mycobacteria in Dormancy through
Transcriptional Control. Faculty of Life Sciences, Chhatrapati Shahu Ji Maharaj
University, Kanpur.
6. Ms. Manisha Bhatnagar, Evaluation of anti-leishmanial and antimycobacterial
activity of herbal products. Amity University, NOIDA, India
D.M.
As Co-guide
1. Dr. Atul Kumar Srivastava:
Assessment of risk factors, clinical profile and outcome of early versus late CMV
infection in Living Renal allograft Recipients, in Indian Context. With Department of
Nephrology. 2014-2016.
2. Dr. Shreepriya Joshi:

Pulmonary infections in renal transplant recipients: a prospective cohort observational
study. With Department of Nephrology. 2015-2017.
3. Dr. Nishita Mohan Philip:

Impact of universal CMV prophylaxis with valganciclovir on CMV infection in live
renal transplant recipients in Indian setting. With Department of Nephrology. 2016-
2018.
M.D.
As Chief Guide
1. Dr. Alok Mohanty: The incidence of hepatitis E virus infection in pregnant women
with hepatitis seen at AIIMS and pregnancy outcome in those infected. 1999-2001.
2. Dr. Naveen Kumar: Standardization and evaluation of PCR technique for early
diagnosis of congenital HCMV infection. 2001-2003.
3. Dr. Taran Prit Saluja: Evaluation of fast plaque TB (Bacteriophage) assay in the
detection of Mycobacterium tuberculosis and its comparison with conventional
culture methods and Polymerase chain reaction. 2002-2004.
4. Dr. Richa Gupta: Transmission rate of HBV and HCV in family members of dually
infected patient. 2005-2007.
5. Dr. Ashish Hota: Hepatitis B viral load monitoring in patients undergoing Anti-HBV
therapy using Quantitative Real-Time PCR. 2006-2008.
6. Dr. Varsha Singhal: Hepatitis B in Health Care Workers: Prevalence, Vaccination
and relation to occupational factor. 2007-2009
30 of 81
7. Dr. Rajeswari Jaykumar: Hepatitis B viral load monitoring in patients undergoing
anti-HBV therapy using quantitative Real Time PCR. 2009-2011
8. Dr. Parveen Kumar. To Study the prevalence of UL97 gene mutation in
Gangyclovir non-responders vis-à-vis responder in Indian renal transplant patients.
2011-2013
9. Dr. Ranjit Kumar. To study the performance of Xpert MTB/RIF in urine of patients
with pulmonary and extra-pulmonary tuberculosis. 2015-2017.
As Co-guide:
1. Dr. Urmila Gupta: Study of the efficacy of ketoconazole in visceral leishmaniasis.
Department of Medicine, 1992-1994.
2. Dr. Sesham Uma Rani: Prenatal diagnosis of congenital Toxoplasmosis using PCR
on amniotic fluid. Department of Obstetrics & Gynaecology. 1996-1998
3. Dr. A.B. Singh: Seroprevalence of Toxoplasma infection among primigravida
women attending antenatal clinical at C.R.H.S, Ballabhgarh, Haryana. Department of
community medicine, AIIMS. 1998-2000.
10. Dr. Dharmendra Gupta: Evaluation of various diagnostic modalities in suspected
cases of tubercular lymphadenitis. VP Chest Institute, Delhi University, 1999.
11. Dr. Abhijit Ghosh: Laboratory evaluation of renal functions in severe anaemia.
Department of Laboratory Medicine, 2000-2002.
12. Dr. Jaya Sinha: Comparison of antibodies to nicotinic acetylecholine receptors and
non-receptor muscle autoantigens in myasthenia gravis. Department of Laboratory
Medicine, 2000-2002.
13. Dr. Niladri Mal: Serum adenosine deaminase isoenzymes in myasthenia gravis.
Department of Laboratory Medicine, 2002-2004
14. Dr. Rachna Rustgi: Evaluation of immune status of Rubella in adolescent unmarried
girls and pregnant women. (Department of Obstetrics and Gynaecology, AIIMS).
2002-2004.
15. Dr. Lokesh Pant: Evaluation of Diagnostic tests in suspected TBM patients.
Department of Medicine, BHU, Varanasi. 2002-2004.
16. Dr. Santosh L Wakode: Absorption of glucose, water and electrolytes from
commercially available oral rehydration solutions in small intestine of rats.
Department of Physiology, AIIMS. 2002-2004.
17. Dr. Mrinal Nanda: Profile of nosocomial infections in the paediatric ICU.
Department of Paediatrics, AIIMS. 2002-2004.
18. Dr. Manjeera Jagannati: Opportunistic infections in AIDS patients attending
AIIMS. Department of Medicine. 2002-2004.
19. Dr. Chanaveerappa B: Spectrum of Opportunistic parasitic infections in AIDS
patients. With Department of Medicine. 2003-2005.
20. Dr. BN Vinodh. Prevalence of Bacteraemia and fungimia in HIV/AIDS. With
Department of Medicine, 2004-2006.
21. Dr. DK Muduly: Focussed abdominal sonography in trauma (FAST) in patients
with blunt trauma abdomen. With Department of Surgery, 2006-2008.
22. Dr. Pawan Kumar Sarda: To study reintroduction of anti-tuberculosis drugs and
risk factors for anti-tuberculosis treatment induced hepatotoxicity. With Department
of Medicine, 2004-2006
23. Dr. Venkanna: Prevalence and treatment response of coccidian parasitic infections
in HIV positive patients at AIIMS. With Department of Medicine, 2005-2007.
31 of 81
24. Dr. Rohit Singla: To study reintroduction of anti-tuberculosis drugs and risk factors
for anti-tuberculosis treatment induced hepatotoxicity. With Department of Medicine,
2007-2009
25. Dr. Malik Ajharuddin: Study of Mycobacteremia in Patients with extrapulmonary
and disseminated tuberculosis. With Department of Medicine. 2007-2009.
26. Dr. Moka Praneeth: Study of Mycobacteremia in Milliary and disseminated
tuberculosis. With Department of Medicine. 2009-2011.
27. Dr. Varun Raghavan: Viral hepatitis co-infection among HIV/AIDS. With
Department of Medicine. 2009-2011.
28. Dr. Anil Satyaraddi: Estimation of Free Rifampicin Drug Levels in Patients on
Anti-Tuberculosis Therapy. With Department of Medicine. 2010-2012.
29. Dr. Aditya Singh Katiyal. A Sudy of Haemostasis parameters in Tuberculosis.
Department of Medicine, Maulana Azad Medical College, New Delhi, 2010-13.
30. Dr. Dibyasundar Mahanta. To study the diagnosis utility of GeneXpert in diagnosis
of pleural and lymphnode tuberculosis. With Department of Medicine. 2012-2014.
31. Dr. Shailesh Patel. Rapid diagnosis of Mycobacterium tuberculosis by GeneXpert in
gastric aspirate of children with smear negative pulmonary tuberculosis. With
Department of Paediatric Dr. RML Hospital and PGIMER, New Delhi, 2014-2016
32. Neha Bidhuri. Rapid Diagnosis of Mycobacterium tuberculosis by GeneXpert in
gastric aspirates of children with clinically and radiologically diagnosed cases of
pulmonary tuberculosis. With Department of Paediatric Dr. RML Hospital and
PGIMER, New Delhi, 2015-2017
33. Pronita Banerjee. Rapid Diagnosis of Suspected Pulmonary TB in Children Less
Than 18yrs by Loop-mediated Isothermal Amplification. With Department of
Paediatric Dr. RML Hospital and PGIMER, New Delhi, 2017-2020.
MSc. /M. Tech Students (only Recent)
2005
Pawan Dharkee, CCS University, Meerut
Naveen Kumar Bhardwaj, Bundelkhand University, Jhansi
Vijaya Bharti, Dept. of Biomedical Science, Bundelkhand University, Jhansi
Dilip Kumar, Dr. B.R. Ambedkar University, Agra
Prasant Kumari, Dr. Bhim Rao Ambedkar University, Agra
Vinay Sagar, Bundelkhand University, Jhansi
Varish Ahmed, Dept. of Biotechnology, Madhav Institute of Technology, Gwalior
2006
Preeti Tripathi, Dept of Biotechnology, CSJM University, Kanpur
Mona Singh, Allahabad Agriculture Institute, Allahabad
Ms. Anjali, Dept. of Biosciences, Sardar Patel University, Vallabh Vidyanagar,
Gujarat
Prodiksha Chaturvedi, Jiwaji University, Gwalior
Ms. Chandni Trehan, Dept. of Biotechnology, Guru Jambeshwar University, Hissar
Parul Aggrawal, Extol Faculty of Life Sciences Bhopal
Arshi Munawwar, Extol Faculty of Life Sciences, Bhopal
Shivani Chabra, Dolphin Institute of Biomedical & Natural Science, HNB Garwhal
Univ. Srinagar
32 of 81
Stephan Carpenter, University of Massachusetts Medical School’s
Jogendra Singh Nim, Ch. Charan Singh University, Meerut
Ginni Singh, Ch. Charan Singh University, Meerut
Garima Sharma, Banasthali Vidyapeeth
2007
Shatakshi Sood, Bioengineering Research Centre, Rai Foundation College, Delhi
Hem Kumar, Ch. Charan Singh University, Meerut
Dolly Dixit, Ch. Charan Singh University, Meerut
Harishankar Yadav, EFLS Extol College, Bhopal
Shah Alam, JRN-RVP-University, Udaipur
Sharad Kr. Nimlekar, Bundelkhand University
Dr. Rajani Malla (Ph.D.), Department of Microbiology, Tribhuvan University,
Kathmandu, Nepal
2008
Kumar Siddarth Talakdar, Jaypee Institute of Information Technology University,
Noida
Deepak Parashar, I.P. College, Bullandshahr
Mamta Mishra, Punjab Technical University, Delhi
Mohd. Tarique, Deptt. of Biotechnology, Jamia Hamdard, New Delhi
Raj Narayan Yadav, Allahabad Agriculture Institute, Deemed University, Allahabad
2009
Tanika Singh, Punjab Technical University, Delhi
Cynthiya, Madurai Kamraj University, Madurai
Manisha Jain, Punjab Technical University, Delhi
Pratiksha Singh, CCS University, Meerut
Pratima Devi, Dr. BR Ambedkar University, Agra
Ravi Rajput, Deptt. of Microbiology, Ch. Charan Singh University, Meerut
Ravi Raj Singh, Deptt. of Microbiology, Jiwaji University, Gwalior
Himank Kumar, College of Nursing, L.H.M.C., New Delhi
Rhea Tyagi, Amity University
Shefali Jain, Dept. of Microbiology, Jiwaji University, Gwalior
Nayeem Ahmed, Deptt. of Microbiology, Ch. Charan Singh University, Meerut
2010
Ravi Raj Singh, Deptt. of Microbiology, Jiwaji University, Gwalior
Nisha Fatima, Deptt. of Biotechnology, Institute of Engg. & Technology, Meerut
Paramjeet Kinha, Vanasthali Vidyapeeth University, Rajasthan
Nayeem Ahmed, Deptt. of Microbiology, Ch. Charan Singh University, Meerut
Ravi Rajput, Deptt. of Microbiology, Ch. Charan Singh University, Meerut
2011
Sanchit Bhatnagar, Amity University, NOIDA
Abhay Jeet Singh, Amity University, NOIDA
Shreyanshi Paul, Amity University, NOIDA
Iqram Singh, Amity University, NOIDA
Siddhartha Singh Shisodia, Amity University, NOIDA
Syed Beenish Rufai, H.N.B. Garhwal University Uttrakhand
33 of 81
2012
Preeti Gujan, Jiwaji University, Gwalior
Bhairab Mondal, Jiwaji University, Gwalior
Sakshi Rawat, N.C. College of Engineering, Kurukshetra University
Niharika Marmat, Vikram University, Ujjain
Karuna Goswami, Jiwaji University, Gwalior
Alpana Singh, Jiwaji University, Gwalior
2014
Vivek Singh Rawat, HNB University, Garhwal
Divya Sharma, Banashtali Vidyapeeth, Jaipur
2016
1. Shruti Kahol, Jamia Hamdard University, Delhi
2. Pavitaran Alambyan, Departmnet of Biophysics, AIIMS, New Delhi
Short Term Trainings Imparted:
1. Conducted a three Months Certificate Course on Molecular Methods in Infectious Disease

Diagnosis (Govt. of India Programme), March- June 1996.
2. Several M.Sc. and Ph.D. students from various universities from within and outside India
have been offered summer and other short term training on the molecular biology and
diagnostic microbiology in my laboratory.
3. National level Continuing Medical Education Programme on Molecular Methods in
Infectious Disease Diagnosis, AIIMS, November 21, 1997.
4. One MD Student from University of Karolinska (Sweden) was taught AIDS and trained for
diagnosing the opportunistic infectious diseases in AIDS patients, under International
Collaborative Programme for 15 days in 1998-99.
5. Conducted a Ten days hands-on molecular biology training programme sponsored by World
Health Organisation and National Institute of Biologicals. July 6-15, 1999.
6. Conducted a hands-on-training programme on gene amplification techniques including
NASBA for senior scientists. January 21-15, 2000.
7. Conducted a hands-on DBT sponsored workshop on Molecular methods for Infectious
Disease Diagnosis for Mid-career Laboratory Managers from December 1-21, 2000.
8. Three months Summer training given to 5 PG /PhD students from AMU, Aligarh; Dr. BR
Ambedkar University, Agra; University of Patiala and Patliputra University, Patna, in 2001.
9. In year 2002, Six months training was imparted to 6 PG/PhD students from, Vikram
University, Ujjain; Garhwal University, Srinagar; Jamia Millia University, Delhi and IIT,
Bombay in 2002.
10. Six months training on molecular biology was imparted to 5 PG/PhD students from Vikram
University, Ujjain, Bundelkhand University, Jhansi and MD University, Rohtak in 2003.
11. Eight students, 4 from Bundelkhand University, Jhansi; 2 from JP Institute of Technology,
Himachal Pradesh, 1 from Allahabad University, Allahabad and 1 PG doctor from Cuttack,
Orissa underwent short term training in Molecular Biology during 2004.
12. One MD student (Eric Fauvel) from University of Paris underwent training in TB laboratory
under my guidance for 3 months, August-November , 2004.
34 of 81
13. Nine students, 4 from Bundelkhand University, Jhansi; 2 from CCS University, Meerut; 2
from Dr. Bhim Rao Ambedkar University, Agra; and 1 from Madhav Institute of
Technology Science, Gwalior; underwent short term training in Molecular Biology in 2005.
14. Nine students, 2 from Bhopal University, Bhopal, 1 from Guru Jambeshwar University,
Hissar, 1 from Sardar Patel University, Anand, Gujarat, 1 from Madhav Institute of
Technology Science, Gwalior, 1 from CSJM University, Kanpur, 1 from Bundelkhand
University, Jhansi, 1 from Allahabad Agricultural University, Allahabad, 1 from Jiwaji
University, Gwalior underwent short term training in Molecular Biology during 2006.
15. One student from University of Massachusetts, USA worked successfully on a research
project in my laboratory from August to November 2006.
16. Organised workshop on Right to information for government employees, on 27th April 2007.
17. Ten national and international participants were trained on NASBA system for HIV Viral
Load monitoring during the Preconference International workshop on January 25, 2008.
18. Twenty five participants were trained on recent advances in the diagnosis of intestinal
parasitic diseases during the Pre-IAMM conference workshop November 21, 2012.
19. Ten participants from NER India were trained during a Short term training course on recent
techniques in infectious disease diagnosis for mid-career doctors/scientists of North East
Region in India from 29thApril to 9th May 2013
ORGANISATION OF SCIENTIFIC CONFERENCES/ MEETINGS
1. Member- National Congress of Medical Microbiologists, at All India Institute of

Sciences, New Delhi, October, 1992.
2. XXXIII National Conference of Indian Society of Gastroenterology at All India Institute
of Medical Sciences, New Delhi, November 1992.
3. Organising Secretary-National Symposium on Toxoplasmosis in India. First
symposium held at AIIMS, New Delhi from September 27-28, 1995.
4. Member- International CME on Laboratory Approach to Paediatric Problems, at All
India Institute of Medical Sciences, New Delhi, October 11-13, 1995.
5. Course Director- Three Months Certificate Course on Molecular Methods in Infectious
Disease Diagnosis (Govt. of India Programme) March- June 1996.
6. Organising Secretary-National Continuing Medical Education Programme on
Molecular Methods in Infectious Disease Diagnosis, AIIMS, November 21, 1997
7. Organising Secretary-National Symposium on Rapid Diagnosis of Infections in
Immunocompromised Hosts, AIIMS, November, 22-23, 1997.
8. Course Co-ordinator for WHO-AIIMS-NIB Hands-on Workshop on Molecular
methods in Infectious Disease Diagnosis. July 5-15, 1999.
9. Organising Secretary-First National Conference of Laboratory Medicine, AIIMS, New
Delhi from January 27-29, 2000.
10. Course Co-ordinator- Hands-on Workshop on Molecular Methods in Disease
Diagnosis. AIIMS, New Delhi, January 21-25, 2000.
11. Course Director- DBT-AIIMS, Hands-on Wet Workshop on Automation and Molecular
Methods in Infectious Disease diagnosis. December 1-23, 2000.
12. Organising Secretary, Hands-on Workshop on Molecular Methods in Infectious
Disease Diagnosis, AIIMS, New Delhi, February 16-20, 2002
13. Organising Secretary, Second National Conference of Laboratory Medicine, AIIMS,
New Delhi, Feb. 21-23, 2002.
35 of 81
14. Organising Secretary, International Symposium on Leishmaniasis, New Delhi, Feb.
23-24, 2002
15. Course Director- DBT-AIIMS Hands-on Workshop on Molecular Biology in Infectious
Disease Diagnosis, May 1-23, 2002
Disease Diagnosis, August 4-23, 2003
Disease Diagnosis, February 17- March 5, 2005.
18. Course Director- Hands-on Workshop on HIV Viral Load monitoring, AIIMS, New
Delhi, March 25-26, 2006.
19. Course Director- Hands-on Workshop on Molecular Diagnosis of Tuberculosis, AIIMS,
New Delhi, March 25-26, 2006.
20. Course Director- Hands-on Workshop on Laboratory Diagnosis of Opportunistic
Intestinal Parasites in AIDS Patients, AIIMS, New Delhi, March 25-26, 2006
21. Course Director- Hands-on Workshop on Laboratory Diagnosis of acute Toxoplasmosis
in AIDS, AIIMS, New Delhi, March 26, 2006.
22. Organising Secretary, International Conference on Opportunistic Pathogens in
AIDS (ICOPA-INDIA), New Delhi, February 27-29, 2006.
23. Chairman, International Conference on Opportunistic Pathogens in AIDS (ICOPA-
INDIA), New Delhi, February 27-29, 2008.
24. Chairman, Organising Committee, Second National Conference of Tropical
Parasitology (Tropacon-2), New Delhi, October 30- November 2, 2008.
25. Chairman, International Conference on Opportunistic Pathogens (ICOPA-
INDIA), New Delhi, September 27-30, 2010.
26. Chairman, Organising Committee, One day TB awareness and anti-spitting rally and
awareness programmes organized on the occasion of World TB Day, New Delhi, 24th
March 2014.
27. Chairman, Organising Committee, TB awareness Marathon, organized on the occasion
of World TB Day, New Delhi, 24th March 2014.
28. Chairman, Organising Committee, One day “Brain storming symposium on
Tuberculosis: Challenges in diagnosis and management” and expert panel discussion,
organized at the occasion of World TB Day, New Delhi, 24th March 2015.
29. Chairman, Organising Committee, Hands On-Workshop on The laboratory Diagnosis of
Intestinal Parasitic Diseases: under the aegis of Indian Association of Medical
Microbiologist Delhi Chapter (MICRO-D-CON 2015). December 10, 2015.
30. Chairman, Organising Committee, CME on Rapid Diagnostics: During the Bio-Asia
Global Summit under the aegis of Federation of Asian Biotech Associations [FABA] ,
Hotel Novotel, Hyderabad. February 8, 2016.
31. Chairman, Organising Committee, National symposium on Challenges in Tuberculosis
Diagnosis and Management: t organized at the occasion of World TB Day, March 30,
2016.
32. Chairman, Organising Committee, National Conference on Scientific Updates on
Zoonotic Disease Control, at AIIMS, New Delhi, On the occasion of World zoonosis
day- July 6, 2016.
33. Chairman, Organising Committee, PG Assembly, 2016 for MD students titled
“Preparing for the future” under the aegis of IAMM-Delhi, August 22-24, 2016.
36 of 81
34. Chairman, Organising Committee, Hands on Workshop for Technical Staff for Quality
Control in Serology. under the aegis of IAMM-Delhi, September 9-12, 2016.
35. Chairman, Organising Committee, Symposium on “Challenges in Diagnosis and
Elimination of Tuberculosis” on Worlf TB day-March 24, 2017.
36. Chairman, Organising Committee, Indian Association of Medical Microbiologists –
Delhi Chapter meeting. March 25, 2017.
37. Chairman, Organising Committee, National Conference on Scientific Updates on
Zoonotic Disease Control, at AIIMS, New Delhi, On the occasion of World zoonosis
day- July 6, 2017.
Organization of Medical and-Social Awareness Camps
Actively involved in social upliftment of underprivileged and providing free medical help and
awareness programmes through medical camps, public lectures etc.
• 2009 Organised a WORKSHOP ON SOLID WASTE MANAGEMENT, at Jindal
International School, Rohini on January 11, 2009.
• 2008, Co-organised a Free Medical Check-up camp at Jindal International School, Sector,
28, Rohini, Delhi on Sunday, the 20th April
• 2007, Co-organised a Free Medical Check-up camp at Jindal International School, Sector,
28, Rohini, Delhi on Sunday, the 22nd April.
• 2007 Organised a Seminar-Cum-Workshop on RTI, Act, 2005 on Sunday, the 27th. May,
at AIIMS, New Delhi
• 2006, Organised One Day Free Medical Camp with CAP Foundation at Jindal Public
School, Dashrathpuri, Dwarka Palam Road, New Delhi on Sunday, the 27th September.
• 2004 , Organised medical camp at Gurgaon through an NGO
• 2002, Organised kala-azar and malaria diagnostic camps various districts of Bihar
• 2000, Organised kala-azar detection camp in Samastipur district of Bihar
• 1998-9, Organised kala-azar detection camp in Samastipur, Vaishali, Patna, Hazipur,
Bihar
• 1996-1997, Organised kala-azar detection camp in Darbhanga, Samastipur, Shahibganj,
Dumka and Vaishali districts, Bihar
• 1993 Organised a medical camp to help, diagnose and treat the victims of poisonous
smoke broke out in Kardam Puri, Trans-Yamuna area of Delhi. Findings Published in
Lancet.
37 of 81
Research projects Directed with main outcomes
As Principal Investigator
Title Funding agency Period

1. PCR for the Diagnosis of Toxoplasmosis DBT, India 1991-1993
Developed an in-house PCR kit for the diagnosis of antenatal
and acquired Toxoplasmosis. The protocol and primers are
being routinely used in diagnostic laboratory.
2. TNF-alpha in Malaria AIIMS 1992-1993
High levels of TNF- were found in patients with fulminant
and cerebral falciparum malaria, as compared to benign
malaria. The results are published in peer reviewed journals.
3. Developing Indigenous ELISA, DAT & Latex DBT, India 1996-1999
agglutination test kits for the diagnosis of Acute
Toxoplasmosis.
Developed an in-house modified direct agglutination test kit.
The kit is patented in India for the diagnosis of human and
animal toxoplasmosis.
4. Are Visceral and post Kala-azar dermal leishmaniases DBT, India 1996-2000
caused by same stain of L. donovani?
This study revealed that VL and PKDL isolates of Leishmania
donovani have significant genetic heterogeneity . These
isolates also have significant difference in their drug
susceptibility patter to standard drugs. Several papers have
been published from the project.
5. Identification of Drug Resistant strain (s) of clinically DBT, India 1996-2000
relevant Mycobacteria specially M. tuberculosis and genes
associated with resistance.
A data base was prepared for the first time from North India
and several new species and strains of M. tuberculosis were
identified. These strains were used as resource by other
scientists of the country.
6. Isolation of free living amoeba from AIIMS water supply. AIIMS 1996-1999
Acanthamoebae were isolated in majority of drinking water
samples collected from households. The isolation was
significantly higher from the pre-filter collection and
overhead tanks. The findings are published.
7. PCR and Cytokine assays in the diagnosis of visceral ICMR, India 1999-2001
leishmaniasis.
This pilot project revealed possibility of animal reservoirs of
Indian VL. This hypothesis lead us to plan a bigger study to
screen various domestic and wild animals using molecular
methods of screening.
8. Collection of well-characterized clinical samples for the DBT, India 1996-2000
purpose of evaluation of tests developed by various groups
for early detection of M.tuberculosis.
As evident from the title, a repository of Mycobacterial
isolates and clinical samples was established. The well
characterized isolates and clinical material was/is being
38 of 81
sourced out to various other scientists working on TB
diagnosis. Several daughter projects were planned out from
this resource.
9. Collection of well-characterized clinical samples and DBT, India 2000-2003
strains of M.tuberculosis and development of molecular
techniques for the detection of drug resistant strains.
As an offshoot of the previous study, several molecular
methods were developed by our laboratory and others. The
samples and isolates in our repository were used for
evaluation and validation of various tests developed in-house
by Indian scientists and also commercially for the diagnosis
and detection of drug resistant M. tuberculosis.
10. Base line Database collection and documentation of Good DST, India 2003-2005
manufacturing and supply practices adopted by the
manufacturers of TORCH- ELISA kits and quality
control assessment at the user level of these kits.
The study revealed that quality control and Human Resource
standards adopted by majority of small and middle-level
private laboratories are dismal in India. The recommendations
were submitted to Government of India, which in-turn
formulated important guidelines and accreditation of these
laboratories.
11. Expression, Characterization & purification of DBT, India 2003-2006
recombinant kinesin like protein of VL & PKDL and
developing test methods using the above antigen.
A novel recombinant kinesin-like antigen was prepared from
an Indian isolate of Leishmania donovani (Ld-rKE16).
Invention is patented globally. The technology was transferred
to a commercial firm. Using this novel antigen, ELISA and
rapid diagnostic test kits are prepared. The kit has 99%
sensitivity and 100% specificity. Several national
Governments are using this kit. The kit has also been
endorsed by WHO.
12. Screening of marine products for in-vitro anti- CSIR, India 2003-2005
Mycobacterial activity.
A natural product was found to have anti-mycobacterial
activity. The molecule was transferred to a pharmaceutical
company for further evaluation.
13. Comparative Evaluation of various in-vitro methods for BioMerieux, 2004-2007
diagnosing pulmonary and extra-pulmonary tuberculosis. India
Various microbiological and serological methods were
compared for the accurate diagnosis of PTB and EPTB. The
results are published in reputed journals. These results helped
Government of India to ban the serology.
14. Rapid and accurate diagnosis of Tuberculosis using a ICMR, India 2004-2007
novel set of primers directly from clinical samples.
Various monoplex and a novel multiplex PCR system was
developed. The multiplex PCR detects M. tuberculosis, M
avium and other NTM in a single tube. The results of
39 of 81
validation and cross evaluation are published in reputed
journals.
15. Evaluation of toxicity of Kalsome in Mouse model. DST, India 2005-2007
Kalsome is a new form of liposomal amphotericin B being
used for the treatment of Leishmaniasis and fungal infections.
It uses ergosterol as lipid capsule. A real-time PCR was
developed to evaluate the efficacy of this drug. In mice model
16. The role of TNF FNγ and the success of anti-tubercular Aust-Ind Council 2007-2009
therapy in Immune Restoration Disease in HIV/MTB co-
infected patients responding to ART.
17. Transmission of Drug Resistant Hepatitis B Virus in Close DST, India 2006-2009
Family Contacts of HBV-Related Chronic Liver Disease
Patients.
High rate of transmission was demonstrated in household
contacts of Hepatitis B infected source patients. Close contact
and clothes were incriminated in the transmission of this virus
to contacts.
18. Proteomic analysis of the M. tuberculosis during the stage DBT, India 2006-2011
of acquisition of resistance to the Isoniazid and
Rifampicin.
Four Novel proteins are identified which are overexpressed
during the acquisition of drug resistance. The results are
published in peer reviewed journal. A patent has also been
filed.
19. Genotyping of Mycobacterium tuberculosis isolates from ICMR, India 2007-2011
Delhi & determining their Transmission Dynamics using
Mol. methods.
This community based study showed that a significant
number of asymptomatic household contacts of index patients
can be diagnosed well before they clinically manifest, using
molecular and moderns diagnostic tools. The study concluded
that contact tracing was most useful of treating and
controlling tuberculosis.
20. A novel multiplex PCR for simultaneous identification and DBT, India 2007-2011
discrimination of M. tuberculosis complex, M. avium
complex and other NTM ....clinical specimens.
This was in continuation of previous study. The novel
multiplex PCR developed for the diagnosis and differentiation
of M. tuberculosis (novel Esat-6 primers), 16SrRNA and
hsp60 was evaluated across the country on various types of
clinical samples and standard strains. The PCR was found to
be 98% sensitive and 97% specific. The invention is patented
in several countries and ready for commercialization.
21. Detection of Hepatitis A, E, Salmonella , E. histolytica and DBT, India 2007-2010

Giardia lamblia from drinking water samples using novel
multiplex PCR.
A pentaplex PCR was developed and evaluated for the
simultaneous diagnosis of Hepatitis A, E, Salmonella typhi, E.
40 of 81
histolytica and Giardia lamblia from drinking water and stool
samples. The technology is ready for commercialization.
22. Isolation and purification of active compounds with anti- CCRUM, India 2007-2010
leishmanial activity from Unani Medicinal Plants
23. Role of Micronutrient Supplementation in Childhood University of 2008-2012
Tuberculosis. Bergen, Norway
This comprehensive study revealed several new findings, that
included efficacy of Gene-Xpert in archived gastric aspirate
and induced sputum samples; high rate of MDR in paediatric
tuberculosis, as compared to adults; better diagnostics tools
and algorithms and new biomarkers for childhood
tuberculosis. Six paper in high impact journals have been
published and many more are in pipeline.
24. Doctor’s Office Diagnostic Instrument for detection of M. Indo-Sweden 2009-2011
tuberculosis collaboration
This grant was primarily coordinated by Prof. VK Chaudhary
from Delhi University. The innovations are in developmental
stage.
25. Animal studies on Chimeric Vaccine for the Prophylaxis ICMR, India 2010-2014
of Leishmaniasis and Tuberculosis.
A new chimeric vaccine against TB and Leishmania (both)
has been developed and the innovation has been patented
globally through PCT route. Two papers in high impact
journals have been published.
26. Cloning Expression purification and evaluation of ICMR, India 2010-2014
recombinant antigens for the diagnosis prognosis and
prediction of MDR/XDR tuberculosis.
Five novel antigens have been identified and patent has been
filed and technology is being considered for transfer for
commercialization. Three publications in reputed journals
have been published.
27. A novel loop medicated isothesonal samplification DBT, India 2011-2014
(LAMP) assay for rapid detection and differentiation of
mycobacterium tuberclusosis M. avium complex and other
mycobacterium species directly from clinical samples.
A novel set of 6 primers and probes has been developed. One
publication in reputed journals has been published.
28. Leishmania kinesisn Motor Domain with BCG as a ICMR, India 2012-2014
vaccine formulation against experimental visceral
Leishmaniasis.
29. Molecular Epidemiology and Genetic Characterization of ICMR, India 2012-2014
M. tuberculosis from HIV seronegative and HIV
seropositive patients.
No major difference was found in the genotypes of MTB
isolated from HIV-TB co-infected patients vis-à-vis HIV
uninfected patients.
30. Sero-epidemiology of Toxoplasmosis in women of Child Abbott Health 2011-2012
bearing Age in India. Care, India
One publication in a highly reputed journal has been
41 of 81
published. On the basis of this publication which shows
several new observations, PI has been invited to deliver talks
on Toxoplasmosis within and outside India as guest speaker.
31. A side by side comparison of current gold standard Genotek/ 2013-2014
methods for diagnosing tuberculosis from sputum with Imperial Life
DNA Genotek chemistries Sciences, India
32. Kinetoplastid Drug Development: Strengthening the European 2013-2016
preclinical pipeline- KINDReD. Commission,
Two publications in reputed journals have been published. At Belgium
least two compounds have been identified as potential drugs
against VL and one compound against CL.
33. Molecular Epidemiology and drug resistance pattern of DBT 2014-2017
Mycobacterium tuberculosis from North-East region of
India
34. Medicinal Orchids of Arunachal Pradesh: DBT 2013-2017
Micropropagation, phytochemical characterization and
biological activity
35. Batch Efficacy Testing for Infectious Diseases markers on Siemens India 2014-2017
Advia Centaur system
36. Evaluation of Adhesive Sensors for the detection of Bill & Melinda 2015-2017
Tuberculosis specific volatile organic compounds Gates
Foundation with
Technion R & D
Foundation Ltd.
Israel
PATENTS- 8
1. Sarman Singh and Sivakumar R. “Polypeptides for the diagnosis and therapy of
Leishmaniasis”. WO 2005/063803 A1 (14-07-2005). Commercialized
2. Sarman Singh and Pawan Sharma. “Methods for Amplification and Detection of
Mycobacterium tuberculosis”. WO 2005/061730 A1 (07-07-2005).
3. Sarman Singh. “Oligonucleotides for Detection of Leishmaniasis and Methods Thereof”.
WO 2005/061729 A1 (07-07-2005). Indian Patent No. 246347 (2003-2023)
4. Sarman Singh “A Kit for detection of anti-Toxoplasma Antibodies in human and animal
samples using direct agglutination test”. 1611/DEL/2003. Indian patent No. 246721
(2003-2023)
5. Sarman Singh & Krishnamoorthy Gopinath. A Process for Clearing the Blood
Contamination for easy Detection of Microorganisms. Patent Application no.
743/DEL/2007.
6. Sarman Singh, Pawan Sharma, Venkataswamy Manival, Kanury V.S. Rao, Anil
Chatterji, Parameshwaran and Perunninakulath Subrayan “Indian green mussel (Perna
virdis) as a source for inhibiting the growth of Mycobacterium tuberculosis.”
7. Sarman Singh & Ayan Dey. Constructing a DNA Chimera for vaccine development
against Leishmaniasis and Tuberculosis. Patent Application no. PCT/IN2009/000093.
42 of 81
8. Sarman Singh, Krishnamoorthy Gopinath, Amit Singh & Niti Singh. Novel Protein
Markers of drug resistance in Mycobacterium tuberculosis. Patent Application no.
1752/DEL/2008.
9. Sukriti Singh, Pragati Singh, Smriti Singh, Niti Singh, Sarman Singh. A Semilunar Air
cooling device with easy to change, wash and replace air-filters and an external water
reservoir cum collector. Patent Application # 3276/DEL/2014
Gene Sequences and Genome Projects Submitted to Gene-Bank (1135)
i. Leishmania:
ii. Mycobacterium:
iii. Cytomegalovirus:
Whole Genome Projects (4)
(1) Whole genome sequencing of XDR TB isolate of East African Indian lineage from India
Identifiers: BioSample: SAMN06203364; Sample name: L-823
Organism:Mycobacterium tuberculosis, strain: AIIMS/LM/SS/PTB/L-823
Package: Pathogen: clinical or host-associated; version 1.0
Accession: SAMN06203364 ID: 6203364
BioProject Nucleotide
(2) Whole genome sequence of leishmania strain AIIMS/LM/SS/PKDL/LD-974 Clinical isolate from
Bihar, India.
Identifiers: BioSample: SAMN03457191; Sample name: LD-974; SRA: SRS893466
Organism: Leishmania sp. AIIMS/LM/SS/PKDL/LD-974, strain: AIIMS/LM/SS/PKDL/LD-974
Accession: SAMN03457191
ID: 3457191
BioProject SRA Nucleotide
(3) Pathogen: clinical or host-associated sample from Mycobacterium tuberculosis

Organism: Mycobacterium tuberculosis, strain: AIIMS/LM/SS/PTB/L-182
ID: 6761088
BioProject
(4) Pathogen: clinical or host-associated sample from Mycobacterium tuberculosis

Organism: Mycobacterium tuberculosis, strain: AIIMS/LM/SS/PTB/L-31
ID: 6760364
BioProject
43 of 81
PUBLICATIONS
BOOKS WRITTEN- 7
1. Practical Manual on Molecular Methods in Infectious Disease Diagnosis. Singh S.

Department of Biotechnology, Govt. of India, 1996.
2. Toxoplasmosis in India. Singh S, Mahajan RC, Dubey JP (Eds.). Pragati Publishing
Company, New Delhi, 1997.
3. Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing Company,
New Delhi, 1999.
4. Toxoplasmosis in India. Singh S (Editor.). Third Edition, Pragati Publishing Company,
New Delhi, 2010.
5. TORCH Group of Congenital Infections. Singh S. Pragati Publishing Company, New
Delhi, 1999.
6. Standard Operative Manual: Hospital Infection Control. Singh S (Ed). National AIDS
Control Organisation, Government of India, New Delhi, 1999
7. Conquering your enemy: The HIV/AIDS. Singh S. Pragati Publishing Company, New
Delhi, 2000.
CHAPTERS PUBLISHED IN BOOKS
(1) Singh S, Singh N. Seroepidemiology of Toxoplasmosis in sheep and goats of

Rajasthan and their butchers.IN: Somvanshi R, Lokeshwar RR (Eds.). Current
Advances in Veterinary Science and Animal Production in India. Lucknow,
International Book Publishing Co. 1994 : PP 204-12.
(2) Singh S, Chang KP. Genetic Heterogeneity of Indian Leishmania donovani. IN:
Kala-azar Research in India. Sundar S (ed.), IMS, Banaras Hindu University,
Varanasi, 1996: pp 197-204.
(3) Singh S. Recent Advances in the Laboratory diagnosis of Leishmaniasis. IN: Kala-
azar Research in India. Sundar S, Sundar S (ed.), IMS, Banaras Hindu University,
Varanasi, 1996: pp 39-56.
(4) Singh S. Toxoplasma gondii in animal health. IN: Prospects of Livestock and
poultry Development in 21st Century. Verma R & Johari DC (Eds.), IVRI,
Bareilly, 1997: pp 204-212.
(5) Singh S. Clinical Significance of Physiologic parameters. Biswas NR, Jain DK,
Jain SK. (Eds.), Hospital and Clinical Pharmacy, RP Centre for Ophthalmic
Sciences, New Delhi, 1997 pp 86-95.
(6) Singh S. Opportunistic infections in Immunosuppressed Humans and Animals. In:

An Introduction to Immuno-pathology, Chauhan RS (Ed), GB Pant University of
Agriculture & Technology, Pantnagar, 1998 pp 239-272.
44 of 81
(7) Singh S. Toxoplasma: An emerging disease in man and animals. Zoonotic
Parasites- their diagnosis and control” A handbook of III National Training
Programme, Centre for Advanced Studies., Department of Parasitology, Veterinary
College, University of Agricultural Sciences, Bangalore, 1998 pp 97-100.
(8) Singh S. Cytomegalovirus infection and its diagnosis in organ transplant

recipients. Viral infections in Nephrology. Aggarwal S (ed), New Delhi, 1999
(9) Singh S, Dubey JP. Human Toxoplasmosis in India before and after AIDS
epidemic. Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati
Publishing Company, Ghaziabad & New Delhi, 1999.
(10) Somvanshi R, Singh S. Spontaneous Toxoplasmosis in Laboratory Rats.

Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing
Company, Ghaziabad & New Delhi, 1999.
(11) Singh S. Advances in cellular and molecular biology of Toxoplasma gondii.

Toxoplasmosis in India. Singh S (Editor). Second Edition, Pragati Publishing
(12) Singh S. Cytokines in Toxoplasmosis. Toxoplasmosis in India. Singh S (Editor.).

Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi, 1999.
(13) Biswas NR, Singh S. Treatment of acquired Toxoplasmosis. Toxoplasmosis in

India. Singh S (Editor.). Second Edition, Pragati Publishing Company,
Ghaziabad & New Delhi, 1999.
(14) Singh S, Singh N. Conjugal Toxoplasmosis. Toxoplasmosis in India. Singh S

(Editor.). Second Edition, Pragati Publishing Company, Ghaziabad & New Delhi,
1999.
(15) Singh S. Common questions asked by a pregnant woman about toxoplasmosis.

Toxoplasmosis in India. Singh S (Editor.). Second Edition, Pragati Publishing
(16) Singh S. Diagnostic and Prognostic markers of anti-kala-azar therapy and

vaccination. IN: Proceeding of V Round Table Conference Series. No. 5. Gupta S
& Sood OP (Ed). Ranbaxy Science Foundation, New Delhi. 1999 pp 95-114.
(17) Singh S. Diagnosing Human Immunodeficiency virus infection and AIDS. IN:
Proceeding of VI Round Table Conference Series. No. 6. Gupta S & Sood OP
(Ed). Ranbaxy Science Foundation, New Delhi. 2000 pp 51-90.
(18) Singh S. Anti-Leishmania therapy. IN: Antimicrobials in Laboratory Medicine.

Rattan A. (Ed). B.I. Churchill Livingstone Pvt. Ltd. New Delhi, 2000: pp 221-234.
45 of 81
(19) Singh S. Strongyloidiasis in Man and Animals. IN: Text Book of Helminthology in
India. Sood ML. (ed). Ludhiana. International Book Distributors, Dehradun, 2001:
pp 167-186.
(20) Singh S. Immunology and Immunological Diagnosis of Toxoplasmosis. IN:

Advances in Immunology and Immunopathology. Chauhan RS, Singh GK, Agarwal
DK (eds). Society for Immunology and Immunopathology, Pant Nagar, 2001:
pp190-201.
(21) Singh S, Jose K.J., Biswas A. Blood borne viruses transmission (Hepatitis, HIV)
via unsterile needles and prevention. In : AIDS INDIA. Report of the, third
international conference on AIDS India. Chapter VIII.. Samuel N.M. & Upham
Nance (eds), The Department of Experimental Medicine & AIDS Resource Centre,
The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India. 2002 pp 25-29.
(22) Singh S. AIDS associated intestinal parasitic infections: diagnostic aspects. IN:
Diarrhoeal diseases: current status, Research trends and field studies. Raghunath
D, Nayak R. (eds). Tata McGraw-Hill Publishing Co. Ltd., New Delhi, 2003 pp:36-
56.
(23) Singh S & Sivakumar R. Laboratory Diagnosis of Visceral Leishmaniasis. In:

Trend and Research in Leishmaniasis. Raghunath D, Nayak R. (eds). Tata
McGraw-Hill Publishing Co. Ltd., New Delhi, 2005 pp: 113-130.
(24) Singh S. Laboratory Diagnosis of HIV. Manual for management of HIV/AIDS in

Children. NACO/IAP/UNICEF. New Delhi. 2005 p 171.
(25) Singh S, Sood R. Rattan A. Mycobacterium tuberculosis. IN, Essential of

Tuberculosis in Children. Seth V & S K Kabra (editors). J P Brothers Medical
Publishers Pvt. Ltd., New Delhi. 2006, pp 51-65.
(26) Singh S. & Gupta S. Laboratory Investigations in Emergency. Manual of Medical

Emergencies, Pushpanjali Medical Publications Pvt Ltd, Delhi; 3rd Edition, 2007 pp
846 – 860.
(27) Singh S. Avidity Testing to Pinpoint Timing of maternal Infections during
Pregnancy. Congenital Intrauterine Infections. Deepika Deka (editor). J P Brothers
Medical Publishers Pvt. Ltd., New Delhi. 2009, pp 81-89.
(28) Singh S. Laboratory techniques for Prenatal Diagnosis of Maternal-Fetal
Infections. Congenital Intrauterine Infections. Deepika Deka (editor). J P Brothers
(29) Singh S. Human Toxoplasmosis a food borne parasitic disease. In: Toxoplasmosis
in India. Singh S (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad
& New Delhi, 2010.
46 of 81
(30) Singh S. Cellular and Molecular Biology of Toxoplasma gondii. In: Toxoplasmosis
in India. Singh S (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad
& New Delhi, 2010.
(31) Singh S. Cytokines in Toxoplasmosis. In: Toxoplasmosis in India. Singh S
(Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi,
2010.
(32) Singh S. Toxoplasmosis in AIDS Patients. In: Toxoplasmosis in India. Singh S
(Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi,
2010.
(33) Singh S. Laboratory Diagnosis of Toxoplasmosis. In: Toxoplasmosis in India.
Singh S (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New
Delhi, 2010.
(34) Singh S. Avidity Testing to Pinpoint Timing of Maternal Torch Infection during
Pregnancy. In: Toxoplasmosis in India. Singh S (Editor.). Third Edition, Pragati
Publishing Company, Ghaziabad & New Delhi, 2010.
(35) Singh S. Incidence and Prevalence of Toxoplasmosis in Pregnant Women. In:
Toxoplasmosis in India. Singh S (Editor.). Third Edition, Pragati Publishing
(36) Singh S. Treatment of acquired Toxoplasmosis. In: Toxoplasmosis in India. Singh
S (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad & New Delhi,
2010.
(37) Singh S. Common questions asked by a pregnant woman. In: Toxoplasmosis in
India. Singh S (Editor.). Third Edition, Pragati Publishing Company, Ghaziabad &
New Delhi, 2010.
(38) Singh S, Gopinath K, Sood R. Rattan A. Mycobacterium tuberculosis. IN,
Essential of Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P
Brothers Medical Publishers Pvt. Ltd., New Delhi. 2011, pp 41-56.
(39) Singh S, Gopinath K, Rattan A. Non-Tuberculous Mycobacteria. IN, Essential of
Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P Brothers
(40) Munawwar A, Singh S. Hepatitis B and C viral Co-infections in AIDS Patients.
Proceedings of International Conference on Biotechnological approaches to
neuroimmunomodulation and infectious diseases. Singh PP (editor): 2008: pp 175-
188.
(41) Tarai B, Bawa N, Singh S, Rattan A. Laboratory Diagnosis of Mycobacterial
(Tuberculosis) Infections in Children: Conventional Methods. IN, Essential of
Tuberculosis in Children. Vimlesh Seth & S K Kabra (editors). J P Brothers
(42) Mishra J, Saxena A, Singh S. Chemotherapy of Leishmaniasis: Past, Present and
Future. IN: Frontier in Medicinal Chemistry. Allen B. Reitz / Atta-ur-Rahman / M.
Iqbal Choudhary (Eds.), Bentham Science Publishers. 2012, Vol 6 pp 97-130.
(43) Shankar P, Mishra J, Srivastava S, Singh S. In-vitro diagnostic methods for
visceral leishmaniasis. IN: Advances in developing affordable in vitro molecular
diagnostics. Puri CP, Abidi N, Bhanushali P, Pere A, Gupta SK (eds.) Yashraj
Research Foundation, Navi Mumbai, 2013: pp 111-138. ISBN No: 978-81-910540-
40.
47 of 81
(44) Shankar P, Mishra J, Singh S. Hepatitis A and E in Potable Water: A threat to
Health. IN: Water & Health. Singh PP & Sharma VP (Eds). Springer India. 2014, pp
29-51.
(45) Srivastava S, Shankar MM, Singh S. Molecular diagnosis of tuberculosis,
leishmaniasis and toxoplasmosis: The three intracellular pathogens. Dutta A. (ed.)
The National Academy of Sciences, India (NASI). ISBN No. 978-93-81891-31-5
2016; pp. 127-157.
(46) Gupta A, Singh A, Singh S. Glycogen as Key Energy Storehouse and Possibly
Responsible for Multidrug Resistance in Mycobacterium tuberculosis. IN: Drug
Resistance in Bacteria, Fungi, Malaria and Cancer. Arora G, Sajid A, Kalia VC
(Editors), Nature Springer, Switzerland, 2017, pp 263-85. ISBN:978-3-319-48682-6
(47) Srivastava S, and Singh S. Toxoplasmosis: a zoonotic disease of extreme
importance in pregnant women and immunocopmpromised patients. Yadav AK,
Tandon V, Hoti SL (Eds). Advances in medico-veterinary parasitology: an Indian
perspective. Panima Publishing Coorp. New Delhi; 2018, pp 93-106. ISBN:81-
8653-589-2
RESEARCH PAPERS PUBLISHED
1. Kochhar R, Talwar P, Singh S, Mehta SK. Invasive candidiasis following cimetidine therapy. Am
J Gastroenterol 1988; 83: 102-3. (IF: 5.608)
2. Kochhar R, Singh S, Talwar P, Mehta SK. Candidiasis after cimetidine therapy. Gastrointest
Endoscopy 1988; 34: 283-4. (IF: 4.825)
3. Singh S*, Samantaray JC. Human Intestinal myiasis. J Assoc. Phys India 1988; 39(12): 741-2.
4. Singh S*, Samantaray JC. Blood films in the diagnosis of Malaria. Lancet 1989; II: 1165-66. (IF:
25.8)
5. Singh S*, Kochhar R, Singh N, Talwar P, Mehta SK. Endoscope contaminated with Trichosporon
beigelli. J Hosp Infection 1989; 14: 49-53. (IF: 2.442)
6. Singh S* , Samantaray JC. Tropical anthelminthic treatment of recurrent genitourinary
enterobiasis. Genitourinary Medicine 1989; 65: 284-6. (IF: 3.427)
7. Singh S*, Singh N, Samantaray JC, Tandon BN. Filarial ascites associated with carcinoma of
pancreas. Am J Gastroenterol 1989; 84: 1131. (IF: 5.608)
8. Singh S*, Kochhar R, Datta U. Severe duodenal Candidiasis in an IgA deficient patient with
associated T cell defects. Indian J Gastroenterol 1990; 9: 95-6.
9. Singh S*, Singh N, Samantaray JC, Roy S, Garg SP. Scalp phthiriasis. Rev Infect Dis 1990; 12:
560.
10. Singh S*, Samantaray JC, Bhargava DK. Giant hydatid cyst of gastrosplenic ligament simulating
massive ascites. J Clin Gastroenterol 1990; 12: 481-2. (IF: 2.403)
11. Singh S*, Samantaray JC. So called non-pathogenic intestinal parasites. Am J Gastroenterol 1990;
85:764-5. (IF: 5.608)
12. Singh S*, Samantaray JC, Kinra G. Genito-urinary Enterobius vermicularis infection: vagina
acting as reservoir. Indian J Med Microbiol 1989; 7: 152-4.
48 of 81
13. Singh S*, Samantaray JC, Sharma MP. Fatal strongyloidiasis in India. Indian J Gastroenterol
1990; 9: 100.
14. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in treatment of visceral
Leishmaniasis. Lancet 1990; 336: 810-811. (IF: 25.8)
15. Singh S*, Rattan A, Samantaray JC. Spirochetal dysentery. A case report with review of literature.
Tropical Gastroenterol 1990; 11(3): 152-7.
16. Singh S. Laboratory diagnosis of intestinal parasitosis. Indian J Paediatr 1990; 57: 789-92.
17. Singh S* Rattan A, Samantaray JC. Acute spirochetal dysentery in a child with Fallot’s tetralogy.
Am J Gastroenterol 1991; 86: 655-6. (IF: 5.608)
18. Singh S* Singh N, Kochhar R, Jatava LK, Talwar P, Mehta SK. Candida albicans and human
ABO Blood groups. Indian J Med Microbiol 1991; 9(1): 34-39.
19. Singh S*. Trematodes in Indian: A review. Trop Gastroenterol 1991; 12:119-131.
20. Singh S*, Nautiyal BL. Seroprevalence of Toxoplasmosis in Kumaon region of India. Indian J
Med Res 1991; 93: 247-49. (IF: 1.224)
21. Singh S*. Urine analysis in paediatric practice. Indian J Paediatr 1991;58: 717-23.
22. Singh S*. Fungal Diarrhoea. Mycopathologia 1991; 114: 41-42. (IF: 0.915)
23. Fotedar R, Banergee U, Singh S* Shriniwas, Verma AK. House fly (Musca domestica) as a carrier
of pathogens in a hospital environment. J Hosp Infect 1992; 20(3): 209-215. (IF: 2.442)
24. Singh S* Singh N, Kochhar R, Talwar P, Mehta SK. Cimetidine therapy and duodenal candidiasis:
Role in healing process. Indian J Gastroenterol 1992; 11: 21-2.
25. Singh S*. Spiramycine in the treatment of toxoplasmosis is it worth in developing countries like
India. J Assoc Physician India 1992; 40: 140.
26. Singh S* Das SC. Paramecium colonising urinary tract of a patient on dialysis: a rare entity.
Nephron 1992; 62: 243-44. (IF: 1.574)
27. Singh S* Rattan A, Kumar S. Skin tuberculosis due to Mycobacterium chelonei after an yellow
jacket bite. Tuber Lung Dis 1992; 73(5): 305-6. (IF: 2.035)
28. Singh S*, Gupta S, Singh YN, Mirdha B, Hak B. Large single candidal liver abscess treated with
aspiration and antifungal drugs. Indian J Gastroenterol 1992; 11: 176-77.
29. Singh S*, Singh N, Roy S, Garg SP. Family outbreak of scalp phthiriasis. Indian J Paediatr 1992;
59: 639-42.
30. Singh S*, Singh YN. Gastrointestinal tuberculosis in a SLE patient: diagnosis by stool
examination. J Assoc. Physician India 1992; 40: 135-6.
31. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in the treatment of stibomine and
pentamidine resistant kala-azar. J Infect Dis 1992; 166: 215-6. (IF: 5.363)
32. Singh S*, Saluja S, Mirdha B. Resistant Malaria simulating Indian Kala-Azar. Indian Practitioner
1992; 45: 815-9.
33. Singh S*. Pseudoresistant malaria in tropical countries. Lancet 1992; 340: 1419-20. (IF: 25.8)
34. Singh S*, Sharma MP. Strongyloides stercoralis in Northern India. Indian J Med Microbiol
1992; 10:197-203.
49 of 81
35. Mirdha B, Singh S*. Transient Isosporiasis in an apparently normal child. Indian J Paediatric
1993; 60: 197-99.
36. Singh YN, Singh S*, Rattan A, Samantaray JC, Wali JP, Malaviya AN. Pneumocystis carinii
infection in AIDS patients: First report from India. J Assoc Physic India 1993; 41: 41-42.
37. Rattan A, Gupta SK, Singh S et al. Detection of antigens of Mycobacterium tuberculosis in
patients of infertility by monoclonal antibody based sandwich ELISA.. Tuber Lung Dis 1993; 74:
200-03. (IF: 2.2)
38. Singh S*, Singh N, Karmarkar MG. Low cost Refractometer for measurement of protein
concentration and specific gravity of body fluids. Tropical Doctor 1993; 23: 171-3. (IF: 2.291)
39. Singh S*, Singh N, Samantaray JC, Das GB, Verma IC. Trichuris vulpis infection in an Indian
tribal population. J Parasitol 1993; 79: 457-8. (IF: 1.3)
40. Singh S*, Raju GV, Samantaray JC. Parasitic gut flora in a North Indian population with
Gastrointestinal symptoms. Trop Gastroenterol 1993; 14(3): 104-108.
41. Singh S*, Singh N, Pandav R, Pandav CS, Karmarkar MG. Toxoplasma gondii infection & its
association with Iodine deficiency in a residential school in a tribal area of Maharashtra. Indian J
Med Res 1994; 99: 27-31. (IF: 1.624)
42. Singh S*. Risk factors for salmonella infection: loss of gastric acidity linked to candidiasis. High
risk in developing countries. BMJ 1994; 308:596-7. (IF: 9.224)
43. Rattan A, Kishore K, Singh S*, Jaber M, Xess I, Kumar R. Evaluation of a safe sputum processing
method for detecting tuberculosis. J Clin Pathol 1994; 47: 411-13. (IF: 2.245)
44. Sharma M, Reed SL, Singh S*, Talwar GP, Ghosh S. Characterisation of monoclonal antibodies to
conserved antigens of Entamoeba histolytica and E. dispar and development of stool ELISA.
Hybridoma 1994; 13: 123-130. (IF: 0.411)
45. Singh S*, Sachdev MPS. Acanthamoeba keratitis. British Med J 1994; 309: 273. (IF: 9.224)
46. Singh S*. Sex education in Indian schools. Natl Med J India 1994; 7: 194-5. (IF: 1.0)
47. Singh S*, Ahlawat S, Singh N, Chaudhary VP. High seroprevalence of TORCH infections in
multiply transfused -thalassemic children in India. Eur J Haematol 1995; 54: 64-66. (IF: 1.863)
48. Suri M, Kabra M, Singh S*, Rattan A, Verma IC. Group B meningococcal meningitis in India.
Scand J Infect Dis 1995; 26: 771-3. (IF: 1.56)
49. Singh S*, Singh N, Razavi KA. Tuberculosis following immunosuppressive treatment after
exposure to toxic smoke. Lancet 1995; 345: 1379-80. (IF: 25.8)
50. Ahlawat S, Singh S*, Bhargava M. Tumour necrosis factor-, a marker of disease activity in acute
lymphoblastic leukaemia: a preliminary report. Indian J Haematol Blood Transf 1995; 13: 61-63.
51. Singh S*, McGwire BS, Chang KP. Kinetoplast and nuclear DNA polymorphism of visceral
Leishmania isolates from North-eastern India. J Protozool Res 1995; 5: 27-32.
52. Singh S*, Gilman-Sacks A, Chang KP, Reed SG. Diagnostic and prognostic value of rK39 antigen
in Indian Leishmaniasis. J Parasitol 1995; 81: 1000-3. (IF: 1.3)
53. Singh S*, Singh N, Handa R. Tumour Necrosis Factor- in malaria and its correlation with disease
prognosis. J Parasit Dis 1995; 19: 127-30.
54. Singh S*. Recent advances in the laboratory diagnosis of intestinal parasitosis (editorial). Trop
Gastroenterol 1996; 17: 1-5.
50 of 81
55. Singh S*, Chaudhary VP, Wali JP. Transfusion-transmitted Kala-azar in India. Transfusion 1996;
36: 848-9. (IF: 3.278)
56. Bhaskar S, Singh S*, Sharma M. A single-step immunochromatographic test for the detection of
Entamoeba histolytica antigen in stool samples. J Immunol Methods 1996; 196: 193-98. (IF: 2.402)
57. Handa R, Wali JP, Kaushik P, Gupta R, Singh S*, Gambhir M, Wig N, Biswas A, Aggarwal P.
Toxoplasma encephalitis in AIDS. J Assoc Physic India 1996; 44: 838.
58. Singh S*, Singh N, Maniar JK. AIDS associated Toxoplasmosis and its correlation with Tumour
Necrosis Factor alpha. J Parasit Dis 1996; 20: 49-52.
59. Handa R, Singh S*, Singh N, Wali JP. Fever of unknown origin: a prospective study. Trop Doctor
1996;26: 169-70. (IF: 0.391)
60. Wali, J.P., Singh S*. Tuberculosis as an occupational hazard in health care workers. Israel J Occ
Hazards, 1996. (suppl): 8-9.
61. Singh S*, Singh N. Re-using unsterile needles: HIV reaches in small villages of rural India.
Integration 1996; I: 17.
62. Singh S*. Alkylphosphocholine in visceral Leishmaniasis: in-vitro and in-vivo study. J Parasit Dis
1996; 20:185-8.
63. Singh S*. Automated microbiology culture system for up gradation of the emergency
Microbiology Services. J Acad Hosp Adm 1997; 8: 17-20.
64. Singh S*, Singh N, Dwivedi S.N. Evaluation of seven commercially available kits for the sero-
diagnosis of Toxoplasmosis. Indian J Med Res 1997; 105: 103-7. (IF: 1.224)
65. Singh S*. Toxoplasmosis. Vaigyanik (Hindi); April-June 1997: 49-51
66. Singh S*. AIDS Care in India. AIDS Reader 1997; 7: 101-106.
67. Singh S*, Singh N, Handa R. High serum levels of TNF- in malaria and Kala-azar. J Assoc
Physic India 1997; 45: 526-29.
68. Wig N, Handa R, Aggarwal P, Biswas A, Singh S*, Wali JP. Kala-azar in AIDS. J Assoc Physic
India. 1997; 45: 582.
69. Wali JP, Aggarwal P, Nandy A, Singh S*, Addy M, Guha SK, Dwivedi SN, Karmarkar MG, Maji
AK. Efficacy of Sodium Antimony gluconate and Ketoconazole in the treatment of Kala-azar: a
comparative study. J Commun Dis 1997; 29: 73-83.
70. Singh S*. AIDS epidemic in India. Drug Bulletin. 1997; 6 (2): 1-16.
71. Singh S*. Toxoplasmosis in India: before and after AIDS epidemic. Ann National Acad Med
1997;33:15-24.
72. Singh S*, Somvanshi R. Manav aur labhkari pashuon ka rogjanak: Toxoplasma. Vigyan Garima
Sindhu 1997; 22: 95-102.
73. Singh S*, Lodha R, Passi GR, Bhan MK. Cholistatic jaundice due to congenital Toxoplasma
gondii infection. Indian J Paediatr 1998; 65: 154-57. (IF: 0.92)
74. Singh S*, Prasad R, Mohanty A. HIV and Hepatitis -B viral infections in Jailmates of Ghaziabad,
North India. Proceedings 12 World AIDS conference, (Geneva), 1998 Monduzzi Editors, Bologna :
159-162.
75. Dwivedi SN, Singh S. On the economy in blood testing: A clinical Appraisal. ISMS Bulletin
1998;13: 19-21.
51 of 81
76. Biswas NR, Sen S, Singh S*, Gopal N, Pandey RM, Giri D. Sub-acute toxicity study of a
polyherbal drug (Prostina) in rats. Indian J Pharmacol 1998; 30: 239-244.
77. Somvanshi R, Singh S. A case report of Spontaneous Toxoplasmosis in Laboratory Rats. J Vet
Parasitol 1998;12: 141-2.
78. Singh S*, Singh C. Sentinel surveillance of Chlamydia trachomatis in school going girls and
women with secondary infertility in Delhi. J Trop Paediatr 1998; 44: 377-8. (IF: 0.592)
79. Singh S*, Shalini, Astha, S Peter, Aggarwal P, Wali JP. Disseminated fatal Nocardia farcinica in
Acquired Immunodeficiency Syndrome. J Assoc Physic India. 1998;46:1053-6.
80. Handa R, Singh S*, Singh N, Wali JP. Brucellosis in North India: results of a prospective study. J
Commun Dis 1998, 30: 85-87.
81. Aggarwal P, Handa R, Singh S*, Wali JP. Kala-azar- New developments in diagnosis and
treatment. Indian J Paediatr 1999; 66: 63-71. (IF: 0.92)
82. Singh S*, Guleria R, Kumar S. Multidrug Resistant Fatal Falciparum Malaria in a Pregnant
Woman. J Assoc Physic India 1999; 47: 346.
83. Singh S*, Prasad R, Mohanty A. High prevalence of Sexually transmitted and blood borne
infections amongst the inmates of a District Jail in North India. Int J STD AIDS 1999; 10 (7) :
475-78. (IF: 1.274)
84. Singh S*, Biswas A, Wig N, Aggarwal P, Sood R, Wali JP. A new Focus of Kala-azar cases in
Kumaon region of India. J Commun Dis 1999; 31 (2): 73-77.
85. Singh S*. Hookworm disease misdiagnosed as intestinal lymphoma: transfused 38 units of blood.
Scand J Infect Dis 1999; 31: 217. (IF: 1.56)
86. Singh S*, Singh N, Singh C. Seroprevalence of Chlamydia trachomatis antibodies in school going
girls vis-à-vis women with BOH and secondary infertility. Indian J Med Microbiol 1999; 17: 142-5.
(IF: 0.75)
87. Handa R, Wali JP, Singh S*, Aggarwal P. A prospective study of Lyme arthritis in North India.
Indian J Med Res 1999; 110: 107-9. (IF: 1.224)
88. Singh S*, , Sood R, Wali JP, Dwivedi SN. Hepatitis B, C and Human Immunodeficiency virus
infection in multiply injected Kala-azar patients in Delhi. Scand J Infect Dis 2000; 32(1): 3-6. (IF:
1.56)
89. Singh S*, Singh R, Dwivedi SN. Blood borne viral infections in kala-azar patients receiving
injectable anti-leishmnaial drugs in Bihar. J Lab Med , 2000, 1: 9-16.
90. Singh S*, Veena Kumari, Guleria R, Pande JN. Fatal hepatitis E virus infection presenting as
haemorrhagic pneumonia in an adult Indian patient. J Lab Med, 2000, 1: 17-18.
91. Singh S*, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infections in Kala-azar patients
receiving injectable anti-kala-azar treatment. Intern J Infect Dis 2000; 4: 203-8. (IF: 2.52)
92. Singh S*. Biological Contamination of Drinking water in New Delhi: Isolation of Free living
amoebas as a highly sensitive index of water contamination. Water International 2000; 25 (3): 403-
9. (IF: 0.5)
93. Tyagi M, Singh S*, Singh H. Iodinated natural rubber latex: preparation, characterisation &
antibacterial activity assessment. Artif Cells Blood Substit Immobil Biotechnol 2000;28(6):521-33
94. Tyagi M, Singh S*, Rattan A, Singh H. Surface modification and antimicrobial evaluation of
foley's urinary catheter. Trends in Biomaterials & Artificial Organs 2000; 14: 52-56.
52 of 81
95. Singh S*, Singh N, Handa R. Tumour necrosis factor- alpha in patients with malaria. Indian J
Malariol 2000; 37: 27-33. (IF: 0.9)
96. Singh S*, Mohapatra DP, Siva Kumar R.. Successful replacement of foetal calf serum with human
urine for in vitro culture of Leishmania donovani. J Commun Dis. 2000; 32:289-94.
97. Singh S*. Typhoid fever: Pathogenesis and Laboratory Diagnosis. J Indian Acad Clin Med 2001;
2:17-20
98. Singh S*, Mohanty A, Joshi YK, Deka D, Dwivedi SN. Outcome of hepatitis E virus infection in
Indian pregnant women admitted to a tertiary care hospital. Indian J Med Res 2001; 113 : 35-39.
(IF: 1.6)
99. Aggarwal P, Wali JP, Singh S*, Handa R, Wig N, Biswas A. A Clinico-Bacteriological study of
peripheral tuberculous lymphadenitis. J Assoc Phys India 2001; 49: 808-12.
100. Sivakumar R, Singh N, Singh S*. Nested polymerase chain reaction in the diagnosis of congenital
Cytomegalovirus infection. Indian J Pediatr 2001; 68: 1043-46. (IF: 0.92)
101. Singh S*, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Hepatitis E virus infection carries
high fatality rate in Indian pregnancies. eBMJ; 2001; 322:151. (IF: 3.592)
102. Kaur M, Sivakumar R, Singh S*. Current trends in the laboratory diagnosis of tuberculosis- an
overview. J Lab Med 2002; 3: 6-11.
103. Singh S*. Human Strongyloidiasis in AIDS Era: Its Zoonotic importance. Review article. J Assoc
Phys India 2002; 50: 415-422.
104. Singh S*. Prevalence of TORCH infections in pregnant women. Indian J Med Microb 2002; 20:
57-58. (IF: 0.75)
105. Singh S*. High prevalence of viral and other sexually transmitted diseases in Indian prisons. BMJ
2002; 324: 850. . (IF: 9.2)
106. Singh S*, Veena Kumari, Singh N. Predicting Kala-Azar Disease Manifestations in Asymptomatic
Patients with Latent Leishmania donovani Infection by Detection of Antibody against Recombinant
K39 Antigen. Clin Diagn Lab Immunol 2002; 9: 568-72. . (IF: 2.09)
107. Anonymous. Diagnosing and treating Leishmaniasis. Lancet Infectious Diseases, 2002; 2: 264.
(IF: 8.5)
108. Singh B.A, Shashi Kant, Singh S*, Kapoor SK. Seroprevalence of Toxoplasma infection among
primigravid women attending antenatal clinic at a secondary level hospital in North India. J Indian
Med Assoc, 2002; 100;: 591-97.
109. Singh S*. Food scarcity and HI/AIDS epidemic in India. 2002.
www.indev.org/articles/foodsecurity_hiv.html.
110. Trajkovic V, Singh G, Singh B, Singh S*, and Sharma P. Effect of Mycobacterium tuberculosis-
Specific 10-Kilodalton Antigen on Macrophage Release of Tumor Necrosis Factor Alpha and Nitric
Oxide. Infect Immun 2002 ;70 (12): 6558-6566. (IF: 4.004)
111. Singh S*. Systemic versus local medication of vulvo-vaginal infections. eBMJ. 2002;325:586 (IF:
3.52)
112. Singh S*, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of
hepatitis E virus infection. Indian J Paed, 2003; 70: 37-39. (IF: 0.9)
53 of 81
113. Natarajan K., Latchumanan V.K., Singh B, Singh, S, and Sharma P. Maturation of dendritic cells
by Mycobacterium tuberculosis specific antigen (MTSA) leads to down regulation of T helper
responses to mycobacterial antigens. J Infect Dis. 2003; 187: 914-28. (IF: 6.2)
114. Bharathi MV, Basheer AM, Nedunchelliyan S, Singh S*, Meenachi Selven MS. Comparison of
modified direct agglutination and indirect haemagglutination tests for detection of Toxoplasma
gondii antibodies in goats in Chennai. J Vet Parasitol 2003; 17: 49-51. (IF: 0.7)
115. Singh S*. Herbal medicines put into context: Indian experience on using herbal medicines in AIDS
therapy. BMJ 2003;327:881
116. Singh S*. Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during
pregnancy. Indian J Med Microbiol 2003; 21: 69-76. (IF: 0.9)
117. Singh S*., Sivakumar R. Recent Advances in the Diagnosis of Leishmaniasis. J Postgrad Med.
2003; 49:55-60. (IF: 1.2)
118. Singh S*. Leishmaniasis: diagnosing and treating the disease. BMJ 2003;326:377
119. Singh S*. Book Review. Indian J Med Microbiol 2003;21:296-296 (IF: 0.9)
120. Singh S*. Human immunodeficiency virus transmitted through sheep brain anti-rabies vaccination.
Vaccine. 2003; 21:4119. (IF: 3.00)
121. Singh S*. Food crisis and AIDS: Indian perspective. Lancet. 2003; 362: 1938-9. (IF: 22.2)
122. Singh S*. Laboratory Diagnosis of Congenital TORCH infections. J Lab Med 2003; 4: 6-22.
123. Kothari S, Sivakumar R, Singh S*. Absence of ∆32 mutation in CCR5 gene in a HIV-1 resistant
Indian male spouse of an AIDS patient with 10 years unprotected exposure. J Lab Med 2003; 4: 28-
32.
124. Singh S*. New strategies for increasing the detection of HIV: analysis of routine data.
BMJ 2003;326:1066
125. Singh S*, Kumari V, Singh N. HIV-1 infection in a patient of acute lymphocytic leukaemia missed
by HIV-spot and HIV-scan rapid tests. Indian J Med Microbiol 2004; 22: 64-65. (IF: 0.9)
126. Singh S*, Kaur Manjot. High rate of primary and acquired drug resistance in Indian Isolates of
Mycobacterium tuberculosis. Int J Infect Dis, 2004; 8 (suppl. 1): S48. (IF: 2.2)
127. Singh S*, Pandit AJ. Incidence and Prevalence of Toxoplasmosis in Indian pregnant women: A
prospective study. Am J Reprod Immunol. 2004 Oct; 52(4):276-283. (IF: 3.2)
128. Singh S*. Mucosal Leishmaniasis in an Indian AIDS patient. Lancet Infect Dis, 2004; 4: 660-61
(IF: 16.2)
129. Singh S, Sivakumar R. Challenges and new discoveries in the Treatment of Leishmaniasis.
Review. J Infect Chemother, 2004; 10 (6): 307-315. (IF: 1.52)
130. Shahdad S, Kaur M, Khattar S, Singh S*. A case of Pulmonary Mycobacterium celatum in an
Indian AIDS Patient. Int J Infect Dis, 2005; 9 (1): 62-63. (IF: 2.32)
131. Singh S*, Dey A, Sivakumar R. Applications of Molecular Methods for Leishmania control.
Expert Rev Mol Diagn. 2005; 5 (2): 251-65. (IF: 4.2)
132. Singh S*. Visceral Leishmaniasis: an opportunistic infection in HIV-infected patients. Lancet
Infect Dis, 2005; 5: 197. (IF: 16.2)
54 of 81
133. Wig N, Anupama P, Singh S*, Handa R, Aggarwal P, Dwivedi SN, Jailkhani BL, Wali JP. Tumour
Necrosis Factor-alpha Levels in Patients with HIV with Wasting in South Asia. AIDS Patient Care
STDS. 2005 Apr;19(4):212-5. (IF: 2.52)
134. Singh S*, Sivakumar R. Polypeptides for the diagnosis and therapy of Leishmaniasis.
PCT/IN03/00400. Expert Opinion on Therapeutic Patents, Volume 15, Number 10, 1 October 2005,
pp. 1439-1465. (IF: 1.488)
135. Sivakumar R, Sharma P, Chang KP, Singh S*. Cloning, Expression and Purification of a Novel
recombinant antigen from Leishmania donovani. Protein Expr Purif, 2006, 46:156-165. (IF: 1.7)
136. Singh S*. New Developments in diagnosis of leishmaniasis. Indian J Med Res, 2006; 123:311-330.
(IF: 1.88)
137. Upadhyay A, Aggarwal R, Kapil A, Singh S*, Paul VK, Deorari AK. Profile of Neonatal Sepsis in
a tertiary care neonatal Unit from India.: A retrospective study. J Neonatol , 2006; 20: 50-57.
138. Redhu N S., Dey A, Balooni V, Singh S*. Leishmania-HIV Co-infection: An Emerging Problem
in India. AIDS, 2006; 20 (8): 1213-15. (IF: 5.62)
139. Dey A, Singh S*. Transfusion Transmitted Leishmaniasis. Indian J Med Microbiol, 2006; 24: 165-
170. (IF: 0.75)
140. Gupta S, Mathur P, Singh S*. Multiple opportunistic intestinal infections in a patient co-infected
with Human Immunodeficiency Virus and hepatitis B virus- a case report. Trop Gastroenterol.
2006; 27 (2)): 97-98.
141. Redhu N S., Dey A, Balooni V, Singh S*. Use of Immunoglobulin G (IgG) Avidity to Determine
the course of Disease in Visceral and Post Kala-Azar Dermal Leishmaniasis. Clin Vaccine
Immunol, 2006; 13 (8): 969-971. (IF: 2.02)
142. Dey A, Singh S*. Genetic heterogeneity among visceral leishmaniasis strains isolated from eastern
India. Infection, Genetics & Evolution. 2007; 7: 219-222. (IF: 3.52)
143. Gupta S, Singh S*. Hepatitis B and C virus co-infections in HIV positive North Indian Patients.
World J Gastroenterol 2006; 12 (42): 6879-83. (IF: 2.55)
144. Singh S*, Gopinath K, Shahdad S, Kaur M, Singh B, Sharma P. Non-tuberculous Mycobacterial
Infections in Indian AIDS patients detected by a Novel set of ESAT-6 Polymerase Chain Reaction
Primers. Jpn J Infect Dis., 2007, 60:14-18. (IF: 1.76)
145. Mishra J, Saxena A, Singh S*. Chemotherapy of Leishmaniasis: Past, present and future. Current
Medicinal Chemistry, 2007; 14 (10): 1153-1169. (IF: 4.5)
146. Dey A, Sharma U, Singh S*. First case of indigenous visceral leishmaniasis from central India. Am
J Trop Med Hyg, 2007: 77 : 95-98. (IF: 2.54)
147. Gopinath K, Manisankar M, Kumar S, Singh S*. Controlling multidrug resistant tuberculosis in
India. Lancet, 2007; 369: 741-42. (IF: 25.9)
148. Gopinath K, Kumar S, Manisankar M, Singh S*. A Novel Method for Clearing the Red Blood Cell
debris from the BacT/ALERTTM Blood Culture Medium for Improved Microscopic and Anti-
mycobacterial Drug Susceptibility Test Results. J Clin Lab Analys, 2007; 21:220-226. (IF: 1.52)
149. Sharma U, Redhu NS, Mathur P, Singh S*. Re-emergence of visceral leishmaniasis in Gujarat,
India. J Vect Borne Dis, 2007; 44: 230-232.
150. Gupta S, Mathur P, Wig N, Singh S*. Immune Restoration Syndrome with Atypical manifestation
of disseminated Penicillium marneffei and Cytomegalo Virus co- infections in an AIDS patient.
AIDS Res Therapy, 2007 (8th October): e21 (IF: 1.45)
55 of 81
151. Singh S*, Sankar MM, Gopinath K. High rate of extensively drug resistant tuberculosis in Indian
AIDS patients. AIDS, 2007; 21: 2345-47. (IF: 5.6)
152. Gupta S, Gupta R, Singh S*. Seroprevalence of HIV in pregnant women in North India: a tertiary
care hospital based study, BMC Infect Dis 2007, 7:133 Nov. 15, 2007: doi:10.1186/1471-2334-7-
133. (IF: 2.62)
153. Gupta S, Gupta R, Singh S*. Role of Horizontal Transmission in Hepatitis B Virus Spread among
Household Contacts in North India. Intervirology, 2008 51(1):7-13. (IF: 2.1)
154. Sivakumar R., Dey A, Sharma P, Singh S*. Expression and characterization of a recombinant
kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a
commercially available antigen from a newly isolated (KE16) strain of L. donovani. Infec Genet
Evol. 2008 (8): 313-322. PMID:18374635 (IF: 3.52)
155. Gupta S, Narang S, Nunavath V, Singh S*. Chronic diarrhoea in HIV patients: prevalence of
coccidian Parasites. Indian J Med Microbiol, 2008; 26: 172-175. (IF: 0.9)
156. Dey A, Sharma P, Redhu NS, Singh S*. Kinesin Motor Domain of Leishmania donovani as future
vaccine candidate. Clin Vaccine Immunol. 2008; 15: 836-842. [doi:10.1128/CVI.00433-07] (IF:
2.02)
157. Gopinath K, Kumar S, Singh S*. Prevalence of mycobacteremia in Indian HIV infected patients
detected by MB/BacT automated culture system. Eur J Clin Microbiol Infect Dis, 2008; 27 : 423-
431. (IF: 3.52)
158. Grewal HM, Gupta S, Singh S*. Opportunistic pathogens in AIDS: trends, diagnosis and priorities.
Expert Rev Anti Infect Ther. 2008 Apr; 6(2):163-6. (IF: 3.42)
159. Singh S*. Scaling Up Anti-Mycobacterial Drug Susceptibility Testing Services in India: It is High
time. Indian J Med Microbiol; 2008; 23:209-211. (IF: 0.9)
160. Kumar P, Srivatsava MV, Singh S*, Prasad HK. Filtration of CSF improves isolation of
Mycobacteria. J Clin Microbiol. 2008, 46(8):2824-5. (IF: 4.02)
161. Sankar MM, Gopinath K, Singla R, Singh S*. In- vitro antimycobacterial drug susceptibility testing
of Non-Tubercular Mycobacteria by Tetrazolium Microplate Assay. Ann Clin Microbiol
Antimicrob; 2008: Jul 11;7:15. (IF: 1.5)
162. Singh S*, Saluja TP, Kaur M, Khilnani GC. Comparative evaluation of Fast-Plaque assay with
PCR and other conventional in-vitro diagnostic methods for the early detection of Pulmonary
Tuberculosis. J Clin Lab Analys; 2008, 22 (5): 367-74. (IF: 1.45)
163. Singh S*, Balooni V, Singh N. Social and gender biases in HIV/AIDS care in India. Asian Pacific J
Trop Med, 2008; 1 (3): 60-64.
164. Sharma U, Singh S*. Insect vectors of Leishmania: distribution, physiology and their control. J
Vector Borne Dis 2008, 45; 255–272.
165. Sarda P, Sharma SK, Mohan A, Makharia G, Jayaswal A, Pandey RM, Singh S*. Role of acute
viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity. Indian J
Med Res. 2009;129: 64-67. (IF: 1.8)
166. Akhtar P, Singh S*, Bifani P, Kaur S, Srivastava BS, Srivastava R. Variable-number tandem repeat
3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on
transcription. J Med Microbiol. 2009; 58:798-805. (IF: 2.5)
167. Sharma U, Singh S*. Immunobiology of Leishmaniasis. Indian J Exp Biology. 2009; 47: 412-23.
(IF: 1.6)
56 of 81
168. Mandal S, Maharjan M, Ganguly S, Chatterjee M, Singh S*, Buckner FS, Madhubala R. High
Throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a
colorimetric β-lactamase assay. Indian J Exp Biology. 2009; 47 (6): 475-79. (IF: 1.6)
169. Gopinath K, Singh S*. Urine as an adjunct specimen for the diagnosis of active pulmonary
tuberculosis. Int J Infect Dis 2009; 13 (3): 374-379. (IF: 2.5)
170. Gopinath K, Singh S*. Multiplex PCR Assay for Simultaneous Detection and Differentiation of
Mycobacterium tuberculosis, M. avium Complexes, and Other Mycobacterial Species Directly from
Clinical Specimens. J Applied Microbiol, 2009; 107: 425-35 (IF: 2.56)
171. Dey A, Kumar U, Sharma P, Singh S*. Immunogenicity of candidate chimeric DNA vaccine
against tuberculosis and leishmaniasis. Vaccine, 2009; 27: 5152–5160. (IF: 3.0)
172. Dey A, Singh S*. Progress of Science from Microscopy to Microarrays. (Part 1): Diagnosis of
Parasitic Diseases. J Lab Physic, 2009; 1 :2-6
173. Goswami R, Somvanshi R, Singh SM, Singh S*. A preliminary survey on incidence of helminthic
and protozoal diseases in rats. Indian J Vet Pathol, 2009; 33: 90-92.
174. Kumar P, Nath K, Rath B, Sen MK, Vishalakshi P, Chauhan DS, Katoch VM, Singh S, Tyagi J,
Sreenivas V, Prasad HK. Visual Format for Detection of Mycobacterium tuberculosis and M. bovis
in Clinical Samples Using Molecular Beacons. J Mol Diagn, 2009; 11: 430-438. (IF: 3.478)
175. Sharma SK, Singla R, Sreenivas V, Kumar S, Jha B, Rathore J, Singh S. Acute viral hepatitis as a
confounding factor in patients with antituberculosis treatment induced hepatotoxicity. Indian J Med
Res. 2009; 130:200-201. (IF: 1.8)
176. Sankar MM, Kumar P, Munawwar A, Singh J, Parashar D, Singh S*. Recovery of M. tuberculosis
from sputum treated with Cetyl Pyridinium Chloride. J Clin Microbiol. 2009; 47(12):4189-90. (IF:
3.4)
177. Sharma S, Chanana B, Gulati S, Venkatesh P, Singh S*. Acute bilateral vision loss as the
presenting feature of subacute sclerosing panencephalitis. Indian J Pediatr. 2009;76: 952-3. (IF:
0.9)
178. Kumar V, Hassan M I, Tomar A K, Kashav T, Nautiyal J, Singh S, Singh T P and Yadav S.
Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards
identification of molecular markers of male fertility; J. Biosci. 2009; 34: 899–908. (IF: 0.9)
179. Singhal V, Bora D, Singh S*. Hepatitis B in Health Care Workers: Indian Scenario. J Lab Physic
2009; 1 (2): 41-48.
180. Singh S*, Munawwar A. Human toxoplasmosis: A food borne Parasitic Disease. Proc. Nat Acad
Sci. India. 2009; 79 (sp issue): 207-220.
181. Sharma U., Velpandian T., Sharma P, Singh S*. Evaluation of anti-leishmanial activity of selected
Indian plants known to have antimicrobial properties. Parasitol Res 2009: 105; 1287-1293. (IF:
1.4)
182. Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. Assessing Aquaglyceroporin Gene
Status and Expression Profile in Antimony- Susceptible and Resistant Clinical Isolates of L.
donovani from India. J Antimicrob Chemo. 2010, Mar;65(3):496-507. (IF: 5.4)
183. Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, Sreenivas V, Singh S. Safety of
different reintroduction regimens of antituberculosis drugs after development of antituberculosis
treatment-induced hepatotoxicity. Clin Infect Dis. 2010;50:833-9. (IF: 9.8)
57 of 81
184. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, Singh S, Rao KVS. Genome-Wide Analysis of
the Host Molecular Network that regulates Intracellular Survival of Mycobacterium tuberculosis.
Cell 2010 Mar 5; 140(5):731-743. (IF: 31.2)
185. Gupta S, Singh S*. Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at
a Tertiary Care Centre in North India. BMC Infect Dis. 2010; 10 (1):53. (IF: 2.4)
186. Gopinath K, Singh S*. Non-tubercular Mycobacteria in TB Endemic Countries: Are we neglecting
the danger? PLoS- NTD, 2010 April; 4 (4): e615 (IF: 5.3)
187. Kumar P, Sen M.K., Chauhan D.S., Katoch V.M, Singh S, Prasad H.K.. Assessment of the N-PCR
assay in the diagnosis of pleural tuberculosis: Detection of Mycobacterium tuberculosis in pleural
fluid and sputum samples collected in tandem. PLoS ONE; 2010; 5(4): e10220. (IF: 3.1)
188. Mishra J, Carpenter S, Singh S*. Low serum zinc levels in an endemic area of visceral
leishmaniasis in Bihar, India. Indian J Med Res, 2010, 131: 793-98. (IF: 1.8)
189. Singla R, Sharma SK, Mohan A, Makharia G, Sreenivas V, Jha B, Kumar S, Sarda P, Singh S.
Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res,
2010, 132: 81-86. (IF: 1.8)
190. Raghuvanshi S. Sharma P, Singh S, Kaer LV, Das G. Mycobacterium tuberculosis evades host
immunity by recruiting mesenchymal stem cells. PNAS , 2010; 107: 21653-58. (IF: 9.8).
191. Singh S*. Journal of Laboratory physicians (JLP): Success Story despite many challenges. J Lab
Physicians. 2011 Jan;3(1):1-3.
192. Yadav VK, Kumar V, Chhikara N, Kumar S, Manral P, Kashav T, Saini S, Srinivasan A, Singh S,
Singh TP, Yadav S. Purification and Characterization of native zinc-binding molecular weight
multiprotein complex from human seminal plasma. J Sep Sci. 2011; 34(9):1076-83.
193. Singhal V, Bora D, Singh S*. Prevalence of Hepatitis B Virus Infection in Healthcare Workers of a
Tertiary Care Centre in India and Their Vaccination Status. J Vaccine Vaccinol 2011; 2 :2: 1-4.
194. Singh S*., Sharma U, Mishra J. Post-kala-azar-dermal Leishmaniasis in India: recent
developments. Int J Dermatol. 2011;50 (9): 1099-1108. ( IF: 1.5)
195. Singh S*. Katoch VM. Commercial Serological tests for the diagnosis of active tuberculosis in
India: time to introspection. Indian J Med Res. 2011; 134: 583-587. ( IF: 1.8)
196. Sharma U, Singh D, Kumar P, Dobhal MP, Singh S*. Antiparasitic activity of Plumericine &
isoplumericin isolated from Plumeria bicolor against Leishmania donovani. Indian J Med Res.
2011; 134: 709-716. ( IF: 1.8)
197. Sumatoh HR, Oliver BG, Kumar M, Elliott JH, Vonthanak S, Vun MC, Singh S, Agarwal U,
Kumar A, Tan HY, Kamarulzaman A, Yunihastuti E, Saraswati H, Price P. Mycobacterial antibody
levels and immune restoration disease in HIV patients treated in South East Asia. Biomark Med.
2011 Dec;5(6):847-53. (IF: 2.64)
198. Singh D, Sharma U, Kumar P, Gupta YK, Dobhal MP, Singh S*. Antifungal activity of plumericin
and isoplumericin. Natural Product Commun; 2011; 6 (11): 1567-68. (IF: 0.8)
199. Singh S*, Gopinath K. Mycobacterium avium subspecies Paratuberculosis and crohn's regional
ileitis: How strong is association? J Lab Physicians. 2011; 3 (2): 69-74.
200. Tomar AK, Sooch BS, Raj I, Singh S, Singh TP, Yadav S. Isolation and identification of
Concanavalin A binding glycoproteins from human seminal plasma: A step towards identification
of male infertility marker proteins. Dis Markers. 2011 Jan 1;31(6):379-86. (IF: 1.56)
58 of 81
201. Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S*, Margolis
L. Semen of HIV-1 Infected individuals: local shedding of Herpes viruses and Reprogrammed
Cytokine Network. J Infect Dis. 2012; 205 (1): 97-105. ( IF: 6.2)
202. Kumar V, Yadav VK, Hassan I, Singh AK, Dey S, Singh S, Singh TP, Yadav S. Kinetic and
Structural Studies on the Interactions of Heparin and Proteins of Human Seminal Plasma using
Surface Plasmon Resonance. Protein Pept Lett. 2012; 19 (8):795-803. ( IF: 1.07)
203. Tomar AK, Sooch BS, Singh S, Yadav S. Quantification studies in human seminal plasma samples
identify prolactin inducible protein as a plausible marker of azoospermia. Biomarkers. 2012 ;17 (6):
545-51. ( IF: 2.2)
204. Tomar AK, Sooch BS, Singh S, Yadav S. Differential proteomics of human seminal plasma: A
potential target for searching male infertility marker proteins. Proteomics Clin Appl. 2012;6:147-
51. ( IF: 2.96)
205. Price P, Haddow LJ, Affandi J, Agarwal U, Easterbrook PJ, Elliott J, French M, Kumar M, Moosa
MY, Oliver B, Singh S, et al. Plasma Levels of Vitamin D in HIV Patients Initiating Antiretroviral
Therapy Do Not Predict Immune Restoration Disease Associated with Mycobacterium tuberculosis.
AIDS Res Hum Retroviruses. 2012 ; 28 (10) 1216-9. (IF: 2.58)
206. Kumar S, Tomar AK, Singh S, Saraswat M, Singh S*, Singh TP, Yadav S. Human serum albumin
as a new interacting partner of prolactin inducible protein in human seminal plasma. Int J Biol
Macromol. 2012;50(2):317-22. (IF: 2.858)
207. Munawwar A, Singh S*. AIDS associated Tuberculosis: a catastrophic collision to evade the host
immune system. Tuberculosis. 2012; 92 (5):348-7. [ DOI: 10.1016/j.tube.2012.05.006] (IF: 3.5)
208. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, Durier N. Rapid Identification and Drug
Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-
Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12. J Lab Physicians. 2012
Jul;4(2):120-6.
209. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, Durier N.Rapid Identification and Drug
Commercial Assays: Part 2: Nitrate Reductase Assay v1.3.12. J Lab Physicians. 2012 Jul;
4(2):112-9.
210. Singh S*, Kumar P, Sharma S, Mumbowa F, Martin A, Durier N. Rapid Identification and Drug
Commercial Assays: Part 1: Microscopic Observation Drug Suceptibility Assay v2.4.12. J Lab
Physicians. 2012 Jul;4(2):101-11.
211. Singh S*, Singh, J, Kumar S, Gopinath K, Balooni V, Singh N, Mani K. Poor Performance of
Serological Tests in the Diagnosis of Pulmonary Tuberculosis: Evidence from a Contact Tracing
Field Study. PLoS ONE 2012. http://dx.plos.org/10.1371/journal.pone.0040213 (IF: 3.78)
212. Lagrange PH, Thangaraj SK, Dayal R, Despande A, Ganguly NK, Girardi E, Joshi B, Katoch K,
Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D,
Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, et al. A toolbox for tuberculosis
diagnosis: an Indian multicentric study (2006-2008) microbiological results. PLoS One.
2012;7(8):e43739. doi: 10.1371/journal.pone.0043739. (IF: 3.78)
213. Nandan D; Bhatt GC; Dewan V; Yadav TP; Singh S*. Isolated tuberculous liver abscess in a 3-
year old immunocompetent child. Paediatr Int Child Health. 2013; 33(3): 187-189. (IF: 1.08)
59 of 81
214. Jayakumar R., Joshi YK, Singh S*. Laboratory Evaluation of Three Regimens of Treatment of
Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir. J Lab
Physicians 2012;4(1):10-6.
215. Kumar V, Yadav VK, Hassan I, Singh AK, Dey S, Singh S, Singh TP, Yadav S. Kinetic and
Structural Studies on the Interactions of Heparin and Proteins of Human Seminal Plasma using
Surface Plasmon Resonance. Protein Pept Lett. 2012;19(8):795-803. (IF: 1.98)
216. Lagrange PH , Thangaraj SK, Dayal R , Despande A, Ganguly NK, Girardi E, Joshi B , Katoch K ,
Katoch VM , Kumar M, Lakshmi V, Leportier M , Longuet C, Subbalaxmi V. S. M, Mukerjee D,
Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BSA,
Vernet G, Goletti D. A Toolbox for Tuberculosis Diagnosis: An Indian Multicentric Study (2006-
2008): Microbiological Results. PLoS ONE 2012; 7(8): e43739. doi:10.1371/journal.pone.0043739
(IF: 3.78)
217. Singh S*, Sankar MM, Kumar M, Sharma SK, Disseminated Tuberculosis Caused by a Rare and
Multidrug Resistant “Beijing” Genotype of Mycobacterium tuberculosis. Chest, 2012; 142: 253A-
253A. doi:10.1378/chest.1388948 (IF: 5.08)
218. Magee MJ, Blumberg HM, Broz D, Furner SE, Samson L, Singh S, Hershow RC. Prevalence of
drug resistant tuberculosis among patients at high risk for HIV attending out patient clinics in
Delhi, India. Southeast Asian J Trop Med Public Health. 2012; 43(2):354-63.
219. Lisco A, Introini A, Munawwar A, Vanpouille C, Grivel JC, Blank P, Singh S*, Margolis L. HIV-1
imposes rigidity on Blood and semen cytokine network. Am J Reprod Immunol. 2012; 68 (6): 515-
21. doi: 10.1111/aji.12015. (IF: 3.08)
220. Chhikara N, Saraswat M, Tomar AK, Dey S, Singh S, et al. Human Epididymis Protein-4 (HE-4):
A Novel Cross-Class Protease Inhibitor. PLoS ONE 2012;7(11): e47672.
doi:10.1371/journal.pone.0047672 (IF: 3.78)
221. Tomar AK, Sooch BS, Raj I, Singh S, Yadav S. Interaction analysis identifies semenogelin I
fragments as new binding partners of PIP in human seminal plasma. Int J Biol Macromol. 2013; 52:
296-99 doi: 10.1016/j.ijbiomac.2012.10.011. (IF: 2.85)
222. Sankar MM, Balooni V, Singh J, Singh S*. Diagnostic performance of commercially available
enzyme-linked immunosorbent assay kit in the diagnosis of extrapulmonary tuberculosis. J Lab
Physicians. 2013 Jan;5(1):11-6. doi: 10.4103/0974-2727.115902.
223. Singh N, Mishra J, Singh R, Singh S*. Animal Reservoirs of Visceral Leishmaniasis in Bihar,
India. J Parasitol. 2013 ; 99: 64-7. (IF: 1.5)
224. Sankar MM, Kumar P, Munawwar A, Kumar M, Singh J, Singh A, Parashar D, Malhotra N,
Duttagupta S, Singh S*. Usefulness of multiplex PCR in the diagnosis of genital tuberculosis in
females with infertility. Eur J Clin Microbiol Infect Dis. 2013; 32(3):399-405 PMID:23052988 (IF:
3.18)
225. Mishra J, Madhubala R, Singh S*. Visceral and Post Kala-Azar Dermal Leishmaniasis isolates
show significant difference in their in-vitro drug susceptibility pattern. Parasitology
Research. 2013;112(3):1001-9. (IF: 2.18)
226. Tomar AK, Sooch BS, Singh S, Yadav S. Aggregation analysis of Con A binding proteins of
human seminal plasma: A dynamic light scattering study. Int J Biol Macromol. 2013;53:133-7. (IF:
2.85)
227. Bhatt GC, Nandan D, Singh S. Isolated tuberculous liver abscess in immunocompetent children –
Report of two cases. Pathog & Glob Health. 2013; 107(1):35-37.
doi:10.1179/2047773212Y.0000000071 (IF: 0.85)
60 of 81
228. Jain S, Singh S, Sankar MM, Saha R, Rangaraju RR, Chugh TD. Catheter-related bacteremia due to
M. chelonae in an immunocompromised patient: an emerging nosocomial pathogen. Indian J Med
Microbiol. 2012;30(4):489-91. (IF: 1.05)
229. Yadav VK, Chhikara N, Gill K, Dey S, Singh S, Yadav S. Three low molecular weight cysteine
proteinase inhibitors of human seminal fluid: Purification and enzyme kinetic properties.
Biochimie. 2013; 95(8):1552-59. doi:pii: S0300-9084(13)00111-9. (IF: 3.123)
230. Yadav VK, Saraswat M, Chhikara N, Singh S, Yadav S. Heparin and heparin Binding proteins:
potential relevance to reproductive physiology. Curr Protein Pept Sci. 2013 Feb 1;14(1):61-9. (IF:
3.10)
231. Mathur P, Singh S*. Multidrug Resistance in Bacteria: A Serious Patient Safety Challenge for
India. J Lab Physicians. 2013 Jan;5(1):5-10.
232. Kumar P, Singh A, Sharma U, Singh D, Dobhal MP, Singh S*. Anti-mycobacterial activity of
plumericin and isoplumericin against MDR Mycobacterium tuberculosis. Pulm Pharmacol Ther.
2013 Jun; 26(3):332-5. (IF: 2.563)
233. Tomar AK, Sooch BS, Raj I, Singh S, Yadav S. Interaction analysis identifies semenogelin I
fragments as new binding partners of PIP in human seminal plasma. Int J Biol Macromol.
2013;52:296-9. (IF: 2.85)
234. Sankar MM, Singh J, Diana SC, Singh S*. Molecular characterization of Mycobacterium
tuberculosis isolates from North Indian patients with extra-pulmonary tuberculosis. Tuberculosis
(Edinb). 2013;93(1):75-83. (IF: 3.5)
235. Mishra J, Dey A, Singh N, Somvanshi R, Singh S*. Evaluation of toxicity and therapeutic efficacy
of a new liposomal formulation of Amphotericin B in mice model by real time PCR. Indian J Med
Res. 2013; 137: 767-776. (IF: 2.05)
236. Singh J, Sankar MM, Kumar S, Gopinath K, Singh N, Mani K, Singh S*. Incidence and prevalence
of tuberculosis among household contacts of pulmonary tuberculosis patients in a Peri-urban
population of South Delhi, India. PLoS One. 2013; 8 (7) e69730.
doi:10.1371/journal.pone.0069730. (IF: 3.785)
237. Das S, Roychowdhury T, Kumar P, Kumar A, Kalra P, Singh J, Singh S, Prasad H, Bhattacharya
A. Genetic Heterogeity revealed by sequence analysis of Mycobacterium tuberculosis isolates from
extra-pulmonary tuberculosis patients. BMC Genomics, 2013: June 17: 14 (1): 404. (IF: 5.85)
238. Yadav VK, Saraswat M, Chhikara N, Singh S, Yadav S.Heparin and heparin binding proteins:
potential relevance to reproductive physiology. Curr Protein Pept Sci. 2013 Feb;14(1):61-9. (IF:
3.10)
239. Mishra J, Madhubala R, Singh S*. Visceral and post-Kala-Azar dermal leishmaniasis isolates show
significant difference in their in vitro drug susceptibility pattern. Parasitol Res. 2013
Mar;112(3):1001-9. doi: 10.1007/s00436-012-3222-1. Epub 2012 Dec 18. (IF: 2.15)
240. Oliver BG, Haddow LJ, Agarwal U, Kumar M, Easterbrook PJ, Moosa MY, Singh S, Price P. Pre-
antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated
immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral
therapy. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):e72-4. doi:
10.1097/QAI.0b013e31828e6182. (IF: 4.556)
241. Affandi JS, Kumar M, Agarwal U, Singh S, Price P.The search for a genetic factor associating with
immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis. Dis
Markers. 2013;34(6):445-9. doi: 10.3233/DMA-130991. (IF: 2.65)
61 of 81
242. Parashar D, Kabra SK, Lodha R, Singh V, Mukherjee A, Arya T, Grewal HM, Singh S*; Delhi
Pediatric TB Study Group. Does neutralization of gastric aspirates from children with suspected
intrathoracic tuberculosis affect mycobacterial yields on MGIT culture? J ClinMicrobiol. 2013
Jun;51(6):1753-6. doi: 10.1128/JCM.00202-13. (IF: 4.115)
243. Kumar P, Rufai SB, Singh S*. Heat fixed but unstained slide smears are infectious to laboratory
staff. Indian J Tuberc. 2013 Jul;60(3):142-6.
244. Singh S*. Bio-safety precautions in tuberculosis laboratory. Indian J Tuberc. 2013 Jul; 60(3):135-7.
245. Yadav VK, Chhikara N, Gill K, Dey S, Singh S. Yadav S. Three low molecular weight cysteine proteinase
inhibitors of human seminal fluid: purification and enzyme kinetic properties. Biochimie. 2013
Aug;95(8):1552-9. doi: 10.1016/j.biochi.2013.04.007. (IF: 3.15)
246. Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, GangulyNK, Girardi E, Joshi B, Katoch K,
Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, MalladiSV, Mukerjee D, Nair D, Raja
A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S. Sodha A, Kabeer BS, Vernet G, Goletti D.
A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of
QuantiFERON-TB gold in tube for TB diagnosis. PLoS One. 2013 Sep 6;8(9):e73579. doi:
10.1371/journal.pone.0073579. (IF: 3.57)
247. Mishra J, Singh S*. Miltefosine resistance in Leishmania donovani involves suppression of
oxidative stress-induced programmed cell death. Exp Parasitol. 2013;135(2):397-406.
doi:10.1016/j.exppara.2013.08.004. (IF: 2.15)
248. Mukherjee A, Singh S, Lodha R, Singh V, Hesseling AC, Grewal HM, Kabra SK; Delhi Pediatric
TB Study Group. Ambulatory Gastric Lavages Provide Better Yields of Mycobacterium
tuberculosis Than Induced Sputum in Children With Intrathoracic Tuberculosis. Pediatr Infect Dis
J. 2013 Dec;32(12):1313-7. doi: 10.1097/INF.0b013e31829f5c58. (IF: 2.75)
249. Mukherjee A, Saini S, Kabra SK, Gupta N, Singh V, Singh S, Bhatnagar S, Saini D, Grewal HM,
Lodha R; Delhi TB Study group. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-
Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis. Eur J Clin
Nutr. 2014 Jan;68(1):38-42. doi: 10.1038/ejcn.2013.216. (IF: 2.95)
250. Singh S*. Vitamin D and mortality: meta-analysis of individual participant data from a large
consortium of cohort studies from Europe and the United States. eBMJ 2014;348:g3656
251. Kumar P, Balooni V, Sharma BK, Kapil V, Sachdeva KS, Singh S*. High degree of multi-drug
resistance and hetero-resistance in pulmonary TB patients from Punjab state of India.Tuberculosis
(Edinb). 2014 Jan;94(1):73-80. doi: 10.1016/j.tube.2013.10.001. (IF: 3.5)
252. Singh S*, Munawwar A, Rao S, Mehta S, Hazarika NK. Serologic prevalence of Toxoplasma
gondii in Indian women of child bearing age and effects of social and environmental factors. PLoS
Negl Trop Dis. 2014 Mar 27;8(3):e2737. doi: 10.1371/journal.pntd.0002737 (IF: 4.45)
253. Behera B, Mathur P, Bhardwaj N, Jain N, Misra MC, Kapil A, Singh S. Antibiotic susceptibilities,
streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G
Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care
centre. Indian J Med Res. 2014 Mar; 139(3):438-45. (IF: 1.85)
254. Mathur P, Bhardwaj N, Mathur K, Behera B, Gupta G, Kapil A, Singh S. Clinical and molecular
epidemiology of beta-hemolytic streptococcal infections in India. J Infect Dev Ctries. 2014; 8 (3):
297-303. (IF: 1.55)
255. Jain S, Sankar MM, Sharma N, Singh S, Chugh TD. High prevalence of non-tuberculous
mycobacterial disease among non-HIV infected individuals in a TB endemic country--experience
62 of 81
from a tertiary center in Delhi, India. Pathog Glob Health. 2014 Mar;108(2):118-22. doi:
10.1179/2047773214Y.0000000133. (IF: 1.05)
256. Satyaraddi A, Velpandian T, Sharma SK, Vishnubhatla S, Sharma A, Sirohiwal A, Nakharia GK,
Sinha S, Biswas A, Singh S*. Correlation of plasma anti-tuberculosis drug levels with subsequent
development of hepatotoxicity. Int J Tub Lung Dis, 2014; 18 (2): 188-195. (IF: 2.35)
257. Singh A, Gopinath K, Singh N, Singh S*. Deciphering the sequential events during in-vivo
acquisition of drug resistance in Mycobacterium tuberculosis. Int J Mycobacteriol 2014; 3 (1): 36-
40.
258. Singh S*. Commentary: Slow or long term on-progressor HIV patients: Indian scenario. Indian J
Med Microbiol 2014; 32 (1): 77-78. (IF: 1.85)
259. Kumar P, Benny P, Jain M, Singh. Comparison of an in-house multiplex PCR with two commercial
immunochromatographic tests for rapid identification and differentiation of MTB from NTM
isolates. Int J Mycobacteriol 2014; 3 (1): 50-56.
260. Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K,
Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D,
Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G,
Goletti D. A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-
2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB
Diagnosis. PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. (IF: 3.77)
261. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S*. Comparison of Xpert MTB/RIF
with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis. J
Clin Microbiol. 2014 Jun;52(6):1846-52. doi: 10.1128/JCM.03005-13. (IF: 4.232)
262. Nandan D, Nag VK, Trivedi N, Singh S*. X-linked Hyper-IgM Syndrome with Bronchiectasis. J
Lab Physicians. 2014 Jul;6(2):114-6. doi: 10.4103/0974-2727.141510.
263. Singh S*, Rufai SB, Kumar P, Singh J. Reply to "molecular diagnosis of rifampin-monoresistant
tuberculosis in Indian patients: problems with a discordance analysis". J Clin Microbiol. 2014
Sep;52(9):3504-5. doi: 10.1128/JCM.01731-14. (IF: 4.2325)
264. Nandan D, Jahan A, Dewan V, Singh S, Buxi G. Pure red cell aplasia in a three-months-old infant
possibly secondary to cytomegalo virus infection. Indian J Hematol Blood Transfus. 2014 Sep;30
(Suppl 1):30-2. doi: 10.1007/s12288-012-0226-z. (IF: 0.05)
265. Khandelwal D, Gupta N, Mukherjee A, Lodha R, Singh V, Grewal HM, Bhatnagar S, Singh S,
Kabra SK; Delhi Pediatric TB Study Group. Vitamin D levels in Indian children with intrathoracic
tuberculosis. Indian J Med Res. 2014 Oct;140(4):531-7. (IF: 1.85)
266. Lodha R, Mukherjee A, Singh V, Singh S, Friis H, Faurholt-Jepsen D, Bhatnagar S, Saini S, Kabra
SK, Grewal HM; Delhi Pediatric TB Study Group. Effect of micronutrient supplementation on
treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. Am J
Clin Nutr. 2014 Nov;100(5):1287-97. (IF: 6.95)
267. Singh S*. Early detection of multi-drug resistant tuberculosis in India using GenoType
MTBDRplus assay & profile of resistance mutations in Mycobacterium tuberculosis. Indian J Med
Res. 2014 Oct;140(4):477-9. (IF: 1.85)
268. Kumar P, Pandya D, Singh N, Behera D, Aggarwal P, Singh S*. Loop-mediated isothermal
amplification assay for rapid and sensitive diagnosis of tuberculosis. J Infect. 2014 Dec; 69(6):607-
15. doi: 10.1016/j.jinf.2014.08.017. (IF: 4.55)
63 of 81
269. Mathew JL, Vijayasekharan D, Singh S*. Is Xpert MTB/RIF assay in gastric lavage aspirate useful
for diagnosis of smear-negative childhood pulmonary tuberculosis? Indian Pediatr. 2014 Dec;
51(12):1007-11. (IF: 1.10)
270. Singh S*. Changing trends in the epidemiology, clinical presentation, and diagnosis of Leishmania-
HIV co-infection in India. Int J Infect Dis. 2014 Dec; 29:103-12. doi: 10.1016/j.ijid.2014.07.011.
(IF: 2.15)
271. Munawwar A, Sharma SK, Gupta S, Singh S*. Seroprevalence and determinants of Kaposi
sarcoma-associated human herpesvirus 8 in Indian HIV-infected males. AIDS Res Hum
Retroviruses. 2014 Dec;30(12):1192-6. doi: 10.1089/aid.2014.0184. (IF: 2.33)
272. Yadav VK, Mandal RS, Puniya BL, Singh S, Yadav S. Studies on the interactions of SAP-1 (an N-
terminal truncated form of cystatin S) with its binding partners by CD-spectroscopic and molecular
docking methods. J Biomol Struct Dyn. 2015; 33(1):147-57. (IF: 2.69)
273. Singh A, Gopinath K, Sharma P, Bisht D, Sharma P, Singh N, Singh S*. Comparative proteomic
analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary
tuberculosis turning from drug sensitive to multidrug resistant. Indian J Med Res 2015; 141 (1): 27-
45. (IF: 1.60)
274. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Comparative Lipidome Profile of Sensitive and
Resistant Mycobacterium tuberculosis Strain. Int J Curr Microbiol App Sci. 2015; 1: 189-197.
275. Singh S*, Dey B, Sachdeva KS, Kabra SK, Chopra KK, Chaudhary VK, Sharma P, Katoch VM.
Challenges in tuberculosis diagnosis and management: recommendations of the expert panel. J
Lab Physicians. 2015 Jan-Jun;7(1):1-3. doi: 10.4103/0974-2727.154778.
276. Singh S*, Kumar M, Singh P. Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a
Valid Biomarker? Tuberc Res Treat. 2015;2015:957519. doi: 10.1155/2015/957519.
277. Nag VK, Nandan D, Singh S, Arora SK, Tsanglao W, Arya N. Pulmonary Tuberculosis: A
Predominant Cause of Childhood Bronchiectasis in India. J Commun Dis 2015; 47 (1): 14-18.
278. Yadav VK, Mandal RS, Puniya BL, Kumar R, Dey S, Singh S, Yadav S. Structural and binding
studies of SAP-1 protein with heparin. Chem Biol Drug Des. 2015 Mar; 85(3):404-10. doi:
10.1111/cbdd.12420. (IF: 2.485)
279. Singh S*. EPTB in Disdain: Indian Public Health Scenario. Eradicating TB in India. Global Policy,
2015; 3 (Spl): 56-61.
280. Kumar P, Kumar P, Balooni V, Singh S*. Genetic mutations associated with rifampicin and
isoniazid resistance in MDR-TB patients in North-West India. Int J Tuberc Lung Dis.
2015;19(4):434-9. (IF: 2.85)
281. Greenland K, Dixon R, Khan SA, Gunawardena K, Kihara JH, Smith JL, Drake L, Makkar P,
Raman S, Singh S, Kumar S. The epidemiology of soil-transmitted helminths in Bihar State, India.
PLoS Negl Trop Dis. 2015 May 20;9(5):e0003790. doi: 10.1371/journal.pntd.0003790. eCollection
2015 May. (IF: 4.446)
282. Sharma VK, Pai G, Deswarte C, Lodha R, Singh S, Kang LW, Yin CC, Casanova JL, Bustamante
J, Kabra SK. Disseminated Mycobacterium avium complex infection in a child with partial
dominant interferon gamma receptor 1 deficiency in India. J Clin Immunol. 2015 Jul;35(5):459-62.
doi: 10.1007/s10875-015-0173-1. (IF: 3.15)
283. Gupta AK, Srivastava S, Singh A, Singh S*. De Novo Whole-Genome Sequence and Annotation of
a Leishmania Strain Isolated from a Case of Post-Kala-Azar Dermal Leishmaniasis. Genome
Announc. 2015 Jul 16;3(4). pii: e00809-15. doi: 10.1128/genomeA.00809-15.
64 of 81
284. Singh S*. Can Establishment of Human Microbiome be Customized After Birth with Local
Traditions of First Feed and Intimate Kissing? J Lab Physicians. 2015 Jul-Dec;7(2):73-4. doi:
10.4103/0974-2727.163140.
285. Singh J, Sankar MM, Kumar P, Couvin D, Rastogi N, Singh S*; Indian TB Diagnostics Network.
Genetic diversity and drug susceptibility profile of Mycobacterium tuberculosis isolated from
different regions of India. J. Infect. 2015 Aug;71(2):207-19. doi: 10.1016/j.jinf.2015.04.028. Epub
2015 Apr 29. (IF: 4.45)
286. Rufai SB, Singh A, Kumar P, Singh J, Singh S*. Performance of Xpert MTB/RIF assay in the
diagnosis of pleural tuberculosis using pleural fluid samples. J Clin Microbiol. 2015
Nov;53(11):3636-8. doi: 10.1128/JCM.02182-15. (IF: 4.232)
287. Singh S*, Singh A, Prajapati S, Kabra SK, Lodha R, Mukherjee A, Singh V, Hesseling AC, Grewal
HM; Delhi Pediatric TB study group. Xpert MTB/RIF assay can be used on archived gastric
aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC
Microbiol. 2015 Sep 29;15:191. doi: 10.1186/s12866-015-0528-z. (IF: 2.79)
288. Rabodoarivelo MS, Imperiale B, Andrianiavomikotroka R, Brandao A, Kumar P, Singh S,
Ferrazoli L, Morcillo N, Rasolofo V, Palomino JC, Vandamme P, Martin A. Performance of Four
Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis. PLoS
One. 2015;10(10):e0139382. doi: 10.1371/journal.pone.0139382. (IF: 3.57)
289. Drake LJ, Singh S, Mishra CK, Sinha A, Kumar S, Bhushan R, Hollingsworth TD, Appleby LJ,
Kumar R, Sharma K, Kumar Y, Raman S, Chakrabarty S, Kihara JH, Gunawardena NK, Hollister
G, Kumar V, Ankur A, Prasad B, Ramachandran S, Fishbane A, Makkar P. Bihar's Pioneering
School-Based Deworming Programme: Lessons Learned in Deworming over 17 Million Indian
School-Age Children in One Sustainable Campaign. PLoS Negl Trop Dis. 2015, 19;9(11):
e0004106. doi: 10.1371/journal.pntd.0004106. (IF: 4.05)
290. Goel V, Kumar D, Kumar R, Mathur P, Singh S*. Community Acquired Enterococcal Urinary
Tract Infections and Antibiotic Resistance Profile in North India. J Lab Physicians. 2016 Jan-
Jun;8(1):50-4. doi: 10.4103/0974-2727.176237.
291. Munawwar A, Singh S*. Human Herpesviruses as copathogens of HIV Infection, Their Role in
HIV Transmission, and Disease Progression. J Lab Physicians. 2016;8(1):5-18. doi: 10.4103/0974-
2727.176228.
292. Saraswat M, Joenväärä S, Tomar AK, Singh S, Yadav S, Renkonen R. N-Glycoproteomics of
Human Seminal Plasma Glycoproteins. J Proteome Res. 2016 Mar 4;15(3):991-1001. doi:
10.1021/acs.jproteome.5b01069. (IF: 4.17).
293. Jenum S, Dhanasekaran S, Lodha R, Mukherjee A, Kumar Saini D, Singh S, Singh V, Medigeshi
G, Haks MC, Ottenhoff TH, Doherty TM, Kabra SK, Ritz C, Grewal HM. Approaching a
diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers
across the clinical disease spectrum. Nature Sc Rep, 2016 Jan 4;6:18520. doi: 10.1038/srep18520.
(IF: 5.55).
294. Srivastava S, Shankar P, Mishra J, Singh S*. Possibilities and challenges for developing a
successful vaccine for leishmaniasis. Parasite & Vectors. 2016 May 12;9(1):277. (IF: 3.51).
295. Prajapati S, Upadhyay K, Mukherjee A, Kabra SK, Lodha R, Singh V, Grewal HM, Singh S*;
Delhi Pediatric TB Study Group. High prevalence of primary drug resistance in children with
intrathoracic tuberculosis in India. Paediatr Int Child Health. 2016; 36(3), 214-218 (IF: 1.05).
296. Singh S*. Congenital Toxoplasmosis: Clinical features, outcomes, treatment and prevention. Trop.
Parasitol. 2016; 6(2): 113-122.
297. Tomar AK, Kumar S, Chhillar S, Kumaresan A, Singh S, Yadav S. Human Serum Albumin and
Prolactin Inducible Protein Complex Enhances Serum Capacitation in-Vitro. J Proteins &
Proteomics 2016; 7 (2), 107-113.
65 of 81
298. Goel V, Kumar D, Patwardhan V, Balooni V, Singhal S, Singh S. Trends of Seroprevalence.
Epidemiology and Clincal presentation of HIV in North India: A tertiary Care Hospita Based Study.
World J AIDS 2016; 6 (02), 54-58. (IF: 0.79).
299. Jenum, S., Bakken, R., Dhanasekaran, S., Mukherjee, A., Lodha, R., Singh, S., et al. BLR1 and
FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in
children and predict treatment outcome. Nature Sc Rep, 2016; 6, 38841.
http://doi.org/10.1038/srep38841 (IF: 5.55).
300. Goel V, Kumar D, Raghavendra L, Singh S*. Occurrence of Needlestick and Injuries
among Health-care Workers of a Tertiary Care Teaching Hospital in North India. J Lab
Physicians 2017; 9 (1), 20-25. (IF: 0.67).
301. Rufai SB, Singh S*, Singh A, Kumar P, Singh J, Vishal A. Performance of Xpert
MTB/RIF on Ascitic Fluid Samples for Detection of Abdominal Tuberculosis. J Lab
Physicians 2017; 9 (1), 47-52. (IF: 0.67).
302. Saraswat M, Joenväärä S, Jain T, Tomar AK, Sinha A, Singh S, Yadav S, Renkonen R.
Human spermatozoa quantitative proteomic signature classifies normo-and
asthenozoospermia. Mol & Cell Proteomics 2017; 16 (1), 57-72. (IF: 5.91).
303. Raj V, Gupta V, Pathak M, Sreenivas V, Sood S, Singh S, Verma KK, Khanna N, Das
BK, Gupta S. What puts them at risk? A cross-sectional case-control survey of
demographic profile and sexual behaviour of patients with sexually transmitted infections
at a tertiary care center in North India. Indian J STD AIDS, 2017; 38(1):22-36.
DOI:10.4103/0253-7184.196885. (IF: 0.431).
304. Srivastava S, Mishra J, Gupta AK, Singh A, Mishra PS, Singh S*. Laboratory Confirmed
Miltefosine Resistant Cases of Visceral Leishmaniasis from India. Parasites & Vectors,
2017; 10:49 DOI 10.1186/s13071-017-1969-z (IF: 3.41).
305. Singh A, Gupta A, Gopinath K, Sharma P, Singh S*. Evaluation of 5 Novel protein
biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis:
preliminary results. Nature Sc Rep, 2017; 7:44121 (1-10). DOI: 10.1038/srep44121 (IF:
5.55).
306. Rufai SB, Singh A, Singh J, Kumar P, Sankar MM Singh S*. Diagnostic usefulness of
Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid. J
Infection. 2017; 75(2): 125-131. doi.org/10.1016/j.jinf.2017.04.010 (IF: 4.441).
307. Wattal W, Javeri Y, Goel N, Dhar N, Saxena S, Singh S, Oberoi JK, et al. Convergence of
Minds: For better patient outcome in intensive care unit infections. Indian J Crit Care Med
2017; 21, 154-159. (IF: 0.76).
308. Kumar P, Vats O, Kumar D, Singh S*. Coccidian intestinal parasites among
immunocompetent children presenting with diarrhoea: Are we missing them? Trop
Parasitol 2017; 7:37-40
309. Gupta AK, Singh A, Srivastava S, Singh S*. Visceral Leishmaniasis in Children:
Diagnosis, Treatment, and Prevention. J Pediatr Infect Dis, July 2017; 12(4): 214-221.
66 of 81
310. Patwardhan V, Kumar D. Goel V, Singh S*. Parasitic Infections in Pediatric Population of
India: Epidemiology, Diagnosis, and Strategies for Prevention. J Pediatr Infect Dis, 2017;
12(4):228-237
311. Patwardhan V, Singh S*. Fosfomycin for the treatment of drug-resistant urinary tract
infections: potential of an old drug not explored fully. Int Urol Nephrol. 2017 Jun 14. doi:
10.1007/s11255-017-1627-6. (IF: 1.56).
312. Bhatnagar M, Sarkar N, Gandharv N, Apang O, Singh S, Ghosal S. Evaluation of
antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of
Arunachal Pradesh, India. BMC Complement Altern Med. 2017 Aug 1;17(1):379. doi:
10.1186/s12906-017-1884-z. (IF: 2.228).
313. Patwardhan V, Kumar D. Goel V, Singh S*. Changing prevalence and antibiotic drug
resistance pattern of pathogens seen in community-acquired pediatric urinary tract
infections at a tertiary care hospital of North India. J Lab physicians 2017; 9(4):264-268. .
(IF: 0.67).
314. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Comparative lipidomics of drug sensitive
and resistant Mycobacterium tuberculosis reveals altered lipid imprints. 3Biotech,
2017; 7:335. DOI: 10.1007/s13205-017-0972-6. (IF: 1.37).
315. Singh S*, Sankar MM. Diagnostic algorithms for low-volume CSF samples in tuberculous
meningitis. Lancet Inf Dis, 2017; 17 (12): 1236-37. doi: 10.1016/S1473-3099(17)30639-4
(IF: 19.87).
316. Rufai, S.B., Singh, J., Kumar P., Mathur P., and Singh S. Association of gyrA and rrs gene
mutations detected by MTBDRslV1 on Mycobacterium tuberculosis strains of diverse
genetic background from India. Scientific reports June 2018; 8(1) DOI: 10.1038/s41598-
018-27299-z.
317. Pal R, Hameed S, Sabareesh V, Kumar P, Singh S, Fatima Z. Investigations into Isoniazid
Treated Mycobacterium tuberculosis by Electrospray Mass Spectrometry Reveals New
Insights into Its Lipid Composition. J Pathog. Jun 19;2018:1454316. doi:
10.1155/2018/1454316. eCollection 2018
318. Munawwar, A., Gupta, S., Sharma, S.K, and Singh, S. Seroprevalence of HSV-1 and 2 in
HIV-infected males with and without GUD: Study from a tertiary care setting of India. J
Lab Physicians. 2018 Jul-Sep;10(3):326-331. doi: 10.4103/JLP.JLP_7_18.
319. Sinha A, Singh V, Singh S, Yadav S. Proteomic analyses reveal lower expression of
TEX40 and ATP6V0A2 proteins related to calcium ion entry and acrosomal acidification
in asthenozoospermic males. Life Sci. 2019 Feb 1;218:81-88.
doi:10.1016/j.lfs.2018.12.016.
320. Rufai SB, Singh S. Whole-Genome Sequencing of Two Extensively Drug-Resistant
Mycobacterium tuberculosis Isolates from India. Microbiol Resourc Announc. 2019 Feb
14;8(7). pii: e00007-19. doi: 10.1128/MRA.00007-19
67 of 81
321. Pal R, Hameed S, Kumar P, Singh S, Fatima Z. Understanding lipidomic basis of iron
limitation induced chemosensitization of drug-resistant Mycobacterium tuberculosis. 3
Biotech. 2019 Apr;9(4):122. doi: 10.1007/s13205-019-1645-4.
*indicates corresponding author
ABSTRACTS PUBLISHED:
1. Singh S, Samantaray JC, Kumar R. Intestinal parasitosis in and around Delhi. XXXI
National Conference of ISG at Jaipur on November, 25-29, 1990 .
2. Singh S, Irshad M, Shrivastava AK Rattan A. Blood contamination of laboratory slips and
blood sample containers: a risk of laboratory acquired infections. Proceeding of VII
International Conference on AIDS, Florence, Italy, 1991. vol 7; 434.
3. Singh S, Sharma MP. Strongyloidiasis in Northern India. 32nd National Conference of
ISG at Trivandrum on October, 6-9, 1991.
4. Wali JP, Aggarwal P, Gupta U, Singh S. Ketoconazole in the treatment of drug resistant
Kala-azar. J Assoc. Phys Indian 1991; 39: 867-8.
5. Singh S, Seth P. Toxoplasmosis in AIDS patients in India. Proceeding of second
International Conference on AIDS in Asia and the Pacific, New Delhi, 1992.
6. Singh S, Seth P, Dubey JP. Toxoplasmosis in Indian AIDS patients. Proceeding of VIII
International Conference on AIDS, Amsterdam, The Netherlands, 1992.
7. Singh S, Singh N. Toxoplasmosis is sexually transmitted . Proceeding of IX International
Conference on AIDS, Berlin, Germany, 1993.
8. Singh S, Singh N, Karmarkar MG. Evaluation of Direct agglutination test and ELISA
for the diagnosis of toxoplasmosis. XIX National Conference of Indian Immunology
Society, Bangalore, January 8-11, 1993.
9. Singh S, Singh N, Lakra MS. Blastocystis hominis in patients with gastrointestinal
symptoms. 34th National congress of ISG, Panji (Goa), October 13-17, 1993.
10. Handa R, Singh S, Singh N, Wali JP. Brucellosis in India. Proceeding of the 6th
International Congress for Infectious Diseases, Prague, Czechoslovakia, 1994.
11. Singh S, Singh N, Maniar JK, Saple DG, Seth T. Human Tumour necrosis factor- in
AIDS associated Toxoplasmosis. Proceeding of X International Conference on AIDS,
Yokohama, Japan, 1994.
12. Singh N, Singh S. Vaginal fluid collected with OMNI-SAL collection device as an
alternative to serum for immunodiagnosis. Proceeding of X International Conference on
AIDS, Yokohama, Japan, 1994.
13. Singh S, Ahlawat S, Singh N, Chaudhary VP. TORCH Infections in multiply transfused
Thalassemic Indian Children. 3rd International Conference of the Hospital Infection
Society, London, 1994.
14. Singh S, Chang KP. Genetic heterogeneity among Indian Leishmania donovani isolates.
Proceeding of VIII International Congress of Parasitology, Izmir, Turkey, 1994.
15. Singh S, Chang KP. Diagnostic & Prognostic evaluation of rK39 antigen in Indian
Leishmaniasis. Proceedings of the 43rd Congress of American Society of Tropical
Medicine & Hygiene, Cincinnati, USA, 1994.
68 of 81
16. Singh S, Singh N, Raju GV. Knowledge, attitude & beliefs about AIDS & sexuality in
Medical and Paramedical staff of a teaching hospital. Proceeding of the III International
Conference on AIDS in Asia and the Pacific, Chiang-Mai, Thailand, 1995.
17. Singh S. Molecular tools for the diagnosis of Toxoplasmosis. National Symposium on
Toxoplasmosis in India. New Delhi, September 27-28, 1995,.
18. Singh S. Cytokines in toxoplasmosis. National Symposium on Toxoplasmosis in India.
New Delhi, September 27-28, 1995.
19. Singh S, Singh N, Rattan A. TORCH Infections. International CME on Laboratory
Approach to Paediatric Problems. New Delhi, 1995.
20. Singh S. Immunodiagnosis of Indian Leishmaniasis. Global Meet on Parasitic Diseases,
New Delhi, 1996
21. Singh S, Singh N, Maniar JK. TNF- in AIDS Associated Toxoplasmosis. Global Meet on
Parasitic Diseases, New Delhi, 1996.
22. Singh S*. AIDS Associated Toxoplasmosis: An Indian Scene (Awarded Paper).
Proceedings of 9th International Symposium on Infections in the Immuno-compromised
Host. Assisi, Italy, 1996.
23. Singh S, Singh N, Handa R. Serum concentrations of Tumour necrosis factor- in Indian
patients with Malaria and Kala-azar: its correlation with disease prognosis. 7th
International Congress for the Infectious Diseases, Hong-Kong, June 10-13, 1996 [Abs:
10146].
24. Singh S, Singh N. Human Immunodeficiency virus reaches small villages in rural India.
Proceedings of the XI International Conference on AIDS. Vancouver, Canada, July 6-11,
1996.
25. Chang KP, Chai JJ, Zho XP, Qu JQ, Sundar S, Singh S, Reed SG. RK39 Dipstick vs.
conventional procedures for diagnosis of Chinese and Indian visceral Leishmaniasis.
XIV International Congress for Tropical Medicine & Malaria. Nagasaki, Japan, Nov. 17-
22, 1996.
26. Wali JP & Singh S. Tuberculosis as occupational Hazard in Health Care workers.
International Conference on Communicable Diseases as Occupational Hazard. Tel-Aviv,
February 18-21, 1996.
27. Singh S, Chang KP and Reed SG. Anti-Leishmanial antibodies in asymptomatic family
members of Kala-azar patients of Bihar. Second Global Meet on Parasitic Diseases,
Hyderabad, India, August 18-22, 1997
28. Singh S, Lakra MS. Giardia lamblia in school children, Annual Conference of ISG,
Chandigarh, October 1997
29. Singh S, Shalini, Modi G. Misdiagnosed case of Listeria monocytogenes infection in renal
transplant patient. 35th National Conference of IAMM, Manipal, Nov. 6-9, 1998.
30. Singh S, Mohapatra DP, Shivakumar R, Kumar J. Urine as growth supplement for
Leishmania donovani. 13th National Conference of Parasitology, Bangalore, February 24-
26, 1999
31. Mohapatra DP, Singh S. 13th National Conference of Parasitology, Bangalore, February
24-26, 1999
32. Sivakumar R, Singh S, Mohapatra DP, Saba Shahdad, Kumar J. 13th National Conference
of Parasitology, Bangalore, February 24-26, 1999.
33. Singh S. Free living amoebas in intermittently chlorinated drinking water of Delhi- India.
ISID Congress, Boston, USA, 1998.
69 of 81
34. Singh S, Kumar J, Singh R. Spread of HIV and hepatitis viruses through the use of
injection needles for Kala-azar therapy, in India. XII International AIDS Conference,
Geneva, Switzerland, June-July 1998.
35. Singh S, Prasad R, Mohanty A. HIV and Hepatitis -B viral infections in Jailmates of
Ghaziabad, North India. XII International AIDS Conference, Geneva, Switzerland, June-
July 1998.
36. Singh S, Kumari V, Kumar J, Singh N, Kumar L. Cytomegalovirus reactivation in bone
marrow transplant recipients: Indian experience. 10th International Symposium of
International Immunocompromised Host Society, Davos, Switzerland, June 1998.
37. Singh S, Singh N, Kumar J. Th1 and Th2 type responses in Kala-azar patients. 10th
International Conference of Immunology, New Delhi, November 1-6, 1998.
38. Singh S. Death due to Malaria: its forensic aspects. International Conference and
Workshop on recent advances in medical Toxicology and Legal Medicine. New Delhi,
November 2-7, 1998.
39. Singh S. Epidemiology and economic issues of HIV in the Third world. International CME
of American College of Physicians and American Association of Physicians from India,
Hyderabad August 12-14, 1999.
40. Singh S. ICMR-WHO symposium on Kala-azar. Gave a talk on “problems associated with
repeated injection treatment in kala-azar patients”. The symposium was held on December
18-19, 2000, at Hotel Imperial, New Delhi.
41. Singh S, Kumari Veena. HIV transmission kinetics in discordant Indian couples.
Proceedings of the XIII International Congress of AIDS. Durban, July, 2000 vol. 13,
[MoPe B2165].
42. Singh S. Hospital Infection Control: Practices and Guidelines. Proceedings of First
National Conference of Laboratory Medicine January 27-29, 2000 (Pl-3).
43. Shahdad S, Rattan A, Singh S. Species determination of Mycobacteria isolated from AIDS
patients in India by 16s rRNA sequencing. Proceedings of National Conference of
Laboratory Medicine January 27-29, 2000 (O-12).
44. Astha, Kumari Veena, Singh N, Sivakumar R, Garg S, Kumar N, Singh S. Congenital
CMV infection: Indian Scenario. Proceedings of First National Conference of Laboratory
Medicine, January 27-29, 2000 (O-19).
45. Shahdad S, Rattan A, Singh S. Molecular analysis of isoniazid resistant clinical isolates of
M. tuberculosis in India. Proceedings of First National Conference of Laboratory
Medicine January 27-29, 2000 (PP-12).
46. Kumari Veena, Kumar B, Mohapatra DP, Singh S. Easy and cost effective diagnosis of
Toxoplasmosis on Human serum samples using a modified direct agglutination test (DAT)
and its comparison with ELISA. Proceedings of First National Conference of Laboratory
Medicine, January 27-29, 2000 (PP-13).
47. Kidwai MK, Kumar B, Kumar R, Lakra MS, Sood S, Singh S. Spectrum of Intestinal
Parasitic infections in HIV positive patients presenting at AIIMS. Proceedings of First
National Conference of Laboratory Medicine January 27-29, 2000 (PP-14).
48. Singh S, Agarwal S, Kumari V, Kumar R, Astha, Kidwai MK, Sood S. Automation in
Microbiology at AIIMs, New Delhi. Proceedings of First National Conference of
Laboratory Medicine January 27-29, 2000 (PP-15).
70 of 81
49. Kumar B, Agarwal S, Astha, Sharma Omvati, Singh S. Laboratory Diagnosis of
extrapulmonary tuberculosis. Proceedings of First National Conference of Laboratory
Medicine January 27-29, 2000 (PP-16).
50. Singh S. Shalini Singhal, Niladri Mal, MS Lakra. Identification of conventional and
opportunistic intestinal parasites in HIV infected patients in a city based north Indian
referral hospital. Proceedings of ASCODD. New Delhi, October, 2001.
51. Singh S, Kumari Veena, Shalini Singhal, Niti Singh. An Indian herbal immunomodulator:
Highly effective in the treatment of HIV/AIDS. Proceedings of 6th International Conference
on AIDS in Asia Pacific, Melbourne, Australia. October, 2001. [WePo 1254].
52. Singh S. Prevention of spread of HIV and hepatitis viruses. Proceedings of 3rd International
Conference of AIDS India 2000, Chennai, December, 2001.
53. Singh S. Recent advances in the Laboratory Diagnosis of Leishmaniasis. International
Symposium on Leishmaniasis. New Delhi. February 23-24, 2002.
54. Singh S, S. Shahdad . High Rate of Drug Resistance in the Isolates of Mycobacterium
Tuberculosis from India: Determined by PCR-RFLP of Kat-G Gene. Abstract: 40.009.
Abstract Book of the 10th International Congress on Infectious Diseases, Singapore, March
7-11, 2002, page 101
55. Shahdad S, Singh S. Species Determination of Mycobacteria Isolated from AIDS Patients
in India by 16s rRNA Sequencing. Abstract: 40.019. Abstract Book of the 10th
International Congress on Infectious Diseases, Singapore, March 5-11, 2002, page 103.
56. Singh N, Singh S, Chanaveerappa B, Wali JP. Active Cytomegalovirus Infection in Indian
AIDS Patients Detected by Nested Polymerase Chain Reaction. Abstract: 75.105. Abstract
Book of the 10th International Congress on Infectious Diseases, Singapore, March 2002,
page 210.
57. Singh S, Niti Singh, R. Sivakumar. Diagnostic and prognostic value of Nested Polymerase
Chain Reaction in the post-transplant reactivation of CMV infection. XII International
Symposium of Immunocompromised Host Society (ICHS) at Bergen (Norway). June 22-
27, 2002.
58. Singh S, Kumari Veena, Shalini Singhal, Niti Singh. Prevalence of HIV infection in
Tuberculosis patients of Northern India. XIV World AIDS Conference, Barcelona (Spain)
July 7-12, 2002. Abstract #ThPeB7274.
59. Singh S, Singh N, Balooni Veena, Shalini Singhal. Psycho-social aspects of AIDS
Epidemic in India XIV World AIDS Conference, Barcelona (Spain) July 7-12, 2002.
Abstract # WePeC6242
60. Tripathi BM, Singh S, Pal H. HCV and HIV infection among intravenous drug users
attending a Drug Dependence Treatment Centre in India. Int Conf AIDS 2002 Jul 7-12; 14:
(abstract no. C10974)
61. Shahdad S, Katoch VM, Hasnain SE, Rattan A, Singh S. Species determination of
mycobacteria isolated from environmental samples in India by 16 S rRNA sequence.
LABCON-2, New Delhi. February 21-22, 2002.
62. Sivakumar R, Singh S. Cloning of kinesin gene related antigen gene from an Indian isolate
of Leishmania donovani. LABCON-2, New Delhi. February 21-22, 2002.
63. Kaur M, Kumar B, Kishore N, Sivakumar R, Singh S. Utility of automated mycobacterial
culture system (BACTEC-960) and PCR technique for mycobacterial disease diagnosis- a
preliminary study. LABCON-2, New Delhi. February 21-22, 2002.
71 of 81
64. Singh N, Singh S, Sivakumar R, Agarwal SK, Kumar Lalit, Tiwari SC, Dash SC.
Diagnostic and prognostic value of nested PCR in the reactivation of CMV infection in the
post organ transplant cases. LABCON-2, New Delhi. February 21-22, 2002.
65. Singh S, Sivakumar R, Kaur M , Singh B, Sharma P. Screening for SNPs (Single
nucleotide polymorphism in the tumour necrosis factor alpha promotor region. LABCON-
2, New Delhi. February 21-22, 2002.
66. Singh S, Kumari Veena, Agarwal S, Singh N. Efficacy of an Indian herbal
immunomodulator in the treatment of HIV/AIDS. LABCON-2, New Delhi. February 21-
22, 2002.
67. Singh S. Sir Dorabji Tata memorial Symposium on Diarrhoeal diseases. Bangalore, March
22-23, 2002.
68. Singh S, Kumar B, Kumar J, Astha, Singhal S. Biological Contamination of Delhi drinking
water. LABCON-2, New Delhi. February 21-22, 2002.
69. Singhal S, Kumar B, Lakra MS, Singh S. Prevalence of intestinal parasites in HIV-infected
patients seen at a tertiary care North Indian Hospital. LABCON-2, New Delhi. February
21-22, 2002.
70. Singh S, Balooni Veena, Singh Niti, Sivakumar Ramu. Predicting kala-azar in Leishmania
donovani infected asymptomatic patients. XXVI Annual Conference of IAMM. Bangalore.
November 21-24, 2002.
71. Singh S. Recent advances in diagnosing Toxoplasmosis in immunocompetant and
immunocompromised patients. 27th National Conference of IAMM, Mumbai , November
5- 9, 2003
72. Kaur M, Saluja TP, Singh B, Sharma P, Singh S. Comparative evaluation of of
Mycobacteriophage assay and automated MGIT-960 culture method with PCR using a
novel set of primers for diagnosing tuberculosis. . 27th National Conference of IAMM,
Mumbai , November 5- 9, 2003.
73. Singh S. Virology of HIV. 3rd International Conference on Integrated Medicine, organised
by Mediciti, Hyderabad and Indian Association of Physicians of America. January 4-5,
2003.
74. Singh S. Post-exposure prophylaxis in HIV/AIDS prevention. 4th International Conference
on AIDS India Chennai, November 9-12, 2003.
75. Singh S. High rate of Multi-drug resistant tuberculosis in India: a major challenge for
AIDS prevention measures. 8th International Conference on Emerging Infectious Diseases
in Pacific Rim”, Dhaka, December 11-12, 2003.
76. Singh S. Shahdad S, Rattan A, Katoch VM, Hasnain SE. Predominance of non-tubercular
Mycobacteria in Indian AIDS patients as speciated by molecular methods. ICMR-INSERM
workshop on Tuberculosis. Agra, December 12-14, 2003.
77. Manjot Kaur, Singh S. Detection and Identification of Mycobacteria by PCR Amplification
of 16-23S internal Transcribed Spacer Regions directly from clinical samples. International
Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkhand
University, Jhansi, India, January 13-15, 2004.
78. Sivalumar R, Singh S. Development of Recombinant antigen for the diagnosis of Kala-
Azar in India. International Conference on Recent Advances in Biomedical and
Therapeutic Sciences. Bundelkhand University, Jhansi, India, January 13-15, 2004.
72 of 81
79. Singh N, Singh S, Bisen PS, Chandra R. Evaluation of diagnostic and prognostic value of
nested-Polymerase Chain Reaction in the reactivation of Cytomegalovirus infection in
Renal Transplant Recipients . International Conference on Recent Advances in Biomedical
and Therapeutic Sciences. Bundelkhand University, Jhansi, India, January 13-15, 2004.
80. Kothari S, Sivakumar R, Singh N, Singh S. Genotype & Allele Frequency of a 32-Base
pair deletion mutation in the CCR5 gene among Indian Population. International
Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkhand
University, Jhansi, India, January 13-15, 2004.
81. Singh S. Kaur M. Emergence of multi-drug resistant Mycobacterium tuberculosis in India.
11th International Conference on Infectious Disease, Cancun, Mexico, March 4-8, 2004.
82. Shahdad S, Katoch VM, Hasnain SE, Rattan A, Singh S. Genomes 2004. The Institute of
Genome Research/ Welcome Trust Conference, Hinxton, Cambridge. 14 -17 April. 2004.
83. Singh S. Non-Tubercular Mycobacteria in Indian AIDS patients. Biomeriux Science
Foundation International Conference on Tuberculosis. Annecy, France. July 1-4, 2004.
84. Singh S. Update on HIV in India.. 10th Annual International Continuing Medical Education
Program HIV Update at MediCiti Hyderabad, India. August 7-8, 2004.
85. Singh S, Balooni V, Singhal S, Singh N. Socio-behavioral aspects o AIDS care in India.
The XV International AIDS Conference, Bangkok, Thailand, 2004. Abstract #.
MoPeD3736.
86. Singh S. Non-tubercular Mycobacteria in Indian AIDS patients. International Symposium
on Emerging Trends in Tuberculosis. ICGEB, New Delhi, November 15-17, 2004.
87. Singh S. Social and behavioural aspects of HIV/ AIDS care in India. First Asia /Pacific
Conference on Women, Girls & HIV /AIDS Best Practices, Islamabad, Pakistan.
November 31-December 1, 2004.
88. Singh S, & Manjot Kaur. High rate of Multidrug Resistant M. tuberculosis in India. 9th
International Conference on Emerging Infectious Diseases, Kyoto, Japan, December 7-10,
2004.
89. Mittal CM, Wig N, Anupama P, Mishra S, Singh S. Tumour necrosis factor-alpha and
cardiac function in HIV patients. Int Conf AIDS 2004, Bangkok, Thailand, Jul 11-16;
15 :(abstract no. A10315).
90. Singh S. Non-tubercular Mycobacteria in AIDS: Mid-term national update on Infectious
diseases and clinical Microbiology at Sri Nagar; October 1-3, 2004.
91. Singh S. Recent Advances in the Diagnosis of Leishmaniasis. 28th National Conference of
IAMM, Lucknow, November 25- 28, 2004.
92. Singh S. Diagnosis of acute Toxoplasmosis by avidity test. 29th National Conference of
Indian Association of Medical Microbiologists, Chennai, October 21- 23, 2005.
93. Singh S. Food Borne Toxoplasmosis. 17th National Congress of Parasitology. Held at
Dibrugarh, Assam, October 24-26, 2005.
94. Kaur M, Singh S. Rapid Diagnosis of pulmonary and extra-pulmonary tuberculosis by
PCR Amplification of 16-23S ITS Regions directly from clinical samples. International
Conference on Functional Genomics for Vaccine & Novel Drug Design against
Mycobacteria, IIT Kharagpur (WB) February 10-14, 2005.
95. Singh S. Molecular Epidemiology of Non-Tubercular Mycobacterial in Indian AIDS
patients. International Conference on Functional Genomics for Vaccine & Novel Drug
Design against Mycobacteria. IIT Kharagpur (WB), February 10-14, 2005.
73 of 81
96. Sivakumar R, Balooni V, Sharma P, Chang KP, Singh S. Diagnosis of visceral and post-
kala-azar dermal leishmaniasis using a novel recombinant antigen prepared from an Indian
isolate of Leishmania donovani. Intracellular Pathogens, During the Asian Regional
Workshop on Emerging Infectious Diseases, Seattle Biomedical Research centre, USA and
JNU, India, New Delhi, March 8-10, 2005.
97. Sivakumar R, Balooni B, Sharma P, Chang KP, Singh S. Serodiagnosis of VL And PKDL
Using A Novel Recombinant Antigen From A Recent Indian Isolate Of Leishmania
Donovani. Third World Congress on Leishmaniasis-WorldLeish3. Sicily, Italy, April 10-
15, 2005.
98. Kaur M, Shahdad S, Sharma P, Singh S. Molecular Epidemiology of Non-Tubercular
Mycobacterial in Indian AIDS patients. 3rd International AIDS Society Conference on HIV
pathogenesis and treatment. Abstract # TuPe7.2C01. Rio-de-Janeiro, Brazil. July 24-27,
2005.
99. Singh S. Intestinal Opportunistic Pathogens in Indian AIDS patients seen at a tertiary
medical institute in North India. Indo-US workshop on Diarrhoeal diseases held at NICED,
Kolkata from October 3-5, 2005.
100. Singh S. Epidemiology of Non-Tubercular Mycobacterial infections in AIDS patients.
Fifth International Conference on AIDS in India. Chennai. October 21-24, 2005.
101. Sharma U, Dey A, Singh S. “First case report of indigenous visceral leishmaniasis from
Central India” in International conference on opportunistic pathogens in AIDS held at All
India Institute of Medical Sciences, New Delhi, India from 27th-29th March 2006.
102. Sharma U, Dey A, Singh S. “Leishmania-HIV co-infection: An emerging problem in
India” National Conference on Immunology in health and disease 2006 held at Chhatrapati
Shahu Ji Maharaj University, Kanpur, India from 11th -12th January 2006.
103. Kumar Sandeep, Singh Niti, Katharya, Dhankhar Pawan, Singh Sarman. “A preliminary
Report of Household Contact Investigation for Tuberculosis.” International Symposium on
New Frontiers in Tuberculosis Research, Dec 2006, ICGEB, New Delhi.
104. Singh S. AIDS associated toxoplasmosis. International Conference on Opportunistic
Pathogens in AIDS, March 27-29, 2006. New Delhi.
105. Redhu NS., Dey A, Balooni V and Singh S. HIV-Leishmania Co-infection: A
Retrospective Study from India. International Conference on Opportunistic Pathogens in
AIDS, March 27-29, 2006., New Delhi.
106. Gupta S, and Singh S. Seroprevalence of Hepatitis B and HIV Infections. Among
Pregnant Women Attending Antenatal Clinics at a Tertiary Care Hospital in India.
International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New
Delhi.
107. Gupta R, Gupta S, Mathur P, Aggarwal S, Singh S. Seroprevalence Of Toxoplasma
In HIV Positive Vs. HIV Negative Patients In North India. International Conference on
Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
108. Narang S, Mathur P, Singh S. Intestinal parasite Profile in the Stool sample of HIV
Positive patients. International Conference on Opportunistic Pathogens in AIDS, March 27-
29, 2006., New Delhi.
109. Aruna, Matthew J Magee, Singh S. Drug resistant Tuberculosis in Delhi: A
prevalence. International Conference on Opportunistic Pathogens in AIDS, March 27-29,
2006., New Delhi.
74 of 81
110. Gupta S, Mathur P, Gupta R, Balooni V, Singh S. Hepatitis B Virus and Hepatitis C Virus
Co-infections in HIV Positive Patients in India. International Conference on Opportunistic
Pathogens in AIDS, March 27-29, 2006, New Delhi.
111. Mishra J and Singh S. Prevalence of Herpes simplex IgG (1 & 2) and IgM antibodies
among women of reproductive age group at a Tertiary Care Hospital of Northern India.
International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New
Delhi.
112. Kumar S, Shankar M, Singh S. Tetrazolium Micro plate Assay as a Rapid and Inexpensive
Colorimetric Method for Anti-tubercular Drug Susceptibility testing. International
Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
113. Singh S, Shahdad S, Sharma P. Non-Tubercular Mycobacterial infections in Indian AIDS
patients diagnosed by genus and species specific 16S rRNA and Novel ESAT-6
Polymerase Chain Reaction primers. XVI International AIDS Conference held at Toronto,
Canada, August 13-18, 2006.
114. Singh S. Singh N. Serum cholesterol levels as surrogate marker for HIV diseases
progression: May replace repeated CD4+ cell counts in resource limited countries. XVI
International AIDS Conference held at Toronto, Canada, August 13-18, 2006
115. Singh S. Recent advances in the diagnosis of Leishmaniasis. National Conference on
“Immunology in Health & Diseases” Institute of Life Sciences, Chhatrapati Shahuji Mahraj
University, Kanpur, January 11-12, 2006,
116. Singh S. TORCH investigations and their interpretation. National conference of ISPAT.
February 18, 2006, New Delhi.
117. Singh S. Microarrays in the diagnosis of Parasitic Diseases. Pre-conference CME. XXX
National Conference of Medical Microbiologists” at Nagpur, October 26- 27, 2006.
118. Singh S. Recent advances in the Diagnosis of Leishmaniasis. 18th National Congress of
Parasitology” at Kolkata, November 22-24, 2006.
119. Singh S. Delivered a lecture on “Methods HIV Testing” during the First Hands-on
technicians, National Institute of Biologicals, NOIDA, January 16, 2007.
120. Singh S. Delivered a lecture on “Methods HIV Testing” during the Second Hands-on
121. Singh S. Delivered a lecture on “Methods HIV Testing” during the Third Hands-on
122. Singh S. Provided hands on-training and Delivered a lecture on Recent Advances in the
Diagnosis of Leishmaniasis during the Andhra Pradesh Chapter of IAMM, Hyderabad,
February 9, 2007.
123. Singh S. Delivered a lecture on Quality Assurance in Molecular Diagnostics.
Microbiology Update. Maulana Azad Medical College, Delhi. March 9, 2007.
124. Singh S. Lecture on Molecular Epidemiology of Mycobacterium Paratuberculosis.
National Seminar & Workshop on Johne’s Disease. Indian Veterinary Research Institute,
Izatnagar. August 8, 2007.
125. Singh S. Delivered guest lecture on indigenous developments in the Leishmania
diagnostics. National Conference of Indian Academy of Tropical Parasitology (Tropacon),
Chennai, October 6-7, 2007.
75 of 81
126. Gupta S., Singh S. Horizontal spread of HBV among contacts of HBV-CLD patients.
Indian Journal of Gastroenterology March, 2008 vol 27 (supplement 1) S17.
127. Magee M, Manning G, Gopinath K, Singh S. MDR- M. tuberculosis in High-Risk Groups
of Delhi: Preliminary Results from an On-going Cross-Sectional Study. PS-61292-02. 37th
Union World Conference on Lung Health, Paris – France, 31 October - 4 November 2006.
128. Singh S, Gopinath K, Mani Sankar M, Kumar S. Emergence of XDR-tuberculosis in India.
International Conference of Infectious Diseases, Vienna, Austria. February 22-25, 2007:
abstract No. 13.029.
129. Mishra J, Carpenter S, Singh S. Low serum zinc levels in Bihar: Associated with kala-azar
endemicity. 34th Indian Immunology Society conference, Pune from 16th -18th December,
2007
130. Dey A, Redhu NS, Singh S. Kinesin Motor Domain of Leishmania Donovani as future
vaccine candidate. Vaccine Conference, Amsterdam, December 13-15, 2007.
131. Sharma U, Singh S. Leishmanicidal activity and therapeutic potential of some medicinal
plants. IX International Symposium on Vectors and Vector Borne Diseases Puri, Orissa
(India), 15-17 February 2008.
132. Singh A, Gopinath K., Sharma P., Singh N., Bisht D., Katoch V.M., Singh S. Proteomic
analysis of M. tuberculosis strains sequentially acquired resistance to Isoniazid and
Rifampicin. Ninth Dorabji Tata Symposium on Antimicrobial resistance, Indian Institute
of Science Campus, Bangalore on 10-11th March, 2008
133. Gopinath K., Kumar S., Singh S. Prevalence of Mycobacteremia in Indian HIV infected
patients detected by MB/BacT automated culture system. International conference on
Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29,
2008.
134. Gupta S., Balooni V., Singh S. Occult HBV infection in HIV patients: a preliminary study
at a tertiary care hospital. International conference on Opportunistic Pathogens in AIDS
2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
135. Sankar M., Gopinath K., Singh S., Evaluating tetrazolium Microplate Assay for drug
susceptibility testing in Non-tuberculous mycobacterial isolates. International conference
on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-
29, 2008.
136. Kumar M., Sankar M., Malik A, Singh S., Conventional and molecular techniques in
detection of Mycobacterium tuberculosis Complex in Human Immunodeficiency Virus
Infected Patients. International conference on Opportunistic Pathogens in AIDS 2008
(ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
137. Gupta S., Mathur P., Maskey D., Wig N., Singh S. Immune Restoration Syndrome with
disseminated penicillium marneffei and CMV: 1st report from a non-endemic area.
International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008),
New Delhi, January 27-29, 2008.
138. Gopinath K., Singh A., Singh S. Comparative genomic analysis of ATP Binding Cassettes
transporters of M. tuberculosis and M. avium paratuberculosis. International Conference
on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-
29, 2008.
139. Sharma U, Velpandian T, Sharma P, Singh S. “Development of novel anti-leishmanial
herbal compounds and their molecular mechanism of action against Leishmania donovani”
in Theoretical and practical course ‘Molecular biology of Leishmania’ held at International
76 of 81
Center for Genetic Engineering and Biotechnology, Trieste, Italy from 23th -25th October
2008.
140. Sharma U, Singh S. “Leishmanicidal activity and therapeutic potential of some medicinal
plants” in IX International Symposium on Vectors and Vector Borne Diseases held at Puri,
India from 15th -17th February 2008.
141. Carmen C, Flores M, Pradas MA, Gonzalez R, Neito J, Singh S. Use of Signal –KA kit for
the Diagnosis of Visceral Leishmaniasis. Abstract No. 565. 4th World Congress on
Leishmaniasis (Worlleish 4), Lucknow, February 3-7, 2009.
142. Arshi Munawwar, Swati Gupta, Veena Ballooni, Singh S. : Incidence And Prevalence Of
Human Herpes Viruses In HIV Positive Patients In India. ASICON-2009. Jaipur (India)
143. Sharma U, Velpandian T, Sharma P, Singh S. “Demonstration of In vitro antileishmanial
activity of active extracts from Indian plants” in WorldLeish 4 held at Central Drug
Research Institute, Lucknow, India from 3rd -7th February 2009.
144. Sharma U, Dharmendra Singh, M. P. Dobhal, Singh S. “In vitro anti-leishmanial activity of
plumericin, Isolated from Plumeria bicolor” in X International Symposium on Vectors and
Vector Borne Diseases held at Goa, India from 4th -6th November 2010.
145. Singh S. Invited Lecture as visiting Professor: Opportunistic Infections in AIDS Patients:
Indian Scenario. NIH, Bethesda, USA, March 5, 2010.
146. Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected Indian patients.
Abstract # 53.0065, 14th International Conference of Infectious Diseases, Miami, Florida,
USA, March 8-12, 2010
147. Lisco A, Munawwar A, Saba E, Grivel J C, Vanpouille C, Singh S, Margolis L.. HIV-1
viral shedding in semen and early events of HIV-1 infection of human cervico-vaginal
tissue in an optimized ex vivo model. World AIDS Conference, Vienna, July 18-23, 2010.
148. Kumar M, Oliver B, Kumar A, Agarwal U, Price P , Singh S. Levels of IL-18, sCD14 &
CCL2, CXCL8 and CXCL10 in tubercular Immune Restoration Disease in a North India
Population. World AIDS Conference, Vienna, July 18-23, 2010.
149. Munawwar A, Lisco A, Sharma SK, Gupta S, Vanpouille C, Parashar D, Vats O, Grivel JC,
Margolis L, Singh S. CMV Shedding is significantly higher in semen than blood plasma in
Indian HIV infected population. Australasian HIV/AIDS Conference (ASHM) 2010,
Sydney, October 20-22, 2010.
150. Kumar M, Oliver B, Agarwal U, Kumar A, Singh S, Price P . Plasma Levels of IL-18,
sCD14 & CCL2, CXCL8 and CXCL10 in tubercular Immune Restoration Disease in a
North India Population. Australasian HIV/AIDS Conference (ASHM) 2010, Sydney,
October 20-22, 2010.
151. Munawwar Arshi, Gupta S, Lisco A, Vanpouille C, Sharma SK, Grivel JC, Margolis L,
Singh S. Epstein Barr Virus" A Yet To Be Recognised Virus For Its Role In AIDS : Indian
Scenario. ICOPA-2010, New Delhi: September 28-30, 2010.
152. Munawwar Arshi, Andrea Introini, Christophe Vanpouille, Jean-Charles Grivel, Singh S
and Leonid Margolis: The Complex Interplay Of Cytokines/Chemokines And Reactivated
Herpesviruses In Semen of HIV-1-Infected Individuals. CROI-2011, Boston (USA). Feb
27-March 2, 2011
153. Introini A, Lisco A, Munawwar A., Vanpouille C., Grivel J.-C., Singh S, Margolis L..
HIV-1 and reactivated coinfecting herpesviruses rearrange the cytokine network in semen
of infected individuals. 6th IAS Conference on HIV Pathogenesis, Treatment and
Prevention. Rome, Italy 17-20 July, 2011
77 of 81
154. Munawwar A, A Lisco, Vanpouille C , Grivel J C , Sharma S K , Margolis L , Singh S.
Mycobacterium Tuberculosis Shedding in Semen increases heterosexual transmission rate
of HIV-AIDS impact, 10th International Conference, 12-15.9. 2011 Santa Fe, New Mexico
USA.
155. Tomar AK, Saraswat M, Sooch BS, Singh S, Singh TP, Yadav S. A New Sequence of
positively charged Residues BXXXB Can also Characterize Heparin Binding Site 91.
International Conference on Frontiers in Reproductive Biotechnology & 21st Annual
Meeting of ISSRF, NDRI, Karnal, India, February 9-11, 2011.
156. Singh S. Host and Parasite factors leading to Drug resistance in Leishmaniasis. Anti-
parasitic and anti-cancer drugs. Porto, Portugal, 6-14 September 2011.
157. Singh S, Mishra J. Mechanisms of Miltefosine resistance in Leishmania donovani. Anti-
parasitic and anti-cancer drugs. Porto, Portugal, 6-14 September 2011.
158. Singh S, et al. Paper presented on Mycobacterial culture yields from gastric aspirates collected with
and without sodium bi- carbonate during the 42nd Union World Conference on Lung Health,
Lille, France, 26-30 October 2011.
159. Singh S. Guest Lecture on “Quality control” during the XXXV National Conference of
Indian Association of Medical Microbiologists, Varanasi, November 23-26, 2011.
160. Jayakumar R, Joshi YK, Singh S. Comparing three oral regimens for the treatment of
Chronic Hepatitis B Infection: Tenofovir, Entecavir and combination of Lamivudine and
Adefovir. Indian J Gastroenterol, 2011; 30 (suppl-1): 1-105.
161. Singh S. Plenary Lecture on “Past, Present and future of Research in Medical Faculties” during
the Annual conference of Association of Medical Biochemists of India (AMBICON2011) ,
Government Medical College, Tiruchirapalli, Tamilnadu from December 16-18, 2011
162. Singh S. Guest lecture on “Point of care tests for kala-azar: during the Annual conference
of Association of Medical Biochemists of India (AMBICON2011), Government Medical
College, Tiruchirapalli, Tamilnadu from December 16-18, 2011
163. Singh S, Kumar S, Singh J, Balooni V, Singh S, Mani K. usefulness of Serology in the
diagnosis of pulmonary Tuberculosis. Presented in the 112th Annual ASM meeting at San
Francisco, USA, June 16-19, 2012.
164. Singh S, Gupta A, Sharma P, Singh S. Development of strip based assay for the diagnosis
of tuberculosis directly from patient serum. XXXVI National Conference of Indian
Association of Medical Microbiologists (MICROCON-2012), New Delhi 25th Nov-27th
Nov, 2012. TP-34: 285.
165. Singh J, Sankar MM, Kadian S, Prajapati S, Singh S. Identification of predominant
genotype of MTB among tuberculosis patients from different geographical locations of
India. XXXIV Indian Association of Medical Microbiologists (MICROCON- 2012), New
Delhi. 25th Nov- 27th Nov 2012, TO-11:111
166. Kumar P, Balooni V, Sharma B, Kapil V, Singh S. Usefulness of line probe assay for rapid
diagnosis of MDR-TB. XXXVI National Conference of Indian Association of Medical
Microbiologist (MICROCON-2012), New Delhi, 25th-27th Nov 2012.TO-10:110.
167. Singh A, K Gopinath, P. Sharma, D. Bisht, N. Singh, Singh S. “Proteomics analysis of
sequential isolates of M. tuberculosis from a patient of drug resistant pulmonary tuberculosis”
FEMS2013, at Leizig, Germany, July 21st -25th 2013
168. Singh J, Kadian S, Singh N, Singh S. “Genotyping of M. tuberculosis isolates by
spoligotyping from South Delhi area, Delhi” FEMS2013, at Leizig, Germany, July 21st -25th
2013
78 of 81
169. Singh S. “Toxoplasmosis”. Proceedings of the 7th Annual Conference of Indian Academy
of Tropical Parasitology from 6-8 September 2013 at SGPGI, Lucknow
170. Singh J, Singh N, Aggarwal U, Behera D, Singh S. “Genotypes and drug susceptibility
pattern of Mycobacterium tuberculosis isolates in HIV Seropositive patients” 68th
NATCON, NITRD, New Delhi, Feb 24th -26th 2014.
171. Kumar P, Sharma S, Singh S, “Usefullness of non-commercial rapid DST methods for the
detection of MDR-TB in resource limited settings”. 68TH NATCON, NITRD, New Delhi,
from 23rd- 24th Feb 2014.
172. Singh N, Singh J, Aggarwal U, Behera D, Singh S. “Differences in the population genetics
of Mycobacterium tuberculosis between HIV seropositive and HIV seronegative patients.”
68th NATCON, NITRD, New Delhi, 24th -26th Feb 2014.
173. Shankar P, Kumar M, Mishra J, Singh S. “Expression of cytokines in Balb/c mice
immunized with Chimera DNA vaccine against Tuberculosis and Leishmania co-
infection”. MBC on Leishmaniasis-2014, at Trieste, Italy, October 22nd-24th 2014.
174. Rufai SB, Singh A, Kumar P, Singh J, Singh S. "Performance of Xpert MTB/RIF for
detection of Mycobacterium tuberculosis on pleural fluid samples from high burden
setting", IAMM, Delhi chapter, at VMCC & SJH, New Delhi on 25th April 2015.
175. Kumar P, Rufai SB, Singh J, Singh S, “Loop Mediated Isothermal Amplification Assay for
rapid detection of MTB, M. avium and NTM from clinical samples,” IAMM, Delhi chapter,
at VMCC & SJH, New Delhi on 25th April 2015.
176. Singh J, Sankar MM, Kumar P, Singh S. “A first appraisal of genetic diversity and drug
susceptibility profile of Mycobacterium tuberculosis isolated from different geographical
regions of India.” IAMM, Delhi Chapter, VMMC & SJH, New Delhi, 25th April 2015.
177. Singh A, Gupta AK, Gopinath K, Sharma P, Singh S “Preparation of Novel Recombinant Antigens
for the Rapid Diagnosis of Drug Resistant Tuberculosis” accepted in ICAAC/ICC 2015 (ASM).
San Diego, California, USA. September 17-21, 2015.
178. Singh A, Gupta AK, Singh S, “Identification of novel biomarkers for rapid diagnosis of multidrug
resistant tuberculosis”. Global Healthcare Summit 2016 (GHS 2016) research paper competition by
AIIMS-AAPI, at AIIMS, New Delhi, India. December 29, 2015.
179. Singh A, Gupta AK, Gopinath K, Sharma P, Singh S “Preparation of Novel Recombinant Antigens
for the Rapid Diagnosis of Drug Resistant Tuberculosis” accepted in ICAAC/ICC 2015 (ASM).
San Diego, California, USA. September 17-21, 2015.
180. Goel V, Balooni V, Kumar D, Singhal S, Ahmed S, Singh S. “Prevalence of HIV in a tertiary care
hospital in Delhi: A five year hospital based study” AHPCON, AIIMS, New Delhi.; February 2016.
181. Vats O, Goel V, Kumar D, Singh S “Effects of cigarette consumption, tobacco chewing and alcohol
intake on human seminal quality” AHPCON, AIIMS, New Delhi.; February 2016.
182. Singh J, Sankar MM, Kumar P, Couvin D, Rastogi N, Singh S. and Indian TB Diagnostics
Network. “Molecular characterization of Mycobacterium tuberculosis strains isolated in India.”
ICID, Hyderabad, March 2nd - 5th, 2016.
183. Singh S, Gupta AK, Srivastava S, Singh A, Shankar P. “Superinfection with an endosymbiotic
bacterium Parvibaculum lavamentivorans leads to manifest Leishmania donovani as Post kala azar
dermal leishmaniasis.” 26th ECCMID, at Amsterdam, Netherland, April 9th - 12th 2016.
184. Singh A, Gupta AK, Gopinath K, Singh S. “Identification of novel point-of-care biomarkers:
validation and evaluation for the rapid detection of TB and MDR-TB”. Microbe 2016 at Boston,
USA. 16-21 June, 2016.
185. Singh A, Gupta AK, Singh S, “Identification of novel biomarkers for rapid diagnosis of multidrug
resistant tuberculosis”. Global Healthcare Summit, research paper competition by AIIMS-AAPI, at
AIIMS, New Delhi, India. December 29, 2015.
79 of 81
186. Sankar M, Singh J, Munawwar A, Kabra SK, Sood R, Praneeth M, Singh S. Genotypes
of Mycobacterium tuberculosis isolated from blood of active tuberculosis patients. Int J Infect Dis
2016; 45 (Suppl 1): p-409. DOI:http://dx.doi.org/10.1016/j.ijid.2016.02.873
187. Singh S, Gupta AK, Srivastava S, Singh A, Shankar P. “Superinfection with an endosymbiotic
bacterium Parvibaculum lavamentivorans leads to manifest Leishmania donovani as Post kala azar
dermal leishmaniasis.” 26th ECCMID, at Amsterdam, Netherland, April 9th - 12th 2016.
188. Singh A, Gupta AK, Gopinath K, Singh S. “Identification of novel point-of-care biomarkers:
validation and evaluation for the rapid detection of TB and MDR-TB”. Microbe 2016 at Boston,
USA. 16-21 June, 2016.
189. Singh S. Haemoparasites: Toxoplasmosis. X National Conference of Indian Academcy of
Parasitology. Pondicherry, India, November 4-6, 2016.
190. Singh S. Advances in diagnosis of zoonotic parasitic diseases, 40th National Conference of the
Indian Association of Medical Microbiologists at Chandigarh during 23rd -27th November 2016
191. Singh S. MEET THE EXPERT: Control of vector borne parasitic. 40th National Conference of the
Indian Association of Medical Microbiologists at Chandigarh during 23rd -27th November 2016
192. Singh S. Acute Hepatitis A and hepatitis E viral infections in Urban India: a hospital based study.
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL). Shanghai,
China, February 15-19, 2017.
193. Singh A, Gupta AK, Gopinath K, Sharma D, Sharma P, Bisht D, Sharma P, Singh S, “Comparative
proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant
Beijing type from a patient with pulmonary tuberculosis”. 2nd Asian African Congress of
Mycobacteriology (AASM 2017), at Isfahan, Iran, 25-28 February 2017.
194. Gupta A, Srivastava S, Singh A, Singh S. “Development of rapid immuno-diagnostic test for the
early detection of tuberculosis.” 2nd AASM, at Iran, February 25th - 28th 2017.
195. Rufai SB, Sankar MM, Singh J, Singh S. Predominance of Beijing lineage among pre-extensively
drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care
center experience. 2nd AACM, at Iran, February 25th - 28th 2017.
196. Gupta AK, Singh A, Sharma P, Singh S. Discovering Novel Antigens for the Rapid Diagnosis and
Prognosis of Tuberculosis. ASM Conference on Innovative Microbial Ecology for Mitigation of
Antibiotic Resistance and Bacterial Diseases, Arlington,USA, March 22-25, 2017.
197. Singh J, Rufai B S, Kumar P, Rawat S V, Ahmad H, Ajith J, Singh S.“Comparison of Abbott Real-
Time MTB RIF/INH resistance assay with standard phenotypic and other molecular methods: a
pilot study.” ECCMID, Vienna, Austria, April 22nd -25th 2017.
198. Srivastava S, Mishra J, Gupta AK, Singh A, Mishra PS, Singh S. “Emergence of Miltefosine
Resistant Cases of Visceral Leishmaniasis in India” 6th World Leish, Toledo, Spain, May 16th - 20th
2017.
199. Gupta AK, Srivastava S, Singh A, Singh S. “Post kala-azar dermal leishmaniasis: is it a result of
endosymbiotic infection of Leishmania with Parvibaculum lavamentivorans” 6th World Leish,
Toledo, Spain, May 16th - 20th 2017.
200. Shankar P, Singh S. “Goat (Capra hircus) as a potential animal reservoir for kala-azar in India.”
6th World Leish, Toledo, Spain, May 16th - 20th 2017.
201. Singh S. HIV/AIDS and leishmaniasis in India: Factors that contained the Epidemic of Co-
infection. 6th World Leish, Toledo, Spain, May 16th - 20th 2017.
80 of 81
PUBLICATION FOR GENERAL PUBLIC/ MASS COMMUNICATION
i) Radio Talks (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 23rd March 2015,
ii) TV interview on Tuberculosis. Rajya Sabha TV. New Delhi, Telecast on 24th March 2015,
iii) Radio Talks (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 24th March 2014,
iv) TV interview on Tuberculosis. News Nations TV. New Delhi, Telecast on 24th March 2014,
v) Radio Talks (Live) on Tuberculosis. All India Radio FM Gold. New Delhi, 23rd March 2013.
vi) Articles and interviews on Drug Resistance in Tuberculosis published in top ranking daily
news papers such as The Independent, The Times of India, The Hindu, Hindustan Times, Gulf
News etc. 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015
vii) Several articles and interviews on Banning the Serology for TB diagnosis published in top
ranking daily news papers such as The TIMES, The Times of India, The Hindu, Indian
Express, Hindustan Times, Gulf News etc. 2010-11
viii) Written several articles on Toxoplasmosis and its zoonotic importance in Daily news papers
and magazines both in Hindi and English including PTI and Univarta.
ix) An Interview of International importance on “Risks of hospital acquired infections AIDS &
HBV infection” published in New Scientists (England) August 3, 1991, p10.
x) Written several educational articles for Hindi and English news papers on Kala-azar for general
public.
xi) Presently scientist on panel for “Univarta”: articles of public interest published on
Toxoplasmosis, Genetic & Congenital infectious disease and on PCR based diagnoses.
xii) Publications of mass awareness about water contamination in Delhi, through PTI, Times of
India, HT , Tribune, etc.
xiii) Published several pamphlets and handbooks/handouts in Hindi language for public awareness
various diseases and their diagnosis.
xiv) Participated in a “Documentary film on Universal Precautions” directed by Dr. Ashok Rattan
and Produced by AIIMS, New Delhi, 1993.
xv) Participated as subject expert in a “Documentary film on AIDS: its social impact” produced by
Mass Communication Centre, Jamia Millia University, Delhi, 1992.
xvi) Mass awareness articles in Nav Bharat Times, Hindustan, Tribune (Hindi) and TOI, Hindustan
(English) on Toxoplasmosis, 1998, 1999, 2000.
81 of 81

Biodata March 19

Uploaded by

Copyright:

Available Formats

Biodata March 19

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Biodata March 19

Uploaded by

Copyright:

Available Formats

Prof.

• Personal and educational details 1-2

• Major Research Areas and Fellowships awarded 3

• Awards and Honours 4-7

• External Examiner for Universities/Institutions 7

• Referee for Scientific Journals and Research Grant Proposals 11-12

• Member of Medical and Scientific Societies, Editorial Boards 13

• Conferences / Workshops/ meetings attended/ papers presented 13-28

• Postgraduate Students Guided 28-34

• Short-term/hands-on trainings provided 34-35

• Scientific Conferences, Meeting and Medical Camps Organised 35-37

• Research Projects Directed 38-42

• Gene Sequences and Whole genome Sequences submitted to NCBI 43

• Mass Awareness Publications/ films 81

Name: Prof. Sarman Singh

Date of Birth: November 9, 1956

Position & Affiliation: Director & CEO,

Postal Address: Director’s Bungalow , AIIMS Campus,

Phone: (Office) (+91) 0755- 2672317

Qualifications: University Degree with date:

B.Sc. Agra University 1976

M.B.B.S. KGMC, Lucknow 1982

M.D. (Medical Microbiology) PGIMER, Chandigarh 1987

Internship, Aligarh, UP 1-12-82 30-11-83

Junior Resident (Ortho) RML Hospital, New Delhi 01-01-84 31-12-84

Junior Resident (Clinical Microbiology), PGIMER, Chandigarh 01-01-85 31-12-87

Senior Resident (Clinical Microbiology), AIIMS, New Delhi 12-1-88 31-08-90

Assist. Professor (Clinical Microbiology) AIIMS, New Delhi 31-8-90 30-06-95

Overseas Research Associate (DBT), Chicago, USA 01-01-94 01-01-95

Assoc. Professor (Clinical Microbiology) AIIMS, New Delhi 01-07-95 30-06-99

National Consultant (HIC) WHO/NACO, New Delhi, India 16-07-99 15-02-00

Additional Professor (Clinical Microbiology) AIIMS, New Delhi 01-07-99 30-06-07

Director & CEO, AIIMS, Bhopal 04-06-18 Continue

MAJOR RESEACRH AREAS

• Diagnostic Device Development

1. Fellow Association for Advanced Veterinary Research, 2017

8. Received AIIMS Research Excellence Award for published work on Tuberculosis,

1. Elected President of Indian Association of Medical Microbiologists (Delhi Chapter), for

EXTERNAL MD/PhD/DSc. EXAMINER FOR VARIOUS UNIVERSITIES

1 Dr. BR Ambedkar University, Agra

1. Chairman, Research Advisory Committee of Chettinad Academy of Research and

Journals (only selected)

REFEREE FOR RESEARCH GRANTS:

MEMBER OF EDITORIAL BOARDS OF PEER REVIEWED SCIENTIFIC JOURNALS

MEMBERSHIP OF MEDICAL & SCIENTIFIC SOCIETIES

1. International AIDS Society (Switzerland)

CONFERENCES/SEMINARS/WORKSHOPS: PAPERS PRESENTED/ATTENDED

1. Attended Computers: A management Tool: CMC limited 16-17, December 1985.

For Degree of Ph.D.

2. Dr. Shreepriya Joshi:

3. Dr. Nishita Mohan Philip:

MSc. /M. Tech Students (only Recent)

Short Term Trainings Imparted:

1. Conducted a three Months Certificate Course on Molecular Methods in Infectious Disease

ORGANISATION OF SCIENTIFIC CONFERENCES/ MEETINGS

1. Member- National Congress of Medical Microbiologists, at All India Institute of

Organization of Medical and-Social Awareness Camps

Title Funding agency Period

21. Detection of Hepatitis A, E, Salmonella , E. histolytica and DBT, India 2007-2010